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Microbial infections contribute significantly to morbidity and mortality in humans. Fungi 
are often an under-represented component of the microbial communities that colonise 
mucosal surfaces. The most common human fungal pathogens are the Candida species, 
of which Candida albicans is the most prevalent. C. albicans has an asymptomatic 
carriage rate of approximately 60% in the human population, where it resides as a 
member of the microflora that colonises the mucosal surfaces of the body.  
C. albicans is a polymorphic fungus capable of growing in a number of distinct 
morphological forms. At mucosal surfaces, growth of C. albicans in the unicellular yeast 
form is typically associated with commensalism, whereas the production of filamentous 
hyphae is associated with fungal overgrowth and pathogenesis. In healthy individuals, 
the immune system functions to restrict the growth of C. albicans hyphae, preventing 
infection. However, in the absence of effective immune surveillance, C. albicans hyphae 
can invade the mucosal surfaces of the body, causing infection and tissue damage. 
Translocation of C. albicans across mucosal barriers and invasion of underlying tissues is 
a major risk-factor for the development of life-threatening systemic infection in 
immune-compromised individuals. 
The hyphae of C. albicans secrete Candidalysin, a toxin essential for epithelial damage 
and activation of mucosal immune responses. Cellular damage sustained during 
infection can often result in cell death by apoptosis, necrosis, necroptosis or pyroptosis. 
While cell death is often regarded as being beneficial for microbial pathogenesis, it is 
becoming increasingly clear that cell death can also influence host defence by initiating 
specific immune responses that contribute to microbial clearance.  
Collectively, these data demonstrate that oral epithelial cells respond to the secreted 
fungal toxin Candidalysin by triggering numerous cellular stress responses that are 
intimately linked with the induction of cellular death. Candidalysin was observed to 
induce necrosis, but not apoptosis, necroptosis or pyroptosis, and promoted 
inflammatory responses through a mechanism involving necrosis-dependent release of 
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Chapter 1: Introduction 
1.1 Host-Pathogen interaction 
Infectious diseases are a leading cause of morbidity and mortality worldwide and are a 
major challenge for the biomedical sciences. Recent research has improved our 
understanding of the complex and dynamic interplay that occurs between pathogens 
and the human host, and how these interactions influence disease outcome. However, 
despite these advances, the molecular mechanisms that drive microbial pathogenicity 
and host responses to infection remain to be characterised in full.  
Historically, all microbes were considered to be detrimental organisms responsible for 
the propagation of disease in humans. However, this traditional view of microbial 
pathogenesis changed substantially with the observation that the acquisition of certain 
microbes was not always correlated with symptomatic infection and disease outcome. 
Our view of microbial pathogenicity and host-pathogen interactions has expanded to 
accommodate an awareness of commensal and opportunistic microbes and their role(s) 
in health and disease.   
The human body provides a challenging but nevertheless common niche for microbes. 
Several body surfaces including the skin and the mucosal surfaces of the mouth, 
gastrointestinal, respiratory and urogenital tracts are colonised by a diverse range of 
bacteria, fungi and viruses (Dethlefsen et al., 2007). Collectively, the microbial 
communities that colonise the skin and mucosal surfaces are referred to as the 
microbiota. The microbes that comprise the microbiota may persist in a state of co-
existence with the host (commensalism) or may cause disease (pathogenicity) 
(Magalhaes et al., 2007). However, the classification of microbes as either "commensals" 
or "pathogens" is not mutually exclusive. Indeed, opportunistic pathogens can colonise 
a mucosal surface without causing harm to a host, but may cause disease under suitably 
predisposing conditions. 
Fungi are common members of the microbiota found on all mucosal surfaces, and 
attention to these organisms is increasing in order to better understand how fungi may 
contribute to health and disease. Fungal infections contribute significantly to morbidity 
and mortality in humans (Brown et al., 2012). Like the bacterial microbiota, the 
mycobiota is often altered in disease, and understanding how these alterations 
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contribute to fungal pathogenesis is a growing area of research. Patients with a wide 
spectrum of immune abnormalities, ranging from impaired host defence to alterations 
in the microbial flora often develop fungal infections (Fidel, 2006; Hasan et al., 2009).    
Fungi are a frequently-encountered, but under-represented component of the microbial 
communities that colonise mucosal surfaces. Nevertheless, their contribution to 
morbidity and mortality is significant. The interaction(s) between the fungus Candida 
albicans and the epithelial cells that form the mucosal surfaces of the soft palate within 
the oral cavity are the focus of this study. 
 
1.2 Candida species 
At least 60% of humans harbour Candida species in various parts of the body, making 
Candida one of the most common fungal genuses that colonises humans (Odds, 1988). 
Candida species normally colonise the skin and mucosal surfaces of healthy individuals, 
where they coexist with the host (commensalism). However, during periods of microbial 
dysbiosis or impaired host immunity, Candida can cause infection. Infections caused by 
Candida species are predominantly superficial and occur as a consequence of fungal 
overgrowth at the mucosal surface (Odds, 1988). However, superficial infections caused 
by Candida can also become systemic where Candida species access the bloodstream. 
Systemic candidiasis can occur following medical procedures (Leibovitz et al., 1992), 
from immunosuppressive therapy following transplantation (Sganga et al., 2014), 
surgery (Tortorano et al., 2004) and exposure to broad spectrum antibiotics (Chahoud 
et al., 2013).  Systemic candidiasis (often called candidaemia), is reported to be the 
seventh most common bloodstream infection and the fourth most recurrent infection 
in intensive care units with mortality rates of 40-50%,  despite the use of appropriate 
antifungal therapies (Ostrosky-Zeichner et al., 2010). Therefore, Candida infections are 
a major clinical problem for global healthcare (Odds, 1988; Pfaller et al., 2007). 
Candida infections are caused by at least 17 different Candida species (Sardi et al., 2013). 
The most common Candida species that cause infection are Candida albicans,                       
C. glabrata, C. tropicalis, C. parapsilosis and C. krusei (Pfaller et al., 2007). More recently, 
C. auris has emerged as an important cause of Candida infections worldwide (Ruiz Gaitan 
et al., 2017). The predominant species of Candida responsible for invasive candidiasis in 
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Europe is C. albicans (50% of all reported cases), followed by C. glabrata and                          
C. parapsilosis (14%), C. tropicalis (7%) and C. krusei (2%)  (Tortorano et al., 2006). 
 
1.3 Candida infections  
There are three predominant forms of candidiasis. Candidiasis of the mouth or throat 
(oral thrush or oropharyngeal candidiasis); vaginal candidiasis (vaginal thrush); and 
candidaemia that develops when Candida species enter the bloodstream and 
disseminate throughout the body.  
C. albicans accounts for approximately 50% of all reported cases of oropharyngeal 
candidiasis (Williams and Lewis, 2011). Candida infections of the oral cavity manifest 
with three primary forms, which are described based on clinical presentation. 
Pseudomembranous candidiasis (sometimes referred to as oral thrush) presents as 
white patches on the tongue or other areas of the mouth and throat (Reichart et al., 
2000). Erythematous candidiasis frequently occurs after receipt of a broad-spectrum 
antibiotic, which alters the oral microbial population facilitating overgrowth of Candida. 
Erythematous candidiasis presents as reddened lesions on the dorsum of the tongue 
and palate (Reichart et al., 2000). Chronic hyperplastic candidiasis is usually found in 
middle-aged men who smoke (Arendorf et al., 1983). This form appears either as smooth 
or nodular white patches and is characterised by invading C. albicans hyphae. 
Secondary forms of oral candidiasis are described as Candida-associated lesions. Angular 
cheilitis is an infection that occurs at the corners of the mouth and is often caused by 
co-infection of Candida and Staphylococcus aureus (Dias and Samaranayake, 1995). 
Another secondary form of oral candidiasis is Candida-associated denture stomatitis, 
which is a chronic inflammatory condition affecting more than 65% of individuals who 
wear dental prosthesis and is characterised by erythema of the palate and alveolar 
ridges (chronic atrophic candidiasis). Candida is commonly found on the acrylic surfaces 
of dentures where it forms biofilms, which can serve as reservoirs for recurrent infection 
of the palatal mucosa. 
Vulvovaginal candidiasis is characterised by genital itching, burning, and sometimes 
white discharge from the vagina. Approximately 75% of the female population are likely 
to experience at least one episode of vulvovaginal candidiasis over the course of their 
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lifetime (Ferrer, 2000), and approximately 5% of women develop recurrent vulvovaginal 
candidiasis, resulting in chronic episodes of vaginal irritation that require antifungal 
maintenance therapy (Sobel, 2007).  
In severely immunocompromised patients, Candida infections of the mucosa can 
progressively develop into severe invasive infections that culminate in the acquisition of 
life-threatening candidaemia (Eggimann and Pittet, 2014). In healthy individuals, 
translocation of Candida across the gut often occurs during abdominal surgery or 
following major trauma, and is a major risk-factor for systemic infection.  
Chronic mucocutaneous candidiasis is associated with inherited disorders that result in 
defective CD4+ T helper 17 (Th17) lymphocyte function. Chronic mucocutaneous 
candidiasis presents as chronic and recurrent superficial candidiasis of the skin, nails, 
and mucosal membranes of infected individuals (Eyerich et al., 2010). 
1.3.1 Treatment of Candida infections 
Treatment of Candida infections relies on an extremely limited repertoire of antifungals 
that are classified into three main groups: polyenes, azoles and echinocandins. Polyenes 
such as nystatin and amphotericin were introduced into the clinic in the 1950s as the 
first class of antifungals. Amphotericin kills Candida by specifically targeting ergosterol 
present in the fungal cell membrane causing pores and lysis of the cell (Sokol-Anderson 
et al., 1986). The azole class of antifungals were introduced during the 1980s and 1990s 
and are the most commonly used antifungals in the clinical setting. Three generations 
of azole formulations are used for the treatment of Candida infections and include 
clotrimazole, ketoconazole and fluconazole, respectively. Azoles inhibit the fungal 
enzyme lanosterol-14α demethylase required for the biosynthesis of ergosterol. 
Depletion of ergosterol from the fungal cell plasma membrane causes destabilisation of 
plasma membrane integrity (Odds et al., 2003). The echinocandin class of antifungals 
were introduced in the 2000s and are the newest class of antifungals available. 
Anidulafungin, micafungin and caspofungin inhibit the enzyme β-1,3 glucan synthase 
required for the synthesis of β-1,3 glucans found in the fungal cell wall. Depletion of β-
1,3 glucans causes loss of cell wall integrity resulting in lysis of the fungal cell (Ostrosky-
Zeichner et al., 2010).  
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The emergence of resistance to antifungals poses a significant threat to the effective 
treatment of Candida infections and indeed, to the treatment of fungal infections in 
general. Mechanisms of antifungal resistance in Candida are varied and species specific, 
and include mutation of the ERG11 gene that encodes lanosterol-14αdemethylase and 
overexpression of drug efflux pumps (Sanglard, 2016). 
In recent years, cell-wall polysaccharides (Bromuro et al., 2010; Xin et al., 2008), fungal 
proteins (De Bernardis et al., 2012; Ibrahim et al., 2006; Lin et al., 2009; Luo et al., 2010; 
Raska et al., 2005; Schmidt et al., 2012) and live attenuated fungi (Saville et al., 2008, 
2009) have been studied as therapeutic targets for the development of vaccines against 
Candida infection. Despite this progress however, there are no anti-Candida vaccines 
available for clinical use at this time. 
 
1.4 Candida albicans virulence factors 
Among all pathogenic Candida species, C. albicans remains the most common species 
causing superficial and life-threatening invasive candidiasis (Hasan et al., 2009).                  
C. albicans is a polymorphic fungus that is part of the resident microflora of mucosal 
surfaces in at least 50% of humans (Odds, 1988). Importantly, the morphological 
plasticity of C. albicans (Figure 1-1) is widely regarded to facilitate mucosal 
pathogenicity. Yeast growth (defined as spherical/ovoid unicellular budding cells), is 
typically associated with commensal carriage, whereas hyphae (defined as elongated 
filaments with parallel cell walls that display no constriction at the site of septation) are 
more closely associated with mucosal infection and pathogenesis. C. albicans can also 
adopt a pseudohyphal morphology defined as elongated filaments that are wider than 





Figure 1-1. Morphological plasticity of C. albicans. Three panels illustrating C. albicans 
pseudohyphal, yeast and hyphal morphology. Scale bars represent 5 μm. The inset in the hyphae 
panel shows a hyphal colony cultured for 5 days on Spider medium. Scale bar in the inset of the 
hyphae panel represents 1 μm (Sudbery, 2011). 
 
1.4.1 Hyphae 
In the presence of a healthy immune system and low fungal burdens, C. albicans 
successfully colonise human mucosal surfaces without host challenge. However, 
changes in the effectiveness of host immune surveillance and increased fungal burdens 
with associated hypha formation allow C. albicans to initiate pathogenic growth, causing 
infection. Mutant strains of C. albicans that are unable to produce filaments are non-
invasive and avirulent in vitro and in vivo (Kamai et al., 2001; Lo et al., 1997). Accordingly, 
the formation of hyphae is considered to be a key virulence trait. 
C. albicans forms hyphae under a range of environmental conditions, such as in the 
presence of serum (Taschdjian et al., 1960), neutral pH (Buffo et al., 1984), 5% CO2 
(Mardon et al., 1969) and N-acetyl-D-glucosamine (GlcNac) (Simonetti et al., 1974). The 
hypha-stimulating capacity of these conditions is further enhanced by temperature 
(37oC). Environmental cues activate signal transduction pathways and transcription 
factors within the fungus such as Efg1p (Stoldt et al., 1997) and Cph1p (Liu et al., 1994) 
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(Figure 1-2). Efg1p and Chp1p are activated through different signalling pathways. While 
activation of Efg1p depends on cyclic AMP (Stoldt et al., 1997), Cph1p is activated 
through a mitogen-activated protein kinase (MAPK) pathway (Csank et al., 1998). The 
activation of these transcription factors drive the expression of EED1, UME6 and HGC1 
that are key hypha-associated genes that encode proteins involved in hypha 
development and maintenance (Figure 1-2). Activation of Ume6p (via Eed1p) is required 
for hyphal maintenance, whereas Hgc1p is a hypha-specific cyclin required for the 
initiation of germ tube development and long-term hyphal maintenance (Sudbery, 
2011).  
When C. albicans yeast cells initiate the switch to hyphal growth, a single germ tube 
emerges from the yeast cell and elongates. Elongation of hyphal cells is characterised by 
polarized growth (Soll et al., 1985; Sudbery, 2001) and inhibition of cell separation, 
which is Hgc1p-dependent in association with Cdc28p (Wang et al., 2009) (Figure 1-2). 
During germ tube extension the nucleus migrates out of the mother cell in the tube 
where it undergoes mitosis. As the hypha continues to grow, septa are created which 




Figure 1-2. Summary of hyphal induction in C. albicans. Environmental stimuli induce signal 
transduction, activation of transcription factors (Efg1p and Cph1p) and the expression of hyphal 
associated genes. Emergence of a polarized germ tube occurs through Hgc1p-Cdc28p. Long-term 




1.4.2 C. albicans virulence factors 
The activation of C. albicans signal transduction pathways results in the expression of 
hypha-associated virulence factors that promote pathogenicity but are not required for 
hyphal growth per se. These genes encode for hyphal wall protein 1 (Hwp1p), secreted 
aspartyl protease (Sap) family proteins, agglutinin-like sequence 3 protein (Als3p), 
extent of cell elongation 1 protein (Ece1p) and hyphal regulated 1 protein (Hyr1p). These 
hyphal proteins play crucial roles during specific stages of C. albicans infection. These 
stages can be divided into adhesion, invasion and damage to host cells (Figure 1-3).  
 
 
Figure 1-3. Stages of C. albicans mucosal infection. Representative schematic panels and 
scanning electron micrographs showing the initiation and progression of a C. albicans infection 
in human oral epithelial cells. The three main stages of infection include adhesion, invasion 
(induced endocytosis and/or active penetration) and tissue damage (Wilson et al., 2009). 
 
1.4.3 Adhesion 
Adhesion of C. albicans to host epithelial cells is an important step required for mucosal 
colonisation and infection. Initial adhesion between C. albicans yeast and epithelial cells 
promotes hyphal growth (Moyes et al., 2015). Hyphal growth is accompanied by the 
expression of specific adhesins that facilitate strong attachment to the epithelial surface. 
Indeed, the hyphal morphology of C. albicans is considered to be more adherent when 
compared with the corresponding yeast morphology (Sandin et al., 1982).  
The most studied C. albicans adhesins comprise the Als protein family consisting of eight 
members (Als1-7p and Als9p). Als are glycosylphosphatidylinositol (GPI) proteins that 
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are linked to the β-1,6-glucans present in the fungal cell wall (Hoyer, 2001). Als are thus 
located on the surface of C. albicans and are able to interact with host proteins. Als 
family members share three distinct domains; an N-terminal domain which contains the 
substrate binding region, a central serine/threonine-rich domain with variable tandem 
repeat sequences, and a C-terminal domain containing the GPI-anchor sequence (Hoyer, 
2001). Studies conducted with C. albicans deletion mutants demonstrated the 
importance of Als1p, Als2p, Als3p and Als4p in the ability of C. albicans to adhere to 
epithelial cells (Kamai et al., 2002; Zhao et al., 2004; Zhao et al., 2005). In contrast, 
deletion of ALS5, ALS6 or ALS7 increases the adhesion of C. albicans to epithelial cells 
(Zhao et al., 2007).  
Hwp1p is another important adhesin that mediates interaction with host epithelial cells. 
Host transglutaminase enzymes cross-link C. albicans hyphae (via the N-terminus of 
Hwp1p) to the epithelial surface (Staab et al., 2004; Staab et al., 1999). Hwp1p plays an 
essential role in C. albicans adhesion, as a hwp1Δ/Δ null mutant strain was unable to 
cause oropharyngeal candidiasis in mice (Sundstrom et al., 2002).  
Other C. albicans adhesins include the enhanced adherence to polystyrene 1 protein 
(Eap1p), responsible for adherence to polystyrene beads, epithelial cells and 
Streptococcus gordonii (Li and Palecek, 2003, 2008). C. albicans Iff4p is another protein 
involved in C. albicans adhesion; since overexpression of IFF4 results in increased 
adherence to oral epithelial cells and increased virulence in a mouse model of 
vulvovaginal candidiasis (Fu et al., 2008). Other proteins reported to be important during 
C. albicans adhesion to the host but which have not been characterised in terms of their 
structure and/or capacity to mediate attachment to epithelial cells include, fimbriae (Yu 
et al., 1994), Csh1p (Singleton et al., 2005), Ywp1p (Granger et al., 2005) and Pra1p 
(Soloviev et al., 2007). 
1.4.4 Invasion 
Adhesion of C. albicans to the host epithelium is a critical event that precedes invasion 
of the fungus into the mucosa and underlying tissues. The invasion stage is essential for 
the pathogenesis of candidiasis and can occur through two distinct mechanisms: 
induced endocytosis and active penetration (Wachtler et al., 2012).  
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1.4.4.1 Induced endocytosis 
Induced endocytosis is triggered by C. albicans in numerous epithelial cell lines, including 
HeLa cervical cells (Drago et al., 2000), HET1-A oesophageal cells (Enache et al., 1996), 
TR146 buccal cells (Dalle et al., 2010), FaDu pharyngeal cells (Park et al., 2005), 
OKF6/TERT-2 oral epithelial cells (Zhu et al., 2012) and reconstituted human epithelium 
(Zakikhany et al., 2007). Induced endocytosis is a host-driven process since dead hyphae 
are engulfed similarly to live hyphae (Park et al., 2005). C. albicans Als3p and Ssa1p are 
two key proteins that stimulate the uptake of fungus into the epithelial cell. 
Both Als3p and Ssa1p are thought to bind to epithelial E-cadherin, epithelial growth 
factor receptor (EGFR) and human EGF receptor 2 (HER2), activating the clathrin-
dependent endocytosis machinery (Moreno-Ruiz et al., 2009; Phan et al., 2007; Sun et 
al., 2010; Zhu et al., 2012). The endocytosis pathway involves the recruitment of clathrin, 
dynamin and cortactin to the site of hyphal engulfment and results in cytoskeleton 
reorganization (Moreno-Ruiz et al., 2009). siRNA knockdown of proteins involved in this 
pathway reduced endocytosis by 60% (Moreno-Ruiz et al., 2009). The incomplete 
inhibition of endocytosis suggests that other pathways may be involved in this process. 
Indeed, pathways such as PDGF BB (platelet-derived growth factor BB) and NEDD9 
(neural precursor-cell-expressed developmentally downregulated protein 9) have been 
implicated in C. albicans endocytosis (Liu et al., 2015). Furthermore, recent work has 
demonstrated a role for the aryl hydrocarbon receptor (AhR) in the endocytosis of              
C. albicans through Src family kinase phosphorylation of EGFR (Solis et al., 2017). 
However, the fungal ligand(s) responsible for AhR activation has yet to be identified. 
1.4.4.2 Active penetration 
Active penetration is a fungal-driven process that requires live hyphae to penetrate 
through epithelial cells or pass between intercellular junctions between epithelial cells 
(Dalle et al., 2010).  Active penetration of oral mucosal surfaces is particularly important, 
since the upper most layer of oral epithelium is comprised of differentiated, non-
proliferative cells that are incapable of mediating endocytosis. Thus, in order to breach 
the mucosal barrier to cause infection, C. albicans must invade these cells through the 
alternative route of active penetration (Naglik and Moyes, 2011). The specific 
mechanism by which active penetration occurs has yet to be elucidated. However, 
factors that contribute to this process include hyphal extension, physical force exerted 
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by elongating hyphae and the secretion of hydrolytic enzymes (Villar et al., 2007; 
Wachtler et al., 2012). Different mechanisms of invasion can be observed depending on 
the type of epithelial cell. For instance, oral epithelial cells are invaded through 
endocytosis and active penetration (Wachtler et al., 2012), whereas gastrointestinal 
epithelial cells are invaded via active penetration only (Dalle et al., 2010).   
Many studies have reported an important contribution of Saps in active penetration by 
C. albicans (Dalle et al., 2010; Naglik et al., 2008; Wachtler et al., 2012). Pre-treatment 
of epithelial cells with the inhibitor pepstatin A (inhibits Sap activity) caused a partial 
reduction (but not complete elimination) of invasion and epithelial damage (Naglik et 
al., 2008; Ruchel et al., 1990; Schaller et al., 1999). Saps have been demonstrated to 
contribute to invasion through various mechanisms, including the degradation of host 
glycoproteins such as mucins and E-cadherins (Colina et al., 1996; Villar et al., 2007). 
However, the role of Saps in the process of active penetration remains controversial, 
since work has also demonstrated that Sap1–6p play a limited role during invasion in 
vitro (Lermann and Morschhauser, 2008) and in vivo (Correia et al., 2010). 
The phospholipases are a family of secreted hydrolytic enzymes that degrade a variety 
of phospholipids (Ghannoum, 2000).  Phospholipase PLB1 has been proposed to 
contribute to C. albicans active penetration by degrading host lipids found in epithelial 
cell plasma membranes (Ghannoum, 2000). However, a C. albicans PLB1-deficient 
mutant was observed to invade epithelial cells with no loss of efficiency (Dalle et al., 
2010), thus the contribution of PLB1 to C. albicans active penetration remains 
controversial. 
Lipases are hydrolytic enzymes encoded by LIP1-10 gene family. The lipases of                      
C. albicans have been implicated in fungal invasion (Hube et al., 2000), however the role 
of lipases in invasion remains controversial. A C. albicans lip8Δ/Δ mutant was observed 
to have reduced virulence in a mouse model of systemic infection (Gacser et al., 2007). 
However, ibogaine-mediated inhibition of lipase activity did not reduce invasion in oral 
epithelial cells and enterocytes, suggesting that lipases contribute little to the process 





Following invasion of the mucosal surface, a characteristic manifestation of 
oropharyngeal candidiasis is loss of superficial epithelium through epithelial damage 
caused by invading C. albicans (Villar et al., 2007). Epithelial damage requires C. albicans 
filamentation (hyphae), adhesion and invasion. Importantly, epithelial cells can 
internalise dead C. albicans hyphae but are not damaged (Park et al., 2005), suggesting 
that epithelial damage is fungus-driven and requires the production of damage-inducing 
factors. 
The C. albicans ECE1 gene encodes the damage-inducing factor required for infection of 
mucosal surfaces (Moyes et al., 2016). A C. albicans ece1Δ/Δ mutant can grow as 
hyphae, adhere to and invade epithelial cells, but is incapable of causing damage in vitro 
and in vivo (Moyes et al., 2016). ECE1 encodes a 271 amino acid protein (Ece1p) which 
is enzymatically cleaved by the endoproteinase Kex2p (Bader et al., 2008). Ecep1 is 
cleaved into eight distinct peptides, one of which 
(SIIGIIMGILGNIPQVIQIIMSIVKAFKGNKR (Ece1p62-93)) is further processed by the 
carboxyproteinase Kex1p, which removes the terminal arginine (R) to produce mature 
Candidalysin (SIIGIIMGILGNIPQVIQIIMSIVKAFKGNK (Ece1p62-92)) (Moyes et al., 2016). 
Candidalysin is an amphipathic 31 amino acid cytolytic toxin that is secreted from               
C. albicans hyphae during mucosal infection. Oral epithelial cells respond to Candidalysin 
in a dose dependent manner, with sub-lytic Candidalysin concentrations (< 15 µM) 
activating pro-inflammatory responses, and lytic Candidalysin concentrations (> 15 µM) 
causing epithelial damage and robust pro-inflammatory responses (Moyes et al., 2016). 
Like ece1Δ/Δ, a C. albicans mutant in which only the region of ECE1 encoding 
Candidalysin was deleted (ece1∆/∆+ECE1∆184-279) was also unable to cause epithelial 
damage, pro-inflammatory responses or mucosal infection in vivo (Moyes et al., 2016). 
These data identify Candidalysin as a critical factor required for C. albicans pathogenesis 
and immune activation at mucosal surfaces. 
 
1.5 Physical barriers against C. albicans infection 
Pathogens persist within a specific niche by virtue of virulence factors, which permit 
microbial survival and dissemination in the host. Pathogenic dissemination is associated 
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with cell and tissue damage. Damage at the cellular level includes apoptosis and 
different forms of necrosis, whereas damage at the tissue level includes granulomatous 
inflammation, fibrosis and tumour growth (Casadevall and Pirofski, 2014).  
The C. albicans-host interaction is characterised by a complex interplay between fungal 
virulence factors and host protective mechanisms. The host adopts different protective 
strategies to prevent fungal invasion and restrict the fungus to the commensal state. 
Epithelial cells can function as a passive physical barrier against microorganisms, 
protecting the underlying tissue from invasion. This physical protection is provided by a 
network of strong inter-epithelial cell connections called tight junctions, which maintain 
the structural integrity of the mucosal barrier. Furthermore, goblet cells present within 
the epithelia secrete mucins that reduce direct contact of C. albicans with the mucosal 
surface (Linden et al., 2008). In the oral cavity, saliva can prevent adhesion of C. albicans 
to mucosal and dental surfaces through constant flushing (Bokor-Bratic et al., 2013) and 
through antimicrobial agents contained in saliva such as lysozyme, lactoferrin, histatins, 
cathelicidins, calprotectins and defensins (Hibino et al., 2009).  
 
1.6 Host immune responses against C. albicans infection 
In addition to the physical barrier provided by the mucosal surface, the epithelial cells 
that comprise mucosal barriers are capable of recognising C. albicans and directing 
appropriate immune responses during mucosal infection. 
1.6.1 Host recognition of microbes 
Host cells use pattern recognition receptors (PRRs) to recognise microbes. PRRs 
modulate host immunity via inflammation and cell death (Broz and Monack, 2013; 
Mogensen, 2009) and are required to interact with specific molecular structures present 
on microbes called pathogen associated molecular patterns (PAMPs). PRRs are also 
capable of interacting with danger associated molecular patterns (DAMPs), which are 
released from infected tissues or tissues undergoing destruction. There are three main 
families of PRRs; toll-like receptors (TLRs), C-type lectin receptors (CLRs) and nucleotide-
binding domain leucine-rich receptors (NLRs). These receptors can be expressed at the 
cell surface, in endosomes or in the cytoplasm of cells. The ligation of extracellular or 
intracellular PRRs with PAMPs or DAMPs induces the expression of chemokines, 
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antimicrobial peptides and pro-inflammatory cytokines required for clearance of the 
infecting microbe. Expression of PRRs varies in a tissue- and cell-specific manner, and 
since PRRs recognise different classes of PAMP, different responses to microbes may 
occur. The interactions known to occur between host PRRs and C. albicans PAMPs are 
summarised in Table 1. 
Table 1. Host PRRs that recognise C. albicans PAMPs. 
Family Host PRR Fungal PAMP Reference 
TLR 
TLR2 Phospholipomannan (Jouault et al., 2003) 
TLR3 Double-stranded RNA (Muller et al., 2007) 
TLR4 Mannan 
O-linked Mannan residues 
(Tada et al., 2002) 
(Netea et al., 2006) 
TLR9 CpG DNA (Miyazato et al., 2009) 
CLR 
Dectin-1 β-1,3-glucan (Brown and Gordon, 
2001) 
Dectin-2 High-mannose structures 
α-mannans 
(McGreal et al., 2006) 
(Sato et al., 2006) 
Mannose receptor Mannan (Ezekowitz et al., 1990) 
MINCLE High-mannose structures (Wells et al., 2008) 
Galectin-3 β-1,2-Mannosides (Jouault et al., 2006) 
DC-SIGN High-mannose structures (Cambi et al., 2003) 
NLR 
NLRP3 DAMPs? (Gross et al., 2009) 
NLRC4 DAMPs? (Tomalka et al., 2011) 
Others 
Cdw17 ? (Jimenez-Lucho et al., 
1990) 
EphA2 β-glucans (Swidergall et al., 2017) 
 
PRR-PAMP interaction studies between host and C. albicans have focused on fungal 
recognition by myeloid cells rather than epithelial cells. However, epithelial cells express 
a range of PRRs including dectin-1, galectins and several TLRs that are expressed 
constitutively in the oral epithelium.  
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TLR2 and TLR5 are strongly expressed in oral epithelial cells (Shaykhiev et al., 2008) while 
TLR4 is expressed at low levels (Backhed and Hornef, 2003), suggesting that epithelial 
cells may not respond effectively to stimulation by TLR4 ligands such as 
lipopolysaccharide (LPS) and thus Gram-negative bacteria. Indeed, it has been reported 
that TLR2, TLR4, and Dectin-1 are not involved in activating epithelial immune responses 
to C. albicans as blockade or inhibition of these receptors did not affect cytokine 
responses (Moyes et al., 2010). However, an indirect mechanism of epithelial immunity 
to C. albicans exists that is mediated through epithelial TLR4. Following challenge with 
C. albicans, epithelial cells respond by secreting immune modulators that stimulate 
neutrophils to produce TNFα, which in turn induces upregulation of TLR4 at the 
epithelial surface, enhancing protection against C. albicans infection (Weindl et al., 
2007). More recently, the epithelial receptor tyrosine kinase Ephrin A2 (EphA2) has been 
identified an epithelial receptor for β-glucans on C. albicans yeast cells that stimulates a 
pro-inflammatory anti-fungal response (Swidergall et al., 2017). 
Together, these observations suggest that epithelial cells may use different receptors 
and mechanisms for the recognition of C. albicans compared with myeloid cells. 
1.6.2 Innate responses to C. albicans  
Epithelial cells respond to C. albicans via the NF-κB and MAPK signalling pathways 
(Moyes et al., 2010; Moyes et al., 2014; Moyes et al., 2016). Activation of the MAPK 
pathway appears crucial for the ability of epithelial cells to discriminate between the 
yeast and hyphal morphologies of C. albicans, and to induce appropriate innate immune 
responses to infecting fungus (Moyes et al., 2010). Epithelial cells respond to the 
presence of C. albicans in a “biphasic” fashion. Initially, responses to colonising yeast 
include activation of the NF-κB and PI3K signalling pathways, together with a weak and 
transient activation of all three MAPK pathways (p38, JNK and ERK1/2) (Figure 1-4). JNK 
and ERK1/2 activate the transcription factor c-Jun, whereas the role played by p38 
during the colonisation stage is presently unknown. Nevertheless, the transient 
activation of signalling pathways appears to result in a non-inflammatory response since 
no inflammatory mediators are secreted from epithelial cells following challenge with 
the yeast morphology (Figure 1-4).  
In contrast, as hyphal burdens increase at the mucosal surface and fungal invasion 
occurs (a process that is accompanied by Candidalysin secretion), epithelial cells 
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respond with a robust and sustained activation of NF-κB, MAPK and PI3K signalling 
(Figure 1-4). The activation of these pathways (and in particular the p38 pathway), lead 
to the activation of the c-Fos transcription factor and a strong induction of inflammatory 
responses mediated by the secretion of immune modulators. Immune modulators 
include cytokines, chemokines and antimicrobial peptides including interleukin (IL)-1α, 
IL-8, granulocyte colony-stimulating factor (G-CSF), granulocyte-macrophage colony-
stimulating factor (GM-CSF), β-defensin 3, C-C motif chemokine ligand 20 (CCL20) and 
S100 calcium-binding protein A8/A9 (S100A8/9). In addition, ERK1/2 activation induces 
the phosphorylation of MAPK phosphatase 1 (MKP1), which regulates MAPK-induced 
immune responses by inhibiting the activation of p38 and JNK (Figure 1-4). The PI3K 
signalling pathway (activated via mTOR) appears to participate in protecting the 
epithelial tissue from hypha-induced damage (Moyes et al., 2014) (Figure 1-4).  
The MAPK pathway is thus clearly implicated in multiple physiological processes (Zhang 
and Liu, 2002). Despite its importance however, the study of MAPK signalling using in 
vivo models is hampered due to the embryonic lethality of p38, JNK, ERK1/2 and MKP1 
gene knockouts in mice (Mudgett et al., 2000; Satoh et al., 2011; Yamasaki et al., 2012; 
Zhao et al., 2006). Consequently, studies describing candidiasis in these models is 
lacking.   
Recently, it was shown that C. albicans strains lacking ECE1 or the Candidalysin encoding 
region of ECE1, were unable to trigger p38/p-MKP1/c-Fos activation or inflammatory 
mediators in oral epithelial cells (Moyes et al., 2016). C. albicans ECE1 or Candidalysin 
null strains were also attenuated in a murine model of oropharyngeal candidiasis and a 
zebrafish swimbladder model, concomitant with a lack of epithelial damage and 
neutrophil recruitment (Moyes et al., 2016). Therefore, epithelial activation and 
immune induction by C. albicans hyphae seems to be largely due to the damage-







Figure 1-4. Epithelial responses to C. albicans yeast and hyphae. Epithelial responses to                 
C. albicans yeast and hyphae involve activation of MAPK pathways. Epithelial colonisation by 
yeast triggers a weak and transient activation of PI3K/NF-κB/p38/JNK/ERK1/2/c-Jun signalling, 
resulting in a non-inflammatory response. In contrast, the presence of Candidalysin-producing 
hyphae stimulates robust activation of PI3K/NF-κB/p38/JNK/ERK1/2/MKP1/c-Fos signalling and 
subsequent secretion of immune modulators (Tang et al., 2016). 
 
Fungal invasion of the mucosal surface, concomitant with Candidalysin activity, results 
in the secretion of immune modulatory cytokines from epithelial cells, which stimulate 
the recruitment of host immune cells to the site of infection, thus invoking both innate 
and adaptive defences against C. albicans infection (Figure 1-5). 
Epithelial cells respond to Candidalysin-producing C. albicans hyphae by releasing IL-1α, 
IL-8, G-CSF, GM-CSF, β-defensin 3, CCL20 and S100A8/9 (Moyes et al., 2010; Moyes et 
al., 2016). Production of these molecules promotes the recruitment of neutrophils, 
monocytes, macrophages, innate type 17 cells (T cell receptor αβ (TCR αβ) positive) and 
dendritic cells (DCs) to the site of infection, which help combat the infecting fungus 
(Naglik and Moyes, 2011; Verma et al., 2017). Once these immune cells are recruited, 
recognition of the fungus occurs through interaction of host TLR2, TLR3 TLR4 and TLR9 
with C. albicans cell wall mannans and nucleic acids, and through interaction of host 
CLRs such as Dectin-1 and Dectin-2, DC-SIGN or Mincle with C. albicans cell wall β-glucan 
and mannose structures (Netea et al., 2006) (Table 1). These interactions drive the 
induction of NF-κB/MAPK/Syk signalling pathways and secretion of immune modulators. 
Neutrophils are key players in the antifungal response and phagocytose C. albicans yeast 
and short hyphae through TLR- and CLR-mediated interactions, which results in fungal 
engulfment and killing via oxidative mechanisms. Long hyphae can be killed by 
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neutrophil extracellular traps (NETs) (Urban et al., 2006). Innate Type 17 cells (T cell 
receptor αβ (TCR αβ) positive) are also recruited and activated via the IL-1 receptor (IL-
1R) in response to IL-1α and IL-1β secreted from epithelial cells due to  Candidalysin 
activity (Verma et al., 2017). These innate TCR αβ T cells secrete IL-17, which further 
recruits neutrophils and promotes mucosal barrier function (Verma et al., 2017). 
In addition to TLRs and CLRs, NLRs are activated by DAMPs leading to inflammasome 
activation, induction of pyroptosis and IL-1β and IL-18 release to help combat infection 






Figure 1-5. Epithelial induction of innate immunity during C. albicans infection. Invasion and 
damage of epithelial cells due to Candidalysin activity results in the production of immune 
modulators through the NF-κB/p38/MAPK pathways. Immune modulators in turn recruit 
immune cells to the site of infection. Neutrophils and macrophages are involved in fungal 
phagocytosis and removal through NET formation, intracellular oxidative stress and pyroptosis. 
Innate type 17 cells facilitate inflammatory protective responses. Adapted from (Naglik et al., 
2017). 
 
1.6.3 Adaptive responses to C. albicans 
DCs are a key link between innate and adaptive antifungal host immune responses. DCs 
are recruited to the site of infection in response to chemokines and antimicrobial 
peptides including CCL20 and β-defensins that are secreted from infected epithelial cells 
(Netea et al., 2008). Recognition of the C. albicans PAMP β-glucan by the DC PRR Dectin-
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1 leads to activation of Syk/Caspase recruitment domain-containing protein 9 (CARD9) 
signal transduction within DCs (Rogers et al., 2005; Taylor et al., 2007). Upon fungal 
recognition, DCs phagocytose and degrade the fungus into antigens that are assembled 
onto class II molecules of the major histocompatibility complex (MHC II) and transported 
to the surface of the activated DC. This process of antigen presentation occurs as the DC 
migrates to the local lymph node where the MHC:antigen complexes are presented to 
naïve CD4+ T-helper (Th) cells. Following antigen recognition by a naïve Th cell, cytokines 
produced by the DC stimulate T-cell subset differentiation into one of four classes (Th1, 
Th2, Th17 or Treg (regulatory)).  
In recent years, it has been determined that Th17 cells are the predominant cell type 
that confer protection against C. albicans infections at different mucosal sites in the 
body (Hernandez-Santos et al., 2013). Th17 cells secrete IL-17A, IL-17F and IL-22 
cytokines, which play a key role in the recruitment and activation of neutrophils and 
enhancement of epithelial barrier function (De Luca et al., 2010; Huang et al., 2004). 
Mice deficient in the IL-17 receptor exhibit an increased susceptibility to oropharyngeal 
(Conti et al., 2009) and systemic candidiasis (Huang et al., 2004). Individuals with 
inherent disorders in Th17 antifungal responses often manifest chronic mucocutaneous 
candidiasis (Puel et al., 2011), highlighting the importance of the Th17 response against 
C. albicans infections. 
 
1.7 Host cell death as a defence against infection 
Host cell death is a fundamental defence mechanism that occurs in response to 
microbial infection. Cell death sacrifices infected cells for the benefit of remaining 
tissues. Historically, apoptosis was thought to be the only programmed cell death 
pathway involved in cell development, homeostasis, infection and pathogenesis 
(Elmore, 2007), whereas necrosis was considered to occur incidentally following 
physiochemical insult. Recently however, significant advances in our understanding of 
cell death processes and identification of pathways that describe regulated necrotic 
events have changed this historical viewpoint (Vanden Berghe et al., 2014). The 
signalling pathways that promote cell death are present in all somatic cells in the body 
and play a crucial role in eliminating infected cells and triggering inflammatory 
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responses (Moriwaki and Chan, 2013). Biological processes including apoptotic, 
necrotic, necroptotic and pyroptotic cell death are critical defence mechanisms against 
microbial infection (Jorgensen et al., 2017). Indeed, cell death in response to specific 
microbial stimuli can be induced as a host innate immune response.  
Cells undergoing apoptosis may indirectly contribute to host immunity through the 
release of chemoattractant molecules that recruit DCs that subsequently phagocytose 
dying cells and infecting microbes, and thus may contribute to a protective immune 
response (Elliott and Ravichandran, 2010).  Necrotic death modalities play a critical role 
in host defence by releasing a plethora of immune modulators that recruit a variety of 
immune cells to combat the infecting pathogen (Jorgensen et al., 2017).   
However, pathogens can also benefit from host cell death, as destruction of the cellular 
niche can facilitate infection of neighbouring cells, evasion of immune cells and 
acquisition of nutrients. Thus, to maintain their replicative niche within the host, 
pathogenic microbes have developed multiple mechanisms to manipulate host cell 
death and survival pathways (Labbe and Saleh, 2008; Lamkanfi and Dixit, 2010). For 
instance, some pathogens trigger death of immune cells to destabilise host defence 
mechanisms and avoid elimination from the host. In this regard, microbes have evolved 
mechanisms to cause host cell death and kill phagocytes in order to prevent pathogen 
clearance and promote pathogenicity. A major contributor to host cell death involves 
the production of microbial pore-forming toxins (Bischofberger et al., 2012). Bacteria 
such as Staphylococcus aureus (Kitur et al., 2015), Bacillus anthracis (Fink et al., 2008), 
Pseudomonas aeruginosa (Morimoto and Bonavida, 1992) and Bordetella pertussis 
(Khelef et al., 1993) can produce pore-forming toxins that kill macrophages before 
phagocytosis occurs. In contrast, Chlamydiae spp. require a viable host cell in order to 
replicate and spread. Indeed, Chlamydiae spp. prevent infected cells from undergoing 
cell death by blocking apoptosis via inhibition of cytochrome c release from the 
mitochondria (Fan et al., 1998).  
Pathogenic bacteria such as Streptococcus pneumoniae (Gonzalez-Juarbe et al., 2017; 
Hirst et al., 2002), Clostridium difficile (Chumbler et al., 2012) and Staphylococcus aureus 
(Gonzalez-Juarbe et al., 2017) use pore-forming toxins to facilitate epithelial cell death, 
invasion, and the development of systemic infection. However, pathogens are also able 
to inhibit epithelial cell death to facilitate successful infection. For example, Neisseria 
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gonorrhoae has evolved mechanisms to inhibit epithelial cell death in order to maintain 
its replicative niche and successfully colonise the epithelium (Nudel et al., 2015).  
Host–pathogen interactions and their role in cell death are thus highly complex, 
involving a fine balance between pro- and anti-death strategies for both host and 
pathogen. Different mechanisms of host cell death are triggered in response to different 
microbes. However, apoptosis, necrosis, necroptosis and pyroptosis are the most 
common cell death pathways observed to be activated during microbial infection 
(Bergsbaken et al., 2009; Lamkanfi and Dixit, 2010; Zitvogel et al., 2010). The main 
features of these cell death modalities will be described in the following sections.  
1.7.1 The interplay between apoptosis and necrosis 
Apoptosis and necrosis are the two major modes of cell death. Initially these processes 
were viewed as mutually exclusive cellular states; however, recent findings reveal that 
there is interplay between apoptosis and necrosis. Many death initiators, effector 
molecules and organelles have been identified as key mediators of both processes, 
either by playing a role in both death modalities or by functioning as regulators that 
determine which fate the cell will undertake.  
Both apoptosis and necrosis are initiated in cells that receive stress signals classified as 
extracellular (such as damage, PAMPs and/or DAMPs), or intracellular (including 
mitochondrial damage, oxidative stress and alterations in the level of intracellular ATP 
and calcium) (Fulda et al., 2010). Both extracellular and intracellular stress signals are 
able to initiate destabilisation of the host cell plasma membrane; either directly by 
causing damage, or indirectly by inducing changes in the composition of the lipid bilayer. 
The cell plasma membrane exhibits considerable asymmetry in its bilayer. The outer 
leaflet of the plasma membrane contains large quantities of sphingomyelin (SM) and 
phosphatidylcholine (PC), while the inner leaflet has an abundance of 
phosphatidylserine (PS) and phosphatidylethanolamine (PE) (van Meer, 1989). This 
asymmetry plays an important role in the process of apoptosis (Fadeel and Xue, 2009). 
Indeed, during apoptosis PS is redistributed to the outer leaflet of the plasma 
membrane, an essential step for the recognition of apoptotic cells by macrophages 
(Fadok et al., 1992). While apoptotic cells maintain an intact plasma membrane and 
exhibit changes in lipid bilayer stoichiometry, necrosis is characterized by plasma 
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membrane rupture that causes release of intracellular contents,  which attract immune 
cells and initiate inflammation (Elmore, 2007; Hirsiger et al., 2012).  
During cell death, extracellular and intracellular stress signals affect cell organelles, in 
particular the mitochondria that play a critical role during both apoptotic and necrotic 
processes (Orrenius et al., 2007). The importance of mitochondria in cell death is linked 
to their role as a major source of reactive oxygen species (ROS), the majority of which 
are generated on the inner mitochondrial membrane (IMM), via complex I and III of the 
respiratory chain (Brand et al., 2004). Reactive products of oxygen are extremely 
damaging to cells. Extracellular or intracellular sources of ROS can cause auto-oxidation 
of mitochondrial electron transport chain components generating toxic free radicals 
that can be neutralised by antioxidant enzymes such as superoxide dismutases (SODs) 
(Genestra, 2007). Cells maintain equilibrium between pro-oxidant species and 
antioxidant defence mechanisms, but when this balance is disturbed, oxidative stress 
occurs (Brune, 2005). Sustained production of ROS can cause oxidation of 
macromolecules including nucleic acids, proteins, carbohydrates and lipids that can lead 
to apoptotic or necrotic cell death (Orrenius et al., 2007).  
Increases in ROS are associated with cytochrome c release from mitochondria and 
activation of the apoptotic caspase cascade (Orrenius et al., 2007). Cytochrome c is 
normally bound to the IMM in association with the phospholipid cardiolipin (Ott et al., 
2002). Dissociation of cytochrome c from the IMM is promoted by ROS-dependent 
oxidation of cardiolipin. Oxidation of cardiolipin, together with permeabilization of the 
outer mitochondrial membrane (OMM) by pro-apoptotic proteins enables release of 
cytochrome c into the cytosol and propagation of the apoptotic signal (Ott et al., 2002).   
However, ROS can also circumvent apoptosis to induce necrotic death by two distinct 
mechanisms; inactivation of caspases or by reducing levels of intracellular ATP. 
Inactivation of caspases by ROS is driven through the oxidation of the active site cysteine 
nucleophile contained in all caspase enzymes (Hampton and Orrenius, 1997; Samali et 
al., 1999). Depletion of intracellular ATP can occur following ROS-induced damage to the 
IMM via lipid peroxidation, resulting in loss of mitochondrial membrane potential and 
consequently, loss of ATP production (Chen et al., 1995). The level of intracellular ATP 
can influence whether cell death occurs by apoptosis or necrosis; successful execution 
of the apoptotic program is energy-dependent, while depletion of ATP prevents 
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apoptosis and instead promotes death by necrosis (Eguchi et al., 1997). In addition to 
the production of ROS and ATP, mitochondria play a crucial role in the regulation of 
intracellular calcium homeostasis. Calcium signals orchestrate a variety of critical cell 
functions and are necessary for cell survival (Contreras et al., 2010). However, it is also 
well established that calcium influx or perturbation of intracellular calcium 
compartmentalisation, can cause cytotoxicity, resulting in apoptotic or necrotic cell 
death (Zhivotovsky and Orrenius, 2011).  
Mitochondria can take up and retain calcium, thereby participating actively in the 
process of intracellular calcium compartmentalisation (Carafoli, 2002). Under 
pathological conditions, levels of cytosolic calcium often rise. In response, excess 
cytosolic calcium is stored by the mitochondria in the matrix of the organelle (Kim et al., 
2003). However, accumulation of excessive calcium in the mitochondrial matrix 
activates the mitochondrial permeability transition (MPT). The MPT is a process that 
results in the IMM becoming permeable to molecules responsible for maintaining the 
osmotic balance between the mitochondrial matrix and the mitochondrial 
intermembrane space. Following IMM permeabilisation, aqueous solutions move from 
the intermembrane space into the matrix, causing mitochondrial swelling that 
culminates in disruption of the OMM and release of mitochondrial proteins 
accompanied by oxidative stress and ATP depletion (Kim et al., 2003).   
In summary, numerous cellular stresses including oxidation and impaired calcium 
homeostasis contribute to mitochondria-mediated cellular damage (Fulda et al., 2010). 
Cellular stresses can cause mitochondrial failure that can lead to apoptosis if the cell is 
able to maintain mitochondrial membrane potential and ATP production, or necrosis in 
response to severe ATP depletion (Kim et al., 2003). Thus, cell stresses can initiate, 
propagate and/or mediate apoptosis and necrosis. These processes will be described in 
the following sections.  
1.7.2 Apoptosis 
Apoptosis describes a specific, tightly-regulated form of cellular death. Previous work 
has demonstrated that C. albicans can induce apoptosis in epithelial cells (Villar et al., 
2012; Wagener et al., 2012), macrophages (Gasparoto et al., 2004; Ibata-Ombetta et al., 
2003) and neutrophils (Rotstein et al., 2000). While transcript profiling data showed no 
changes in pro- and anti-apoptotic genes in oral epithelial cells 4 h after C. albicans 
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infection (Villar et al., 2012), differences were observed at later time points (8 h and 24 
h) with upregulation of anti-apoptotic genes (Moyes et al., 2014; Villar et al., 2012). 
Increased expression of anti-apoptotic proteins was also observed in macrophages 
infected with C. albicans (Reales-Calderon et al., 2013). Importantly, while C. albicans 
was observed to induce early apoptotic signalling events in oral epithelial cells and 
macrophages, these events were transient, and cell death was observed to occur by 
necrosis rather than apoptosis (Gasparoto et al., 2004; Villar and Zhao, 2010). 
Little is known about the fungal moieties that induce apoptotic events. Currently, only 
three components have been proposed to play a role in the induction of apoptosis by    
C. albicans. First, glycan moieties were shown to induce apoptosis in mucosal epithelial 
cells, where apoptosis was defined as an increase in the number of epithelial cells that 
exhibited caspase-3 activity and PS exposure following 24 h glycan treatment (Wagener 
et al., 2012). Second, proteins secreted from C. albicans have also been proposed to play 
a role in driving apoptosis in epithelial cells. Apoptosis was triggered in lung and oral 
epithelial cells exposed to Sap4p, Sap5p and Sap6p for 23 h (Wu et al., 2013). PS was 
observed to be redistributed to the outer leaflet of the epithelial plasma membrane in 
response to Sap4p, Sap5p and Sap6p but not in response to sap4Δ/Δ, sap5Δ/Δ or 
sap6Δ/Δ mutant strains (Wu et al., 2013). Third, treatment of epithelial cells with 
farnesol, a secreted quorum sensing molecule, was observed to promote caspase 
activation and PS redistribution leading to apoptosis after 48 h (Scheper et al., 2008). 
The mechanisms of apoptosis are highly complex, involving an energy-dependent 
cascade of molecular events. Apoptosis can be initiated through extrinsic and intrinsic 
pathways. The extrinsic pathway is triggered by extracellular stimuli such as damage, 
PAMPs or DAMPs that are sensed by host death receptors, whereas the intrinsic 
pathway occurs in response to a wide range of intracellular damage or stress signals 
including oxidative stress, cytosolic calcium overload and mitochondrial dysfunction 
through the loss of mitochondrial membrane potential (Elmore, 2007). Extrinsic and 
intrinsic pathways result in activation of the caspase family of proteins that play a central 
role in the initiation and execution of apoptosis (Zamaraev et al., 2017).  
Apoptotic caspases can be divided into two main groups: initiator caspases (caspase-2, 
-8, -9, -10) and effector caspases (caspase-3, caspase-6 and caspase-7) (Zamaraev et al., 
2017) (Figure 1-6). Caspases are composed of a single amino acid chain that contains 
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three domains: a pro-domain containing a CARD or death effector domain (DED), a large 
fragment (p20) and a small fragment (p10) (Zamaraev et al., 2017) (Figure 1-6).  
 
 
Figure 1-6. Apoptotic caspases. Initiator and effector caspases are the two main groups of 
caspases involved during apoptosis. Initiator caspases include caspase-2, -9, -8 and -10. Effector 
caspases include caspase-3, -7 and -6. Adapted from (Zamaraev et al., 2017). 
 
 
All caspases are expressed within cells as inactive zymogens, also known as pro-
caspases. Activation of initiator caspase zymogens occurs through proximity-induced 
dimerisation and subsequent autocatalytic cleavage (Dickens et al., 2012). Effector 
caspases are cleaved by initiator caspases. The effector caspases play an essential role 
in the execution of apoptosis by cleaving multiple cellular substrates resulting in 
destruction of the cell (Stennicke and Salvesen, 2000). 
1.7.2.1 Extrinsic apoptotic pathway 
Extrinsic apoptosis is activated by transmembrane receptor-mediated interactions. 
These interactions require death receptors that contain a death domain on the 
cytoplasmic face of the receptor (Ashkenazi and Dixit, 1998; Locksley et al., 2001). The 
death domain is critical for transmission of the death signal from the cell surface to the 
intracellular environment.  
The best characterised death receptor and its cognate ligand are TNFR1 and TNFα, 
respectively (Rath and Aggarwal, 1999). Upon ligand binding, adaptor proteins are 
recruited to the cytoplasmic domain of the death receptor. Binding of TNFα to TNFR1 
results in recruitment of the adaptor TNFR1-associated death domain protein (TRADD), 
receptor interacting protein kinase 1 (RIPK1), TNF-receptor-associated factor 2 (TRAF2), 
cellular inhibitors of apoptosis (cIAPs) and the linear ubiquitin chain assembly complex 
(LIUBAC), forming Complex 1 (Haas et al., 2009) (Figure 1-7). cIAPs mediate 
ubiquitination of RIPK1 which stimulates activation of NF-κB signalling, thus Complex 1 
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favours pro-inflammatory signalling via NF-κB activation (Bianchi and Meier, 2009). In 
the absence of cIAPs, Complex 1 dissociates and a ripoptosome complex composed of 
RIPK1, Fas-associated protein with death domain (FADD) and pro-caspase-8 forms in the 
cytosol (Tenev et al., 2011; Wang et al., 2008) (Figure 1-7). The binding between FADD 
and pro-caspase-8 promotes the autocatalytic activation of pro-caspase-8, potentiating 
extrinsic apoptosis (Kischkel et al., 1995). 
 
Figure 1-7. Initiation of the TNF-induced extrinsic apoptotic pathway. Binding of TNFα to TNFR1 
induces the formation of Complex 1 that activates NF-κB. In the absence of cIAPs, ripoptosome 
formation occurs, leading to activation of pro-caspase-8 and extrinsic apoptosis. 
 
1.7.2.2 Intrinsic apoptotic pathway 
Intrinsic apoptosis is induced by numerous non-receptor mediated stimuli that generate 
intracellular signals through the mitochondria. Stimuli that trigger intrinsic apoptosis 
include radiation, hypoxia, free radicals and toxins (Elmore, 2007). All intrinsic apoptotic 
inducers can trigger the mitochondrial permeability transition (MPT) and release of pro-
apoptotic proteins from the mitochondrial intermembrane space into the cytosol of the 
cell (Saelens et al., 2004). Cytochrome c is a major pro-apoptotic protein that binds Apaf-
1 and pro-caspase-9 to form the apoptosome complex. Once formed, the apoptosome 
activates pro-caspase-9 (Chinnaiyan, 1999) (Figure 1-8).  
The intrinsic apoptotic pathway is regulated by members of the Bcl-2 family (Cory and 
Adams, 2002). The Bcl-2 family of proteins contain pro- and anti-apoptotic factors that 
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control mitochondrial membrane permeability (MMP) and hence release of cytochrome 
c (Luo et al., 1998). The ratio of pro- and anti-apoptotic Bcl proteins expressed within a 
cell determines whether the pro-apoptotic proteins Bax and Bak are activated (Cory and 
Adams, 2002). Once active, Bax and Bak oligomerise into homodimers and permeabilise 
the mitochondrial membrane causing release of cytochrome c and activation of pro-
caspase-9 through apoptosome formation (Wei et al., 2001) (Figure 1-8). 
 
Figure 1-8. Initiation of the intrinsic apoptotic pathway. Radiation, hypoxia, free radicals and 
toxins are some of the stimuli that activate the intrinsic apoptotic pathway. These stimuli induce 
the expression of the pro-apoptotic protein Bcl-2 which induces Bax and Bak to act on the 
mitochondria, causing release of cytochrome c.  Cytochrome c binds to Apaf-1 with pro-caspase-
9, forming the apoptosome complex, which in turn activates pro-caspase-9, propagating intrinsic 
apoptosis. 
 
1.7.2.3 Execution apoptotic pathway 
Both extrinsic and intrinsic apoptotic pathways converge and activate the execution 
phase of cell death. The execution phase initiates with the activation of effector 
caspases including caspase-3, -6 and -7. Caspase-3 is considered the most important of 
the effector caspases and can be cleaved by initiator caspases (caspase-8, -9 or -10) (Slee 
et al., 2001). Once activated, caspase-3 cleaves numerous substrates including the 
Inhibitor of Caspase-activated DNase (ICAD) and Poly (ADP-ribose) polymerase (PARP) 
(Kaufmann et al., 1993; Sakahira et al., 1998).  
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During apoptosis, ICAD cleavage generates CAD, which is a major nuclease involved in 
DNA fragmentation (Enari et al., 1998). PARP is a protein involved in DNA repair. 
Cleavage of PARP prevents the repair of double stranded breaks in genomic DNA, 
potentiating DNA fragmentation (Boulares et al., 2001). 
In addition to ICAD and PARP, caspase-3 also degrades the cytoskeleton of the host cell, 
leading to cell shrinkage and display of PS on the outer leaflet of the plasma membrane 
(Elmore, 2007). Exposure of PS has been associated with loss of amino-phospholipid 
translocase activity and nonspecific flip-flop of phospholipids (Bratton et al., 1997). PS 
externalisation facilitates non-inflammatory phagocytic recognition that allows 
clearance of apoptotic cells by macrophages without eliciting an inflammatory response 
(Fadok et al., 2001). 
 
Figure 1-9. Extrinsic and intrinsic apoptotic signalling pathways. Extrinsic and intrinsic 
apoptotic pathways feed into the execution phase of the apoptotic pathway which is 
characterised by activation of caspase-3. Active caspase-3 cleaves numerous intracellular 




Unlike apoptosis, necrosis is a caspase-independent cell death modality. Necrosis 
manifests with gross changes in cellular morphology via distinct biochemical processes 
leading to cellular rounding followed by swelling (oncosis) and plasma membrane 
rupture (Festjens et al., 2006). Loss of membrane integrity provokes an inflammatory 
response by exposing cellular contents to the immune system. Such contents include 
DAMPs and immune modulators including IL-1α, IL-33, S100, S100A8, S100A9 and 
S100A12 and ATP (Kaczmarek et al., 2013). These molecules behave in a similar manner 
to PAMPs that, through interaction with their cognate PRRs, activate inflammatory 
responses (Wallach et al., 2014). 
Although C. albicans induces apoptotic events in epithelial cells (Villar et al., 2012) and 
phagocytes (Gasparoto et al., 2004; Ibata-Ombetta et al., 2003), the apoptotic response 
does not progress to completion, and the predominant cell death modality observed 
was necrosis (Gasparoto et al., 2004; Villar and Zhao, 2010). Importantly, while the 
presence or absence of necrosis reflects the viability status of the associated cell/tissue, 
the presence of necrosis alone does not indicate precisely how cell death has occurred. 
In order to elucidate the specific mechanism(s) of cell death that are induced during the 
process of necrosis, examination of specific signalling pathways is required. Necroptosis 
and pyroptosis are programmed necrosis pathways that are triggered by microbes to 
promote pathogenicity, and by host cells to induce defence mechanisms against 
pathogens (reviewed in (Ashida et al., 2011).  
1.7.4 Programmed necrosis 
Investigation of programmed cellular necrosis has been undertaken predominantly in 
the context of bacterial infections. Among cell death triggers, secreted bacterial toxins 
have been reported to activate necroptosis and pyroptosis in macrophages and 
epithelial cells. Some examples include toxins of Bacillus anthracis (Fink et al., 2008), 
Staphylococcus aureus (Kitur et al., 2015) and Streptococcus pneumoniae (Gonzalez-
Juarbe et al., 2017). Recent studies have shown that C. albicans triggers pyroptosis in 
macrophages that phagocytose yeast cells (Wellington et al., 2014). Furthermore, given 
the role of bacterial toxins in inducing programmed cell necrosis (Fink et al., 2008; 
Gonzalez-Juarbe et al., 2017; Kitur et al., 2015), it may be possible that Candidalysin 
plays a role in triggering pyroptosis, and possibly the unexplored mechanisms of 
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necroptosis. The mechanisms driving necroptosis and pyroptosis will be described in the 
following sections. 
1.7.4.1 Necroptosis 
Necroptosis is a caspase-independent pro-inflammatory cell death pathway that is 
critical for immune activation following injury. Necroptotic death can be triggered by 
ligation of specific cell surface receptors, toxins, excessive ROS and numerous cellular 
stresses (Weinlich et al., 2017). 
Responses to TNF may induce a necroptotic response (Holler et al., 2000). Initially, 
necroptosis proceeds in the same fashion as extrinsic apoptosis (Figure 1-7) with the 
formation of Complex 1 in response to TNF (Haas et al., 2009) (see section 1.7.2.1). In 
the absence of cIAPs, Complex 1 dissociates forming a ripoptosome complex in the 
cytosol comprised of RIPK1, FADD and pro-caspase-8 (Figure 1-10) (Tenev et al., 2011; 
Wang et al., 2008). The ripoptosome complex promotes autocatalytc activation of pro-
caspase-8, which propagates the apoptotic signal (Feoktistova et al., 2012). However, in 
the absence of active caspase-8, RIPK1 dissociates from the ripoptosome to form the 
necrosome complex in the cytosol with RIPK3 (Cho et al., 2009) (Figure 1-10). Caspase-
8 cleaves and inactivates RIPK1 (Lin et al., 1999) and  RIPK3 (Feng et al., 2007), thus 
acting as a negative regulator of necrosome assembly. 
RIPK1 and RIPK3 interact through RIP homotypic interaction motifs (RHIM) (Li et al., 
2012), which triggers a series of auto- and trans-phosphorylations between RIPK1 and 
RIPK3 that results in the activation of the necrosome (Cho et al., 2009). Phosphorylation 
of RIPK3 is particularly important for recruitment and phosphorylation of the mixed 
lineage kinase domain-like protein (MLKL) (Figure 1-10), which is a key pseudokinase 
mediator of necroptosis signalling downstream of RIPK3 (Murphy et al., 2013; Sun et al., 
2002).  
The cell death signals that occur downstream of MLKL have yet to be characterised in 
full. However, it is known that phosphorylation of MLKL stimulates its oligomerisation 
and translocation to intracellular and plasma membranes causing membrane rupture. 
Little is known about the precise mechanism by which MLKL induces membrane 
destabilisation. Phosphorylated MLKL induces necroptosis via the influx of calcium or 
sodium through ion channels (Cai et al., 2014; Chen et al., 2014) and can also bind to 
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membrane phosphatidylinositol phosphates, causing loss of membrane integrity 
(Dondelinger et al., 2014). 
 
Figure 1-10. Necroptotic pathway induction by TNFα. Binding of TNFα to TNFR1 induces the 
formation of Complex 1 that activates NF-κB signalling. In the absence of cIAPs, the ripoptosome 
platform assembles, causing activation of pro-caspase-8 and extrinsic apoptosis. In the absence 
of active caspase-8, RIPK1 dissociates from the ripoptosome and forms a necrosome complex 
with RIPK3. Association of RIPK1 with RIPK3 stimulates auto- and trans-phosphorylation events 
that cause recruitment and activation of MLKL which executes necroptotic cell death. 
 
RIPK1 is an important component of inflammation, apoptosis and necrosis (Pasparakis 
and Vandenabeele, 2015). The study of cell necrosis has been greatly facilitated by the 
discovery of the RIPK1 inhibitor necrostatin-1 (Nec-1) (Degterev et al., 2005), which 
facilitated the identification of RIPK3 as a crucial regulator of necroptosis (Cho et al., 
2009). Indeed, there are instances where the necroptotic pathway can be RIPK3-
dependent but RIPK1-independent (Kaiser et al., 2013; Upton et al., 2010). It has been 
demonstrated that necroptosis can occur following stimulation of TLR4 or TLR3, leading 
to an interaction between TIR-domain-containing adaptor-inducing interferon-β (TRIF), 
RIPK3 and MLKL (Kaiser et al., 2013). More recently, non-receptor mediated RIPK3-
MLKL-necroptosis was observed to be stimulated by ion dysregulation caused by pore-
forming toxins (Gonzalez-Juarbe et al., 2017). Therefore, given the recurrent role of 
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RIPK3, necroptosis is defined as a RIPK3-dependent molecular cascade that promotes 
regulated necrosis (Moriwaki and Chan, 2014).  
1.7.4.2 Pyroptosis 
Similar to necroptosis, pyroptosis is an inflammatory form of cell death with important 
functions in host defence and inflammation. However, unlike necroptosis, pyroptosis is 
induced by inflammasome activation (Bergsbaken et al., 2009).  
Pyroptosis is triggered in macrophages following C. albicans infection (O'Meara et al., 
2015; Uwamahoro et al., 2014; Wellington et al., 2014). In response to C. albicans 
hyphae, epithelial cells release immune modulators and immune cells are recruited to 
the site of fungal infection (Moyes et al., 2010; Steele and Fidel, 2002) (see Section 
1.6.1). Macrophages play a key role in protecting the host by recognising and 
phagocytosing C. albicans yeast cells (Lewis et al., 2012) (Figure 1-11). During 
engulfment, the phagosome containing the yeast fuses with a lysosome generating a 
phagolysosome essential for fungal killing (Figure 1-11). During this process, hydrolytic 
enzymes, antimicrobial peptides, and ROS destroy the engulfed C. albicans within the 
phagolysosome (da Silva Dantas et al., 2016). However, C. albicans has evolved 
strategies to survive and escape from macrophages. One of these strategies involves 
morphological switching of C. albicans from a yeast to a hypha that pierces through the 
phagolysosome membrane and macrophage plasma membrane to escape (Wellington 
et al., 2014). Interestingly, prior to hyphal escape,        C. albicans induces macrophage 
programmed cell death via pyroptosis (Uwamahoro et al., 2014). 
Although C. albicans is able to physically escape from the macrophage phagolysosome, 
the induction of pyroptotic cell death plays an important role in host defence against 
pathogens (Jorgensen et al., 2017). Indeed, pyroptosis leads to the release of immune 
modulators that facilitate the recruitment of additional immune cells including DCs and 
neutrophils. The expression and release of immune modulators during pyroptosis is 
specifically attributed to the activation of a protein platform named the inflammasome, 





Figure 1-11. Phagocytosed C. albicans can escape from macrophages by hypha-mediated lysis 
and pyroptosis.  Following recognition of C. albicans yeast cells (green), macrophages engulf the 
fungus into a phagosome. The phagosome fuses with a lysosome, creating a phagolysosome that 
can kill the internalised fungus. However, C. albicans can circumvent this process by producing 
a hypha that induces pyroptosis and cell lysis, enabling the fungus to escape from the 
macrophage. Adapted from (da Silva Dantas et al., 2016). 
  
1.7.4.2.1 The canonical inflammasome 
The inflammasome is a pro-inflammatory, multi-protein complex comprised of an NLR. 
Inflammasomes can be activated in response to exogenous or endogenous PAMPs and 
DAMPs. NLRs consist of three domains: a CARD, a pyrin domain (PYD) or baculovirus 
inhibitor of apoptosis repeat (BIR) domain; a central nucleotide-binding oligomerization 
domain (NOD); and a C-terminal leucine-rich repeat sequence (LRR) (Martinon et al., 
2002).  
There are different types of inflammasome, but those most closely associated with           
C. albicans infections are the NLRP3 and the NLRC4 inflammasomes (Hise et al., 2009; 
Tomalka et al., 2011; van de Veerdonk et al., 2011; Wellington et al., 2014). NLRP3 is the 
crucial NLR involved in C. albicans infections and is present in both immune cells and 
stromal compartments (Hise et al., 2009; Wellington et al., 2014). In addition to NLRP3, 
C. albicans can also trigger the inflammasome via NLRC4 (Tomalka et al., 2011). NLRC4 
is involved in mucosal defences against C. albicans (Tomalka et al., 2011).  
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In myeloid cells, two independent signals are required to activate the inflammasome. 
The first signal (mediated by the recognition of C. albicans PAMPs by myeloid cell PRRs) 
stimulates the expression of pro-caspase-1, pro-IL-1β and pro-IL-18, and is followed by 
assembly of the inflammasome complex and activation of caspase-1 (Afonina et al., 
2015; Joly and Sutterwala, 2010). The C. albicans factor(s) that comprise the second 
activator signal remain elusive (Joly and Sutterwala, 2010; Wellington et al., 2014). 
Nonetheless, when myeloid cells interact with C. albicans, NLRP3 recruits an adaptor 
protein (apoptosis-associated speck-like protein containing a CARD (ASC)) which 
provides a molecular bridge between NLRP3 and pro-caspase-1 (Figure 1-12).  
In contrast to NLRP3, NLRC4 binds directly to pro-caspase-1 through a CARD-CARD 
interaction (Figure 1-12 B). The interaction between NLRC4 and pro-caspase-1 
culminates in the assembly of the canonical inflammasome, which results in the 
autocatalytic activation of caspase-1. Active caspase-1 then processes pro-IL-1β and pro-
IL-18 from their immature, biologically inactive forms into the biologically functional 







Figure 1-12. Organisation of the NLRP3 and the NLRC4 inflammasome cascades. (A) The NLRP3 
inflammasome contains an NLRP3 receptor, the adaptor protein ASC and caspase-1. The NLRP3 
receptor contains an LRR, NOD and PYD. (B) The NLRC4 inflammasome contains the NLRC4 
receptor and caspase-1. The NLRC4 receptor is comprised of an LRR, NOD and CARD. Both NLRP3 
and NLRC4 inflammasome complexes culminate with pro-caspase-1 activation which cleaves 
pro-IL-1β and pro-IL-18.  
 
In addition to PAMPs, Saps have been associated with the activation of the NLRP3 
inflammasome in macrophages (Pietrella et al., 2013). Saps contribute to C. albicans-
mediated host damage and evasion of the immune response (Naglik et al., 2003). Sap2p 
and Sap6p in particular have been shown to be endocytosed by macrophages where 
they trigger ROS production, release of cathepsin B and efflux of potassium ions prior to 
inflammasome assembly (Pietrella et al., 2013). Once assembled, activation of caspase-
1 occurs, which is required for processing and secretion of active IL-1β and IL-18 
(Pietrella et al., 2013).  
Inflammasome activation has been studied extensively in myeloid cells. Interestingly, 
the two-step process of inflammasome activation may not be required in epithelial cells, 
since NLRC4 and pro-IL-18 are constitutively expressed (Lei-Leston et al., 2017), 
suggesting that assembly of the epithelial inflammasome may not require priming.  
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1.7.4.2.2 The non-canonical inflammasome 
The non-canonical inflammasome is an alternative platform that promotes processing 
of pro-IL-1β and pro-IL-18 in macrophages and epithelial cells (Kayagaki et al., 2011; 
Knodler et al., 2014). The inflammatory caspase-11 can interact directly with LPS and 
intracellular bacteria leading to pro-IL-1β and pro-IL-18 processing and pyroptotic death 
(Hagar et al., 2013; Kayagaki et al., 2013) (Figure 1-13). Caspase-11 induces cytokine 
processing by promoting assembly and activation of the NLRP3 inflammasome (Kayagaki 
et al., 2011) (Figure 1-1). C. albicans Sap2p and Sap6p were observed to stimulate 
activation of the non-canonical inflammasome in macrophages, resulting in caspase-11 
activation and NLRP3 inflammasome-mediated processing and secretion of IL-1β 
(Gabrielli et al., 2015).  
1.7.4.2.3 IL-1β and IL-18 secretion by active inflammasomes elicit immune responses 
Activation of canonical and non-canonical inflammasomes promotes the cleavage and 
secretion of IL-1β and IL-18 from immune and epithelial cells (Dinarello et al., 2013; 
Schaller et al., 2004; Tardif et al., 2004a; Tardif et al., 2004b; Wellington et al., 2014). IL-
1β is a strong chemoattractant for leukocytes and a potent pro-inflammatory cytokine 
that promotes recruitment of immune cells to the site of infection. When the immune 
cells are recruited, IL-1β activates dendritic cells, macrophages and neutrophils, which 
remove invading microbes from the body (Dinarello, 1996). Furthermore, IL-1β 
participates with other cytokines in the process of T-cell activation to induce Th17 cell 
differentiation and adaptive immunity (Ben-Sasson et al., 2009). Similar to IL-1β, IL-18 is 
also expressed as inactive precursor (pro-IL-18) that is secreted from cells following 
inflammasome activation. IL-18 in combination with IL-12 has been shown to promote 
IFN-γ secretion by T cells to induce Th1 differentiation crucial for controlling 
disseminated fungal infection (Mencacci et al., 2000). 
The NLRP3 and the NLRC4 inflammasomes have important roles in host defence against 
C. albicans infection. Indeed, NLRP3-deficient mice and mice deficient in the 
inflammasome components ASC and caspase-1 are more susceptible to disseminated    
C. albicans infection, due to a lack of neutrophil influx to the site of infection (Gross et 
al., 2009; Hise et al., 2009; Joly et al., 2009; van de Veerdonk et al., 2011). However, 
during the early stages of invasive infection, the absence of caspase-1 did not have a 
clear effect on IL-1β production or neutrophil influx in vivo, suggesting that early 
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neutrophil influx was not dependent on the NLRP3 inflammasome (Mencacci et al., 
2000; van de Veerdonk et al., 2011). 
Neutrophils release proteinase 3, neutrophil elastase and cathepsin G that process pro-
IL-1β into mature biologically active IL-1β (Afonina et al., 2015; Joosten et al., 2009). 
During the later stages of C. albicans infection, the inflammatory response becomes 
increasingly dependent upon the inflammasomes of macrophages and T-cells, which 
produce IL-1β that contributes to Th17 responses, and IL-18 that contributes to robust 
Th1 responses (van de Veerdonk et al., 2011). 
1.7.4.2.4 Gasdermin D cleavage by inflammasomes causes pyroptotic cell death 
Besides pro-IL-1β and pro-IL-18, another recently discovered target of canonical and 
non-canonical inflammasomes is gasdermin D, which is also required for the execution 
of pyroptotic cell death (Kayagaki et al., 2015; Shi et al., 2015). Caspase-1 and caspase-
11 cleave gasdermin D, resulting in release of the gasdermin D N-terminus that induces 
pores in plasma membranes, thereby dissipating cellular ionic gradients and resulting in 
lytic cell death (Kayagaki et al., 2015; Shi et al., 2015) (Figure 1-13). Gasdermin D is highly 
expressed in epithelial cells, suggesting a potential role of this protein in driving 




Figure 1-13. Pyroptosis is induced by canonical and non-canonical inflammasome activation. 
Canonical inflammasomes act as sensors for a variety of pathogens and cellular insults. Assembly 
of the NLRP3 inflammasome involves recruitment of the adaptor protein ASC and pro-caspase‐
1, resulting in caspase-1 activation. In the non-canonical pathway, LPS is bound by pro-caspase‐
11 resulting in activation. Caspase‐1 processes the interleukins IL‐1β and IL-18. Caspase-11 
participates in pro-IL‐1β and pro-IL-18 cleavage by potentiating the canonical inflammasome. 
Both caspase‐1 and caspase‐11 process gasdermin D, resulting in the release of the gasdermin 
D N-terminus, which forms a pore in the host cell plasma membrane. Pore formation results in 
rapid loss of membrane integrity, dissipation of the electrochemical gradient, and cell death. 
 
1.7.5 Summary of the characteristic features of different cell death pathways 
The study of pathogen-induced host cell death has gained attention with the recognition 
that this phenomenon may not be an incidental occurrence during infection, but a 
controlled process with significant implications for disease pathogenesis. As described 
above, pathogen-induced cell death may occur by a variety of complex mechanisms 
including apoptosis, necrosis, necroptosis and pyroptosis. Table 2 summarises the 
features characterising these different modes of cellular death. 
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1.8 Project Aims 
Essential information is still missing from our understanding of how epithelial cells 
respond to C. albicans infection. Epithelial cells that comprise mucosal surfaces are 
typically the first-line barrier against C. albicans and are targeted by C. albicans virulence 
factors to cause cell death at the mucosal surface, which may facilitate infection. To 
date, it has been demonstrated that C. albicans induces apoptotic events and necrosis 
in oral epithelial cells (Villar et al., 2012; Villar and Zhao, 2010; Wagener et al., 2012) and 
pyroptosis in macrophages (Uwamahoro et al., 2014; Wellington et al., 2014).  
C. albicans pathogenicity is multifactorial, thus there may be numerous factors that 
contribute to the induction of epithelial cell death. The discovery that Candidalysin is 
required for epithelial damage during mucosal infection (Moyes et al., 2016) establishes 
an intriguing link between host cell stress and death. 
Cell death is an important defence mechanism in response to microbial infection. Thus, 
given the essential role of Candidalysin in causing epithelial damage and triggering 
epithelial signalling pathways during mucosal infection, the central aim of this study is 
to determine whether epithelial cell death responses and signalling pathways are 
activated in response to Candidalysin. 
The specific aims of this project are to: 
1. Determine the role of Candidalysin in activating oral epithelial cell death 
responses by investigating classical hallmarks of cellular stress. 
2. Investigate oral epithelial apoptotic responses to Candidalysin. 
3. Examine the role of Candidalysin in driving programmed necrosis in oral 
epithelial cells focusing on the study of necroptosis and pyroptosis pathways. 
 
Since the activity of Candidalysin was originally characterised on TR146 oral epithelial 
cells (Moyes et al., 2016), the same cell line was used to investigate cell death responses. 
This project will expand upon our understanding of the role played by Candidalysin 
during infection at mucosal surfaces and will provide insight into the ability of 




Chapter 2: Materials and Methods 
2.1 General materials and equipment 
2.1.1 General chemicals 
Dulbecco’s phosphate-buffered saline (D-PBS; Sigma) consisted of 1.4 M NaCl, 27 mM 
KCl, 80 mM Na2HPO4 x H2O, 15 mM KH2PO. For MTT assays, 3-(4,5-dimethylthiazol-2-yl)-
2,5-diphenyltetrazolium bromide (MTT) was supplied by Merck and solubilisation 
solution consisted of 50% dimethylformamide (Prolabo), 0.2% glacial acetic acid (BDH 
Chemicals), 20 mM hydrochloric acid (HCl; BDH Chemicals), 10% (w/v) sodium dodecyl 
sulphate (SDS; Severn Biochem Ltd).  
For protein extraction, Radio Immuno-Precipitation Assay (RIPA) buffer was made of (50 
mM Tris-HCl pH 7.5 (Sigma), 150 mM NaCl (Sigma), 1% (v/v) Triton X-100 (Sigma), 1% 
(w/v) sodium deoxycholate (Sigma), 0.1% (w/v), SDS (Severn Biochem Ltd) and 20 mM 
ethylenediaminetetraacetic acid (EDTA; Sigma). Protease inhibitor was supplied by 
Fisher Scientific and phosphatase inhibitor was supplied by Sigma.  
For western blotting, 4X Laemmli sample buffer was supplied by Alfa Aesar and 
dithiothreitol (DTT) from Sigma. Running buffer 10X (Sigma) consisted of 250 mM Tris 
base, 2.5 M glycine, and 1% SDS. Transfer buffer 10X consisted of 3% (w/v) Tris (VWR 
chemicals) and 14.5% (w/v) glycine (Sigma). 10% methanol (VWR chemicals) was added 
to 1X transfer buffer. Tris-buffered saline 10X (TBS) buffer (Severn Biotech) consisted of 
2.5 M Tris and 15 M NaCl, supplied at pH 7.4. 0.1% TWEEN20 (Sigma) was added to 1X 
TBS to make TBS and TWEEN20 (TBS-T). In all cases, ddH2O was used for dilutions to 1X. 
Antibodies were diluted in 1X TBS-T, using either 5% (w/v) bovine serum albumin (BSA; 
Sigma) or 5% (w/v) milk powder (Sainsbury’s, UK).  
General Caspase Inhibitor Z-VAD-FMK was purchased from R&D. TNF was a kind gift 
provided by Prof Sarah Gaffen (University of Pittsburgh, USA). Recombinant Human IL-
1β was purchased from R&D Systems and Recombinant Human IL-18 was purchased 
from MBL. Peptides were purchased from Proteogenix (France) and Peptide Protein 
Research Ltd (UK).  
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2.1.2 General equipment 
Tissue culture flasks (T182) and 15 mL Falcon tubes were purchased from Jet Biofil. 
Tissue culture plates (96 well, 24 well, 12 well and 6 well) were supplied by Cellstar. 
Black 96-well plates were purchased from Costar. Falcon tubes (50 mL) were purchased 
from Corning. Pipettes (25 mL, 10 mL and 5 mL) and white 96 well plates were purchased 
from Fisher Scientific. Pipette tips (1000 μL, 200 μL and 10 μL), 1.5 mL Eppendorf tubes 
and 10 μL sterile disposable loops were purchased from StarLab. Immulon 96 well plates 
were purchased from Thermo Scientific. Petri dishes (90 mm) were purchased from 
Sterilin. Dual chamber counting slides were purchased from BIORAD. Sterile Nalgene 
Cryogenic vials were purchased from Nalge Nunc International. Microbank Cryovial 
beads were purchased from Pro-Lab Diagnostics.  
Sterile tissue culture was performed in a Scanlaf MARS Class II safety cabinet. Infections 
were carried out in a NUAIRE Class II biological safety cabinet. Epithelial cell cultures 
were incubated in a Binder humidified incubator at 37°C, 5% CO2. Centrifugation at 25°C 
was performed in an Eppendorf Centrifuge 5415C (up to 1.5 mL sample volume) and a 
MSE Mistral 3000 Centrifuge (up to 25 mL sample volume). Centrifugation at 4°C was 
performed in a Howe Sigma 3K10 Centrifuge (up to 50 mL sample volume). 
Centrifugation at 20°C was performed in a MSE Mistral 1000 Centrifuge (MSE Scientific 
Instruments). A Tecan Infinite F50 plate reader was used to read microplates for lactate 
dehydrogenase (LDH) and enzyme-linked immunosorbent assay (ELISA). A Jenway 6300 
spectrophotometer was used to obtain the absorbance of microbial cultures. 
Fluorescence and luminescence were measured using a FlexStation 3 Multi-Mode 
microplate reader (Molecular Devices). 
2.2 Fungal culture 
2.2.1 C. albicans growth medium 
C. albicans cells were cultured in liquid yeast peptone dextrose (YPD) or on solid YPD 
agar, consisting of 1% (w/v) yeast extract (Oxoid), 2% (w/v) Peptone (Melford), 2% (w/v) 
dextrose (BDH Chemicals) and 1.5% (w/v) agar (Melford). 
2.2.2 Creation of C. albicans mutants, growth and maintenance  
C. albicans ECE1 mutants used in this study (Table 2.1) were generated by our 
collaborator Professor Bernhard Hube (Moyes et al., 2016). 
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Table 2.1 Description of C. albicans strains used in this study. 
C. albicans strain Description  Genotype 
BWP17+Clp30 Derived from SC5314 
(Gillum et al., 1984). 
Parent strain of ece1Δ/Δ 
and ece1Δ/Δ+ECE1 (Moyes 






ece1Δ/Δ Homozygous null mutant 







ece1Δ/Δ+ECE1 Homozygous null mutant 
complemented with a 
single wild type copy of 
ECE1. Parent strain of 
ece1Δ/Δ+ECE1Δ184-279 







ece1Δ/Δ+ECE1Δ184-279 Homozygous null mutant 
complemented with a 
single copy of ECE1 with 
Candidalysin excised 








Stocks of C. albicans yeast strains were stored in cryogenic beads (Pro-lab Diagnostics) 
at -80°C. YPD agar was autoclaved and poured into sterile Petri dishes. Once set,                 
C. albicans strains were streaked for single colonies and incubated at 37°C for 2 days in 
a static incubator. For liquid culture, a single colony of C. albicans was inoculated into 
YPD liquid medium and cultured at 30°C in an orbital shaker at 200 rpm overnight. 
Saturated culture (1 mL) was centrifuged and the pellet washed twice with filter-
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sterilised PBS. The absorbance of the culture at a 1:100 dilution was measured at 600 
nm using a spectrophotometer (Jenway 6300). This was used to determine the colony 
forming units (CFU)/mL using previously established growth curves. The fungal cells 
were then diluted to the appropriate number of CFU/mL required for the infection. 
In order to freeze down a stock of C. albicans, 1 mL of an overnight culture of C. albicans 
was added to cryogenic beads according to the manufacturer’s instructions and stored 
at -80°C. 
2.2.3 Candidalysin peptides 
In this study, two Candidalysin peptides (Ece1-III62-93KR (KR) and Ece1-III62-92K 
(Candidalysin or K)) were used. Both Candidalysin peptides are derived from the 
processing of a larger 271 amino acid C. albicans protein, Ece1p (Moyes et al., 2016; 
Richardson et al., 2018). In order for C. albicans to produce mature Candidalysin from 
Ece1p, two sequential processing events are required. First, Ece1p is processed by the 
endoproteinase Kex2p, generating the immature Candidalysin peptide Ece1-III62-93KR. 
Once produced, the immature Ece1-III62-93KR peptide is subsequently processed by the 
carboxypeptidase Kex1p, resulting in the removal of a carboxyl arginine residue to 
generate mature Candidalysin.  
Both Ece1-III62-93KR (KR) and Ece1-III62-92K (Candidalysin or K) were synthesised and 
purified by Proteogenex and Peptide Protein Research; and reconstituted to a stock 
concentration of 10 mg/mL in water. Peptide stocks were stored at -20°C. Amino acid 
sequences are shown below.  
Ece1-III62-93KR (KR)    SIIGIIMGILGNIPQVIQIIMSIVKAFKGNKR 
Ece1-III62-92K (Candidalysin or K)  SIIGIIMGILGNIPQVIQIIMSIVKAFKGNK 
 
2.3 Cell culture 
2.3.1 Cell line growth and maintenance  
In this study the oral epithelial cell line TR146 was used. TR146 cells were established 
from a biopsy specimen of a squamous cell carcinoma of the buccal mucosa that had 
infiltrated a lymph node (Rupniak et al., 1985). TR146 cells form a non-differentiated 
and non-keratinised stratified epithelium that share morphological and functional 
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characteristics of normal buccal mucosa. The TR146 cell line is well characterised and is 
routinely used for infection studies in vitro and represents a robust model of the human 
mucosa (Yadev et al., 2011).   
TR146 cells were grown in Dulbecco’s Modified Eagle Medium Nutrient Mixture F-12 
HAM (DMEM F-12; Thermo Fisher Scientific) supplemented with 15% (v/v) foetal bovine 
serum (FBS; PAA) and 1% (v/v) penicillin/streptomycin (Sigma). 
Cell cultures were passaged when confluent. To passage, cells were washed once with 
10 mL D-PBS and incubated for 20 min in 4 mL 0.05% trypsin-EDTA solution (PAA) at 37°C 
and 5% CO2. After detachment, cells were re-suspended in fresh DMEM F-12 medium 
and either counted and seeded at specific cell densities according to experimental 
requirements or maintained until confluent as described above.  
2.3.2 Cell counting 
A TC20 Automated Cell Counter (BIORAD) was used to determine the number of 
trypsinised (detached) cells per mL of culture medium. Adherent cells were detached 
with Trypsin-EDTA as described and approximately 10 μL of cell suspension was pipetted 
into the cell counter slide. Upon insertion of a counting slide, the TC20 cell counter 
provides a total cell count. 
2.3.3 Cell freezing and thawing 
After trypsin treatment, cells were collected and centrifuged at 4°C at 300 x g for 5 min. 
The culture medium was discarded and the cell pellet (containing at least 2 x 106 cells) 
was re-suspended in 1 mL of freezing medium (90% (v/v) FBS and 10% (v/v) DMSO) and 
transferred to a cryovial.  In order to slowly freeze the cells, cryovials were stored at -
80°C in an isopropanol bath and after 7 days transferred to a liquid nitrogen tank (-
200°C) for long-term storage. 
To re-culture frozen cell stocks, cells were rapidly thawed in a 37°C water bath, then re-
suspended in 10 mL of DMEM F-12 medium and centrifuged at 4°C at 300 x g for 5 min. 
The cell pellet was re-suspended in 10 mL of fresh DMEM F-12 and cells transferred to 
a T182 tissue culture flask. Fresh media was added in order to reach a final volume of 24 
mL and incubated at 37°C, 5% CO2. 
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2.3.4 Cell seeding 
Cells were seeded at different densities depending on the assay performed. The number 
of cells per mL of medium was determined using an automated cell counter as described 
and diluted into fresh DMEM F-12 medium to achieve the desired seeding density. Cells 
were then seeded accordingly in cell culture plates (Table 2.2) and incubated for 24 h at 
37°C, 5% CO2. 
Table 2.2 Cell seeding conditions. 
Assay Plate  Volume  Density 
LDH, ELISA and western blot 12 well  1 mL  5 x 105 
Fluorescent microscopy 96 well 100 µL 5 x 104 
MTT  96 well 100 μL 1 x 105 
ROS, Calcium, iATP and Caspase activity  96 well 100 μL 5 x 105 
 
LDH assay, ELISA and western blot: Seeded plates were serum-starved and further 
incubated 24 h prior to infection with C. albicans ECE1 mutants and Candidalysin 
peptides. Time points of 6 h (MOI = 5; 5 fungal cells to 1 epithelial cell) and 24 h (MOI = 
0.01; 1 fungal cell to 100 epithelial cells) were assessed. Candidalysin peptides were used 
at 70, 30, 15 and 3 μM concentration. Following infection, exhausted culture medium 
was collected and either stored at 4°C for quantification of LDH activity or stored at -
20°C for quantification of proteins by ELISA assay. Protein lysates were also extracted 
(see Section 2.5.1) and stored at -20°C for ELISA assay and western blot.  
Fluorescent microscopy: Time points of 3 h, 6 h and 24 h were assessed. Candidalysin 
peptides were used at 70, 30, 15 and 3 μM concentration. Following treatment, cells 
were washed and treated with different fluorescent dyes (see section 2.4.2). 
MTT, iATP and caspase activity assays: Time points of 5 min, 15 min, 30 min, 1 h, 1.5 h, 
2 h, 2.5 h, 3 h, 6 h and 24 h were assessed. Candidalysin peptides were used at 70, 60, 
45, 30, 15, 3 and 1.5 μM concentration. Infected cells were then assayed for 
mitochondrial fitness (MTT assay), intracellular ATP content, and caspase activity. 
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ROS and Calcium assays: These assays were performed in real time. Candidalysin 
peptides were used at 70, 15, 3 and 1.5 μM concentration. Prior to treatment, cells were 
stained with different fluorescent dyes (see section 2.4.4 and 2.4.6). 
 
2.4 Cell response assays 
2.4.1 LDH (Epithelial cell damage) assay 
Epithelial cell damage was determined by a colorimetric assay that quantitatively 
measures the activity of lactate dehydrogenase (LDH). LDH is a stable enzyme present 
in the cell cytosol that is released into the culture medium only when cell membrane 
integrity is compromised. LDH was measured using a Cytox 96 Non-Radioactive 
Cytotoxicity Assay Kit (Promega) according to the manufacturer’s protocol. Briefly, 
exhausted cell culture medium was diluted 1:10 (v/v) in PBS. Recombinant porcine LDH 
(Sigma) was used to create a standard curve ranging from 15 to 960 milliunits (mU) of 
enzymatic activity/mL. Samples and standards were analysed in technical duplicates. 
Substrate solution (50 μL) was added to each sample and standard and incubated for 20 
min at room temperature protected from light. LDH activity was detected using a 
coupled enzymatic assay, in which a tetrazolium salt (INT) is converted into a red 
formazan product. The intensity of colour is proportional to the amount of LDH 
enzymatic activity. Following incubation, the absorbance at 492 nm was quantified using 
a Tecan Infinite F50 plate reader. 
2.4.2 Detection of epithelial cell death by fluorescence microscopy 
Epithelial cell death was investigated using three different fluorescent stainings (Table 
2.3) contained in the Apoptotic/Necrotic/Healthy Cell Detection Kit (Promokine). 
Following cell treatment with Candidalysin peptides, wells were washed twice with 5X 
binding buffer. Staining solution (5 μL FITC-Annexin V, 5 μL Ethidium Homodimer III (Eth 
Homo III) and 5 μL of Hoechst 33342 in 100 μL 5x Binding Buffer) was added to cells and 
incubated for 15 min at room temperature protected from light. Cells were then washed 
once with 5x Binding buffer and images were acquired using an Olympus CKX41 inverted 
microscope using FITC, Texas Red and DAPI filter sets with 10x magnification. 
Staurosporine 0.1 µM (Sigma) was used to induce apoptosis and 1% (v/v) Triton X-100 
(Sigma) was used to induce cell necrosis as positive controls. 
67 
 
Table 2.3 Characteristics of stains used to detect cell death. 
Cell death Stain Filter Fluorescence colour 
Apoptosis FITC-Annexin V FITC Green  
Necrosis Eth Homo III Texas Red Red  
Healthy Hoechst 33342 DAPI Blue  
 
2.4.3 Measurement of epithelial mitochondrial fitness by MTT assay  
The MTT assay relies on the activity of a mitochondrial enzyme, the NAD(P)H 
oxidoreductase which acts as a reporter of active mitochondria. The MTT assay was 
performed by incubating control and treated cells with 20 μL of yellow MTT solution 
containing a tetrazole compound (5 mg of 3-(4,5-dimethylthiazol-2-yl)-2,5-
diphenyltetrazolium bromide prepared in 1 mL of PBS) at 37°C for 3 h. Following the 
addition of MTT solution, active mitochondria reduced the yellow tetrazole compound 
to a purple insoluble formazan. After incubation, 150 μL of MTT solubilisation solution 
(50% (v/v) dimethylformamide, 0.2% (v/v) acetic acid, 20 μM HCl and 20% (w/v) SDS) 
was added to each well to dissolve the formazan, and the plate was incubated at 37°C 
overnight. A solution of 1% (v/v) Triton X-100 was used as a positive control for inactive 
mitochondria. The intensity of colour is proportional to the number of active 
mitochondria. Following overnight incubation, the absorbance at 580 nm was quantified 
using a Tecan Infinite F50 plate reader. 
2.4.4 Intracellular ROS quantification by DCFH-DA staining 
Intracellular ROS was measured using an OxiSelect™ Intracellular ROS Assay Kit (Cell 
Biolabs) according to the manufacturer’s protocol. Briefly, culture medium was removed 
from cells and 50 μL of 2’,7’-Dichlorodihydrofluorescin diacetate (DCFH-DA) solution 
(20x DCFH-DA stock diluted in 1x DMEM F-12 media) added and the plate incubated for 
1 h at 37°C, 5% CO2. The DCFH-DA solution was replaced with 50 μL D-PBS and baseline 
fluorescence readings (excitation 480 nm/emission 530 nm) were taken for 10 min using 
a FlexStation 3 (Molecular Devices). Ece1 peptides were added and readings were taken 
immediately for up to 30 min. When added to cells, DCFH-DA diffuses into cells and is 
deacetylated by cellular esterases to non-fluorescent 2,7’-Dichlorodihydrofluorescin 
(DCFH), which is rapidly oxidized to highly fluorescent 2’,7’-Dichlorodihydrofluorescein 
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(DCF) by ROS. The fluorescence intensity is proportional to the ROS levels within the cell 
cytosol. The data was analysed using Softmax Pro software.  
2.4.5 Intracellular ATP quantification by luminescence assay 
Intracellular ATP was measured using a CellTiter-Glo® Luminescent Cell Viability Assay 
(Promega) according to the manufacturer’s protocol. Briefly, a substrate solution 
containing luciferin and inactive luciferase (CellTiter-Glo® Reagent) was added to control 
and treated cells (1:1 ratio of CellTiter-Glo® Reagent volume to sample volume). 
Catalytic oxidation of luciferin by luciferase in the presence of cellular ATP, Mg2+ and 
molecular oxygen generates a luminescent signal which is proportional to the amount 
of ATP present within the cells. Luminescence was measured using a FlexStation 3 
(Molecular Devices) and data was analysed using Softmax Pro software. 
2.4.6 Intracellular calcium quantification by fura-2 staining 
Intracellular calcium was quantified by pre-incubating epithelial cells with 50 μL/well of 
a fura-2-AM solution. Fura-2 solution consisted of 5 μL fura-2-AM (Life Technologies) 
(prepared at a concentration of 2.5 mM in 50% Pluronic F-127 (Life Technologies):50% 
DMSO), 5 μL probenecid (Sigma) in 5 mL saline solution (140 mM NaCl, 5 mM KCl, 1 mM 
MgCl2, 2 mM CaCl2, 10 mM glucose and 10 mM HEPES, adjusted to pH 7.4). Plates were 
then incubated for 1 h at 37°C, 5% CO2. For experiments performed with Calcium free 
saline solution, 2 mM CaCl2 was replaced with 1 mM EGTA. During the 1 h incubation 
step, the fura-2-AM enters the cell where cellular esterases catalyse the hydrolysis of 
the AM-ester, releasing fura-2 that generates fluorescence in the presence of free Ca2+ 
ions. Following incubation, excess fura-2 solution was removed and replaced with 50 μL 
of saline solution and baseline fluorescence readings (excitation 340 nm/emission 520 
nm) were taken for 10 min using a FlexStation 3 (Molecular Devices). After baseline 
acquisition, Candidalysin peptides were added and readings immediately taken for up 
to 3 h. Data were analysed using Softmax Pro software and expressed as the ratio 
between excitation and emission spectra. 
2.4.7 Caspase activity measurement by luminescence assay 
Caspase-3, caspase-8 and caspase-1 activity was measured using a Caspase-Glo® 3/7, 
Caspase-Glo® 8 or Caspase-Glo® 1 Assay (Promega), according to the manufacturer’s 
protocol. Briefly, a solution containing a cell lysis reagent and a quenched (non-
luminescent) caspase-specific substrate was added to control and treated cells (1:1 ratio 
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of assay reagent volume to sample volume). The addition of the reagent to cells results 
in cell lysis followed by cleavage of the quenched substrate by active caspase-3, -8 or -
1, and the generation of a luminescent signal. The luminescent signal is proportional to 
the amount of active caspase present within the cells. Luminescence was measured 30 
min incubation with the substrate for caspase-3, 1 h for caspase-8 and caspase-1 using 
a FlexStation 3 (Molecular Devices). Data was analysed using Softmax Pro software. 
2.4.8 Cytochrome c and cytokine quantification by ELISA assay 
ELISA kits were used to determine concentration of cytochrome c, IL-1β and IL-18. Cell 
lysates and/or exhausted cell culture medium were quantified for cytochrome c, IL-1β 
and IL-18.  
Determination of cytochrome c, or cytokine concentration was performed by measuring 
absorbance at 450 nm using a Tecan Infinite F50 plate reader. Analyte concentration 
was obtained from a dose response curve based on the reference standards.  
 
2.5 Protein assays 
2.5.1 Protein extraction 
Whole cell lysates were collected by washing cells with ice cold D-PBS and lysing cells in 
RIPA buffer containing 1X protease inhibitors and 1X phosphatase inhibitors. Plates were 
kept on ice and cells were scraped using a sterile cell scraper. After incubation on ice for 
30 min, the crude lysate was clarified by centrifugation at 20,000 x g, 4oC for 10 min. The 
supernatant containing soluble proteins was collected and stored at -20oC until required 
or used immediately in a bicinchoninic acid (BCA) assay to determine protein 
concentration. 
2.5.2 Bicinchoninic Acid (BCA) assay 
Total protein concentrations were determined using a BCA Protein Assay kit (Thermo 
Scientific) according to the manufacturer’s protocol. This biochemical assay is based on 
a reduction of Cu2+ ions to Cu1+ in the BCA reagent. The amount of Cu2+ reduced is 
proportional to the amount of protein present. This is illustrated by a colour change of 
the sample solution. The amount of protein present is quantified with a BSA (Sigma) 
standard curve. BSA was used at a concentration range of 2000 to 31.25 μg/mL. 
Absorbance was measured at 562 nm using a Tecan Infinite F50 plate reader. 
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2.5.3 Sodium Dodecyl Sulphate Polyacrylamide Gel Electrophoresis (SDS-PAGE) 
Protein samples (10 μg) were mixed with 1X Laemmli (Sample buffer) containing 100 μM 
DTT and appropriate volumes of filtered-sterilised PBS. Samples were heated at 80oC for 
5-10 min (ThermoQ BIOER) and used directly for gel electrophoresis. SDS-PAGE gels 
(12% acrylamide) were fitted into a glass chamber filled with 1X running buffer. Pre-
stained protein ladder (3 μL) (New England BioLabs) and 15 μL of sample were applied 
to the gel and electrophoresis was performed at 90 V for approximately 2 h using a 
Tetracell System (Biorad). After separation, proteins were analysed by western blot 
analysis. 
2.5.4 Western blot analysis 
Following electrophoresis, western blot analysis was used to visualise target proteins. 
Briefly, separated proteins were transferred onto nitrocellulose membranes (BIORAD) 
using a blotting tank. Gel and membrane were placed between a double layer of 
chromatography paper (Whatman), and were then placed between the sponges of a 
transfer cassette. The sandwiched cassette was inserted into a tank between two 
electrodes, with the gel facing the cathode. The tank was filled with transfer buffer and 
the proteins transferred to membrane at 100 V for 1 h (BIORAD). 
Following transfer, the membrane was removed from the cassette and incubated on a 
shaker for 1 h in a blocking solution (5% dry milk prepared in 1X TBS-T). This step is 
required to prevent non-specific binding of the primary antibody to the membrane.  
Membranes were subsequently incubated overnight with primary antibodies (Table 2.4) 
diluted in either 5% dry milk or 5% BSA prepared in TBS-T at 4oC and washed 3X for 10 
min with 1X TBS-T. Secondary IgG horseradish peroxidase (HRP)-conjugated antibodies 
(Jackson ImmunoResearch) were diluted in 5% dry milk in TBS-T (1:10000), and were 
added to the membranes and incubated at room temperature for 1 h. After washing the 
membranes 3X for 10 min, target proteins were detected by incubating membranes in 
a chemiluminescent solution (Immobilon western, Chemiluminescent Substrate; 
Millipore) for 5 min and exposing the membrane to film (GE Healthcare Life Sciences).  
The primary antibody for the loading control Actin (diluted 1:10000) and secondary 
antibody (diluted 1:20000) were incubated with membrane for 30 min at room 
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temperature. Before exposure to film, membranes were incubated with the 
chemiluminescent solution for 30 sec.  








Caspase-8 Anti-Rabbit 10, 57 1:1000 Cell signalling 
Caspase-3 Anti-Rabbit 17, 19, 35 1:1000 Cell Signalling 
PARP Anti-Rabbit 96, 116 1:1000 Cell Signalling 
cIAP2 Anti-Rabbit 70 1:1000 Cell Signalling 
RIPK1 Anti-Rabbit 78 1:1000 Cell Signalling 
P-RIPK1 Anti-Rabbit 78-82 1:1000 Cell Signalling 
RIPK3 Anti-Rabbit 57 1:1000 Abcam 
P-RIPK3 Anti-Rabbit 57-70 1:2000 Abcam 
MLKL Anti-Rat 52 1:1000 Millipore 
P-MLKL Anti-Rabbit 54 1:1000 Abcam 
NLRP3 Anti-Rabbit 85, 110 1:1000 Cell Signalling 
ASC Anti-Rabbit 22 1:1000 Cell Signalling 
Caspase-1 Anti-Rabbit 20, 30-45, 50 1:1000 Cell Signalling 
IL-1β Anti-Rabbit 17, 31 1:1000 Cell Signalling 
IL-18 Anti-Rabbit 22 1:2000 Millipore 
Gasdermin D Anti-Mouse 54, 31, 22 1:1000 Santa Cruz 
actin Anti-Mouse 43 1:10000 Millipore 
 
2.6 Statistical analysis of data 
Assay data was analysed by one-way analysis of variance (ANOVA) using Sigma Plot 12.5 
software and the Holm-Sidak method was applied to establish statistically significant 




Chapter 3: Role of C. albicans Candidalysin peptides in driving 
cell death processes in human oral epithelial cells. 
 
3.1 Introduction 
The balance between cell death and cell survival is a critical factor that determines the 
correct growth and development of tissues and organs within the body, and is a vital 
process that enables health to be maintained, particularly during periods of microbial 
infection. Epithelial cells form the mucosal surfaces of the body and are usually the first 
point of contact between host and pathogen and are the first line of defence against 
microbes. Since epithelial cells are in continuous contact with commensal and 
pathogenic microbes, their ability to discriminate between the two is essential to health 
(Naglik et al., 2011). 
During oropharyngeal candidiasis, the interaction between C. albicans and the oral 
mucosa results in cell death pathways being induced in oral epithelial cells (Chiang et al., 
2007; Park et al., 2005; Villar et al., 2012; Villar and Zhao, 2010). Activation of specific 
death pathways in response to microbial stimuli plays an essential role in modulating 
the pathogenesis of a variety of infectious diseases.  
The ability of C. albicans to switch from commensal to pathogenic growth at mucosal 
surfaces is accompanied by a change in the physical morphology of the fungus from 
spherical yeast to elongated hyphae that cause damage, inflammation and consequent 
release of inflammatory mediators including cytokines and damage-associated 
molecular patterns (DAMPs) (Villar et al., 2005). Research in our group has 
demonstrated that the hypha-associated protein Ece1p, is a key virulence factor of            
C. albicans. Subsequent analysis of Ece1p has identified that this protein is processed 
within the fungus into eight smaller peptides; first into a 32 amino acid (aa) peptide 
(termed Ece1-III62-93KR) and then into a 31 aa peptide (termed Candidalysin). Both 
Candidalysin peptides act by inserting into epithelial cell membranes, which results in 
the induction of pro-inflammatory responses and damage (Moyes et al., 2016). 
 The signalling pathways that promote cell death are present in all somatic cells in the 
body and play a crucial role in eliminating infected cells and triggering inflammatory 
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responses (Moriwaki and Chan, 2013). Thus, the aim of this chapter is to determine the 
role of C. albicans Ece1p and Candidalysin peptides in activating oral epithelial cell death 
responses by investigating classical hallmarks of cellular stress including membrane 
permeability, mitochondrial fitness, intracellular levels of reactive oxygen species (ROS), 
adenosine triphosphate (ATP) and calcium.  To study these responses, an oral epithelial 
cell line (TR146) was used. TR146 were isolated from a biopsy specimen of a squamous 
cell carcinoma of the buccal mucosa (Rupniak et al., 1985) representing closely the site 
where C. albicans colonizes, infiltrates and causes infection. This cell line has been 
extensively used in epithelial - C. albicans and epithelial – Candidalysin interaction 
studies, with TR146 seeding densities, C. albicans multiplicity of infection (MOI) and 
Candidalysin peptide concentrations optimised in previous publications (Moyes et al., 
2010; Moyes et al., 2014; Moyes et al., 2016).   
3.2 Methods 
3.2.1 Epithelial cell damage assay 
TR146 monolayers were treated with C. albicans strains (Table 3-1) at an MOI of 0.01 
and with Ece1-III62-93KR or Candidalysin (described in section 2.2.3) at 70, 30, 15 and 3 µM 
for 24 h.  Epithelial cell damage was determined by measuring LDH activity in exhausted 
cell culture medium using a Cytox 96 Non-Radioactive Cytotoxicity Assay (Promega). 
Recombinant porcine LDH (Sigma) was used to produce a standard curve (see section 
2.4.1). 
3.2.2 Fluorescent microscopy 
TR146 oral epithelial cells were treated with Ece1-III62-93KR or Candidalysin at 70, 30, 15 
and 3 µM, 0.1 µM staurosporine, and 1% (v/v) Triton X-100 for 3, 6 and 24 h. After 
staining with FITC-Annexin V, Ethidium Homodimer III (Eth Homo III) and Hoechst 33342, 
cells were imaged with an Olympus CKX41 inverted microscope (for full details see 
section 2.4.2). 
3.2.3 MTT assay 
TR146 oral epithelial cells were treated with Ece1-III62-93KR or Candidalysin at 70, 60, 45, 
30, 15, 3 and 1.5 μM for 5 min, 15 min, 30 min, 1 h, 1.5 h, 2 h, 2.5 h, 3 h, 6 h and 24 h. 
Mitochondrial fitness was assessed by quantifying the activity of the NAD(P)H-
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oxidoreductase by adding MTT solution for 3 h followed by solubilisation solution 
overnight (for full details see section 2.4.3). 
3.2.4 Detection of intracellular ROS 
TR146 oral epithelial cells were pre-incubated for 1 h with DCFH-DA and treated with 
Ece1-III62-93KR or Candidalysin at 70, 15 and 3 µM. Fluorescence readings were 
immediately taken for up to 30 min (for full details see section 2.4.4).  
3.2.5 Detection of intracellular ATP 
TR146 oral epithelial cells were treated with Ece1-III62-93KR or Candidalysin at 70, 60, 45, 
30, 15, 3 and 1.5 μM for 5 min, 15 min, 30 min, 1 h, 1.5 h, 2 h, 2.5 h, 3 h and 6 h. 
Intracellular ATP levels were quantified by adding a substrate solution and immediately 
measuring luminescence (see section 2.4.5). 
3.2.6 Detection of intracellular calcium 
TR146 oral epithelial cells were pre-incubated for 1 h with Fura-2 solution and treated 
with Ece1-III62-93KR or Candidalysin at 70, 15, 3 and 1.5 µM in assay buffers that contained 




3.3.1 Damage of oral epithelial cells is Candidalysin dependent 
The role of Candidalysin in causing epithelial cell damage was first examined using 
Candida strains (Section 3.2.1, Table 3-1). The TR146 cell line was cultured to confluency 
and infected with Candida strains at a MOI of 0.01 for 24 h. After incubation, exhausted 
medium was collected and quantified for LDH activity (Figure 3-1).  
Infection of epithelial cells with BWP17 and ECE1 revertant (ece1Δ/Δ+ECE1) caused 
significant LDH activity when compared with the vehicle control. In contrast, C. albicans 
mutant strains unable to express and secrete Candidalysin (ece1Δ/Δ and 
ece1Δ/Δ+ECE1Δ184-279) were reduced of damaging the epithelium. These data 





Figure 3-1. Damage of oral epithelial cells by C. albicans ECE1 mutants. TR146 oral epithelial 
cells were infected with a panel of C. albicans ECE1 mutant strains (MOI of 0.01) for 24 h and 
exhausted cell medium was quantified for LDH activity as a marker of cellular damage. Data are 
the mean of three biological replicates (+SEM). Statistical significance was calculated by one way 
ANOVA, *** P<0.001. 
 
Next, I determined if direct application of Candidalysin peptides could also induce 
epithelial damage in a manner similar to C. albicans infection. TR146 monolayers were 
incubated with Ece1-III62-93KR or Candidalysin (see section 2.2.3) at 70, 30, 15 and 3 µM 
for 24 h. Following treatment, exhausted medium was assayed for LDH activity (Figure 
3-2).  
This data demonstrates that TR146 cells released LDH in response to Candidalysin 
peptides in a dose-dependent manner. Treatment with Ece1-III62-93KR or Candidalysin at 
a concentration of 70 and 30 μM caused significant epithelial damage when compared 
with the vehicle control. Damage was not observed at peptide concentrations below 15 
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μM. These results confirm the importance of this toxin for C. albicans-induced epithelial 
damage.  
Figure 3-2. Damage of oral epithelial cells by C. albicans Candidalysin peptides. TR146 oral 
epithelial cells were incubated with C. albicans Candidalysin peptides at different concentrations 
(70, 30, 15 and 3 μM) for 24 h and cell exhausted culture medium was assayed for LDH activity 
as a marker of cellular damage. Data are the mean of three biological replicates (+SEM). 
Statistical significance was calculated by one way ANOVA, ** P<0.01, *** P<0.001. 
 
3.3.2 Induction of cell death processes by Candidalysin peptides 
Cell damage can occur in response to different stress stimuli including chemical, 
physical, infectious, biological, nutritional or immunological factors. Depending on the 
extent of injury, the cell is able to repair itself or can undergo cell death. Cell death 
involves physical changes to the cell membrane and disruption of cellular homeostasis. 
Thus, a qualitative approach was initially used to investigate epithelial membrane 
permeability in oral epithelial cells exposed to Candidalysin peptides. 
TR146 oral epithelial cells were treated with Candidalysin peptides and fluorescence 
microscopy was performed to visualise markers associated with cell damage and death. 








































treatment with Candidalysin peptides. FITC-Annexin V produces green fluorescence 
when bound to phosphatidylserine residues exposed on the outer surface of the lipid 
bilayer of apoptotic cells. Eth Homo III is unable to cross intact epithelial plasma 
membranes, but is able to enter cells with damaged membranes where it intercalates 
with DNA to produce red/yellow fluorescence. Hoechst 33342 (blue fluorescence) was 
used to visualise epithelial nuclei. As positive controls, 0.1 µM staurosporine was used 
to induce apoptosis (Kabir et al., 2002) and 1% (v/v) Triton X-100 was used to induce cell 
necrosis (Kwon et al., 2011). 
Treatment with Ece1-III62-93KR or Candidalysin resulted in TR146 epithelial cells that were 
weakly positive for Annexin V but strongly positive for Eth Homo III staining (Figures 3-
3, 3-4 and 3-5), particularly at higher concentrations of peptides (30 and 70 μM) at all 
time points tested (3, 6 and 24 h).  Epithelial cells appeared more fluorescent for both 
Annexin V and Eth Homo III when treated with Ece1-III62-93KR compared with Candidalysin 
and, in general, the quantity of cells that exhibited positive staining increased over time.  
In summary, epithelial cells treated with Candidalysin peptides display a change in 
membrane permeability with Annexin V binding to phosphatidylserine and Eth Homo III 
penetrating into cells. Thus, treatment of epithelial cells with Candidalysin peptides 
results in characteristic features associated with both apoptotic and necrotic death, but 
predominantly necrotic cell death.  
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    Vehicle control          0.1 µM Staurosporine      1% Triton X-100  
  3 h 
 
 
   
    3 µM            15 µM        30 µM    70 µM 
  Ece1-III62-93KR 
   
 
 
  Ece1-III62-92K 
  (Candidalysin) 
    
 
Figure 3-3. Cell death markers induced in epithelial cells by Candidalysin peptides after 3 h. TR146 oral epithelial cells were pre-incubated with Hoechst 33342 
(blue-fluorescent staining of the entire cell population), FITC Annexin V fluorochromes (apoptotic stain: Green), Eth Homo III (necrotic stain: Red/Yellow) and 
incubated with Candidalysin peptides (70, 30, 15 and 3 μM) for 3 h. 0.1 µM staurosporine was used as control to induce Annexin V postive cells and 1% (v/v) Triton 
X-100 for Ethidium Homodimer III positive cells. Data are representative of three biological replicates. Images were taken with a fluorescence microscope at 100x 
magnification. Scale bars are 500 μm. 
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    Vehicle control          Staurosporine 0.1 µM      Triton X 100 1% 
  6 h 
 
 
   
    3 µM            15 µM        30 µM    70 µM 
  Ece1-III62-93KR 
   
 
 
  Ece1-III62-92K 
  (Candidalysin) 
    
 
Figure 3-4. Cell death markers induced in epithelial cells by Candidalysin peptides after 6 h. TR146 oral epithelial cells were pre-incubated with Hoechst 33342 
(blue-fluorescent staining of the entire cell population), FITC Annexin V fluorochromes (apoptotic stain: Green), Eth Homo III (necrotic stain: Red/Yellow) and 
incubated with Candidalysin peptides (70, 30, 15 and 3 μM) for 6 h. 0.1 µM staurosporine was used as control for Annexin V postive cells and 1% (v/v) Triton X-100 
for Ethidium Homodimer III positive cells. Data are representative of three biological replicates. Images were taken with a fluorescence microscope at 100x 
magnification. Scale bars are 500 μm. 
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    Vehicle control          Staurosporine 0.1 µM      Triton X 100 1% 
  24 h 
 
 
   
    3 µM            15µM        30 µM    70 µM 
  Ece1-III62-93KR 
   
 
 
  Ece1-III62-92K 
  (Candidalysin) 
    
 
Figure 3-5. Cell death markers induced in epithelial cells by Candidalysin peptides after 24 h.  TR146 oral epithelial cells were pre-incubated with Hoechst 33342 
(blue-fluorescent staining of the entire cell population), FITC Annexin V fluorochromes (apoptotic stain: Green), Eth Homo III (necrotic stain: Red/Yellow) and 
incubated with Candidalysin peptides (70, 30, 15 and 3 μM) for 24 h. 0.1 µM staurosporine was used as control for Annexin V postive cells and 1% (v/v) Triton X-100 
for Ethidium Homodimer III positive cells. Data are representative of three biological replicates. Images were taken with a fluorescence microscope at 100x 
magnification. Scale bars are 500 μm.
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3.3.3 Candidalysin peptides induce loss of mitochondrial fitness in TR146 cells 
During periods of cell stress, mitochondrial viability is often negatively affected and is 
commonly used as a robust indicator of cytotoxicity in several cell death pathways.  
Given that Ece1-III62-93KR and Candidalysin induce epithelial cell damage and have an 
impact on membrane permeability, mitochondrial activity was also investigated testing 
mitochondrial fitness by MTT assay. The MTT assay quantifies the activity of 
mitochondrial NAD(P)H-dependent cellular oxidoreductase enzymes, which act as a 
reporter for the presence of metabolically active cells. Thus, TR146 oral epithelial cells 
were treated with Ece1-III62-93KR or Candidalysin at 70, 60, 45, 30, 15, 3 and 1.5 μM for 3 
h and mitochondrial activity was assessed (Figure 3-6). 1% Triton X-100, which lyses 
epithelial cells, was used as a positive control. 
TR146 mitochondrial fitness was negatively affected by both Candidalysin peptides in a 
dose-dependent manner. Notably, Candidalysin had a stronger effect on mitochondria 
than Ece1-III62-93KR. Compared with untreated cells, treatment with Ece1-III62-93KR caused 
a non-significant reduction of mitochondrial activity (Figure 3-6 A), whereas exposure to 
Candidalysin (45 μM or higher) resulted in a significant decrease in mitochondrial fitness 





Figure 3-6. Reduction in mitochondrial fitness in response to Candidalysin peptides. TR146 oral 
epithelial cells were incubated with Ece1-III62-93KR (A) and Candidalysin (B) (1.5, 3, 15, 30, 45, 60, 
70 µM) for 3 h and assayed for mitochondrial fitness by MTT assay. Triton X-100 (1%) was used 
as a positive control. Data are expressed as a percentage of mitochondrial fitness relative to 
untreated cells. Data are the mean of three biological replicates (+SEM). Statistical significance 
was calculated by one way ANOVA, * P<0.05, ** P<0.01, *** P<0.001. 
 
Having observed a concentration-dependent effect of Candidalysin peptides on TR146 
mitochondrial activity, I next assessed whether the loss of mitochondrial fitness was 
time-dependent. To address this, TR146 oral epithelial cells were treated with Ece1-III62-
93KR or Candidalysin at 70 or 15 μM for 5 min, 15 min, 30 min, 1 h, 1.5 h, 2 h, 2.5 h, 3 h, 6 



















































Compared with untreated cells, a significant 60-70% reduction in mitochondrial activity 
was observed in cells treated with 70 µM Ece1-III62-93KR at all time points tested. 
Treatment with 15 µM Ece1-III62-93KR caused a 20% reduction in mitochondrial fitness, 
which was not significant. Interestingly, treatment with Candidalysin caused a significant 
reduction in mitochondrial activity at both high (70 µM) and intermediate (15 µM) 
concentrations. High Candidalysin concentrations caused a significant (70%) loss of 
mitochondrial fitness after only 5 min of treatment. This reduction in activity was further 
increased from 70% to 95% in a time-dependent manner up to 24 h of exposure. 
Intermediate concentrations of Candidalysin reduced mitochondrial activity by 50% at 
all time points tested, with significance being reached from 1.5 h onwards.   
In summary, these data demonstrate that Candidalysin peptides affect TR146 
mitochondria in a dose- and time- dependent manner and the reduction in 




Figure 3-7. Time-course of mitochondrial fitness following treatment with Candidalysin 
peptides. TR146 oral epithelial cells were incubated with Ece1-III62-93KR (A) and Candidalysin (B) 
at 15 and 70 μM between 5 min and 6 h and assayed for mitochondrial fitness by MTT assay. 1% 
Triton X-100 was used as a positive control. Data are expressed as percentage of mitochondrial 
fitness relative to untreated cells. Data are the mean of three biological replicates (+SEM). 
Statistical significance was calculated by one way ANOVA, * P<0.05, ** P<0.01, *** P<0.001. 
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3.3.4 Candidalysin peptides induce production of intracellular ROS in TR146 cells 
During cellular homeostasis, mitochondria generate low levels of reactive oxygen 
species (ROS). However, disruption of the electron transport chain within mitochondria 
can result in high levels of ROS production. The production of ROS within cells is widely 
considered to be a deleterious event that is responsible for damaging numerous 
macromolecules including nucleic acids, proteins, carbohydrates, and lipids. Cells that 
undergo ROS-mediated damage induce host defence/repair mechanisms, but if this 
response is incapable of repairing the ROS-induced damage, cell death may occur (Rahal 
et al., 2014). 
Generation of ROS is triggered by various stimuli, including toxins (Dantas Ada et al., 
2015; Rovin et al., 1990; Zhang et al., 2017; Zhang et al., 2016). Thus, to assess if 
Candidalysin peptides affected the production of intracellular ROS, TR146 oral epithelial 
cells were treated with Ece1-III62-93KR or Candidalysin and measurements of ROS were 
taken in real time over 30 min.  
Both Ece1-III62-93KR and Candidalysin induced the generation of ROS in a dose-dependent 
manner (Figure 3-8). Notably, treatment with 70 µM Candidalysin produced a greater 
spike in levels of intracellular ROS compared to treatment with Ece1-III62-93KR. In both 





Figure 3-8. Quantification of intracellular ROS in oral epithelial cells treated with C. albicans Candidalysin peptides. TR146 oral epithelial cells were pre-incubated 
with DCFH-DA for 1 h and subsequently incubated with Candidalysin peptides (70, 15 and 3 μM). Fluorescence was measured in real time for up to 30 min. All three 
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3.3.5 Candidalysin peptides cause depletion of intracellular ATP in TR146 cells  
Mitochondria are essential organelles required for viability of eukaryotic cells. The 
primary function of mitochondria is the biosynthesis of adenosine triphosphate (ATP). 
Given this critical functionality, loss of general mitochondrial fitness or an inability to 
produce ATP can often result in a gross disruption of cellular homeostasis leading to 
irrecoverable damage and death. 
Since treatment of epithelial cells with Candidalysin peptides was observed to cause loss 
of mitochondrial fitness and increases in ROS, I next quantified levels of intracellular 
ATP. TR146 oral epithelial cells were treated with Ece1-III62-93KR or Candidalysin at 70, 60, 
45, 30, 15, 3 and 1.5 μM for 3 h (Figure 3-9). 1% Triton X-100 was used as a positive 
control. 
Intracellular ATP levels were influenced by Candidalysin peptides in a dose-dependent 
manner but Ece1-III62-93KR was observed to reduce levels of intracellular ATP more 
strongly than Candidalysin. Compared with untreated cells, Ece1-III62-93KR caused a non-
significant decrease in intracellular ATP at 15 μM, but a significant decrease at 30 μM 
and above (Figure 3.9 A). Candidalysin induced a non-significant decrease in intracellular 




Figure 3-9. Intracellular ATP levels following treatment with C. albicans Candidalysin peptides. 
TR146 oral epithelial cells were incubated with Ece1-III62-93KR (A) and Candidalysin (B) (0.15, 1.5, 
3, 15, 30, 45, 60, 70 µM) for 3 h and levels of intracellular ATP were quantified by luminescence 
assay. 1% (v/v) Triton X-100 was used as a positive control. Data are expressed as the percentage 
of intracellular ATP relative to untreated cells. Data are the mean of three biological replicates 
(+SEM). Statistical significance was calculated by one way ANOVA, * P<0.05, ** P<0.01, *** 
P<0.001. 
 
Given that treatment of TR146 cells with Candidalysin peptides resulted in a dose-
dependent reduction in intracellular ATP levels, I next investigated whether the 
observed decrease in ATP was time-dependent. To address this, TR146 oral epithelial 

















































min, 1 h, 1.5 h, 2 h, 2.5 h, 3 h and 6 h and ATP levels quantified as described (Figure 3-
10).  
Compared with untreated cells, Ece1-III62-93KR at 70 µM caused a time-dependent 
decrease in intracellular ATP, which was significant from 1 h of exposure. TR146 cells 
treated with 15 µM Ece1-III62-93KR exhibited no change until 30 min. However, from 30 
min to 6 h, ATP levels were observed to decrease in a time-dependent manner, reaching 
significance from 3 h onwards.  
In general, the observed trends in ATP reduction were more pronounced in response to 
Ece1-III62-93KR than with Candidalysin. Treatment with 70 µM Candidalysin caused an 
initial reduction in ATP at 5 and 15 min followed by a recovery between 30 min and 2.5 
h. A similar trend was also observed with 15 µM of Candidalysin. However, by 6 h, a 
significant (85%) reduction in ATP levels were observed in TR146 cells exposed to 70 µM 
Candidalysin.   
In summary, these data demonstrate that Candidalysin peptides affect the level of 




Figure 3-10. Time-course of intracellular ATP levels following treatment with Candidalysin 
peptides. TR146 oral epithelial cells were incubated with Ece1-III62-93KR (A) and Candidalysin (B) 
at 15 and 70 μM between 5 min and 6 h and assayed for intracellular ATP by luminescence assay. 
Triton X 100 (1%) was used as a positive control. Data are expressed as percentage of 
intracellular ATP relative to untreated cells. Data are the mean of three biological replicates 






























































3.3.6 Candidalysin induces calcium influx in TR146 cells 
Calcium is an important secondary messenger involved in intra- and extracellular 
signaling events and plays an essential cellular role in life and death outcomes (Berridge 
et al., 2000). Disturbances in mitochondrial function that affect levels of intracellular 
ROS and ATP can interfere with calcium homeostasis and cause an accumulation of 
calcium ions in the cytosol (Gorlach et al., 2015; Guo et al., 2013; Heeman et al., 2011). 
Given that treatment of epithelial cells with Candidalysin peptides caused loss of 
mitochondrial fitness, production of intracellular ROS and depletion of intracellular ATP, 
I questioned whether Candidalysin peptides were also capable of inducing changes in 
cytosolic calcium levels. 
Accordingly, TR146 oral epithelial cells were pre-treated with fura-2 solution and then 
incubated with Candidalysin peptides. Intracellular calcium levels were measured for up 
to 180 min post exposure. 
While intermediate (15 µM) and low (3 µM, 1.5 µM) concentrations of Ece1-III62-93KR 
were not observed to affect calcium levels, high concentrations of Ece1-III62-93KR (70 µM) 
showed an immediate and significant increase in intracellular calcium (Figure 3-11).  
Compared with Ece1-III62-93KR, Candidalysin exhibited a delayed response in the increase 
in calcium levels. Treatment of epithelial cells with 70 µM Candidalysin caused an 
increase in cytosolic calcium after 15 min, which was significant at 25 min and sustained 
over the entire time course (180 min). Lower concentrations of Candidalysin (15, 3 and 







Figure 3-11. Intracellular calcium levels of oral epithelial cells in response to treatment with  
C. albicans Candidalysin peptides. TR146 oral epithelial cells were pre-incubated with Fura-2 for 
1 h and subsequently incubated with Ece1-III62-93KR (A) and Candidalysin (B) (70, 15, 3 and 1.5 
μM). Fluorescence was measured in real time for up to 3 h (180 min). Data are the mean of three 




Intracellular calcium levels are normally maintained approximately 20,000 fold lower 
than the extracellular compartment (Clapham, 2007). To maintain the intracellular 
concentration, calcium is actively pumped out of the cell and also into cytosolic 
organelles such as the endoplasmatic reticulum.  
Treatment of epithelial cells with 70 µM Candidalysin caused a significant increase in the 
intracellular calcium levels (Figure 3‐11). However, it was not clear whether the observed 
increase in intracellular calcium was due to influx from the extracellular environment or 
release from intracellular stores (i.e. the ER). To discern between these two possibilities, 
TR146 cells were incubated with Candidalysin in a calcium‐free buffer and intracellular 
calcium levels were assessed. Ionomycin (1 µM; an ionophore that strongly induces 
calcium influx) in calcium-containing buffer was used as a positive control (Figure 3-12). 
The immediate and significant increase in intracellular calcium levels was only observed 
in calcium-containing buffer and was maintained throughout the experiment. In 
contrast, Candidalysin failed to induce an increase in intracellular calcium levels in 
calcium-free buffer. This strongly suggests that the increase in intracellular calcium 
observed in response to Candidalysin occurs as a result of calcium influx from the 







Figure 3-12. Intracellular calcium levels of oral epithelial cells in response to treatment with 
Candidalysin. TR146 oral epithelial cells were stained with Fura-2 for 1 h and subsequently 
incubated with Candidalysin (70, 15, 3 and 1.5 μM) in calcium-free buffer. Fluorescence was 
measured in real time for up to 3 h (180 min). As a positive control, cells were treated with 1 µM 
Ionomycin in calcium-containing medium. Data are the mean of three biological replicates 




The ability of C. albicans to invade and damage the host mucosa is critical for initiating 
and maintaining symptomatic mucosal infection. The hyphae of C. albicans breach 
epithelial barriers using two mechanistically distinct processes; induced endocytosis and 
active penetration (Naglik et al., 2011), and hyphal infiltration into underlying tissues 
causes extensive cell stress that can culminate in cell death (Chiang et al., 2007). 
The Candidalysin toxin is part of a larger 271 amino acid parental protein, Ece1p (Moyes 
et al., 2016). An initial computational analysis of full length Ece1p predicted cleavage of 
Ece1p after lysine-arginine motifs by a protease, producing eight individual peptide 
fragments. Ece1p is indeed cleaved by the endoproteinase Kex2p in vitro (Bader et al., 
2008) and therefore Candidalysin (the third peptide fragment of Ece1p) was predicted 
to terminate with a lysine-arginine motif. Accordingly, in order to characterise the effect 
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undertaken using the peptide sequence: SIIGIIMGILGNIPQVIQIIMSIVKAFKGNKR (Ece1-
III62-93KR). Subsequently, however, an analysis of secreted Candidalysin by mass 
spectrometry revealed that the toxin terminates with a C-terminal lysine residue, lacking 
the C-terminal arginine: SIIGIIMGILGNIPQVIQIIMSIVKAFKGNK (Ece1-III62-92K) (Moyes et 
al., 2016). Thus, having confirmed the amino acid sequence of Candidalysin secreted 
from C. albicans hyphae during epithelial infection, work continued using this toxin. 
Microbial toxins facilitate the survival and proliferation of pathogens within an infected 
host by altering the cellular environment and inducing cell stresses that culminate in a 
range of pathologies (Los et al., 2013). Cells respond to toxin-induced stresses in various 
ways ranging from the activation of survival pathways to the initiation of cell death that 
eliminates injured cells from the host (Fulda et al., 2010). Successful activation and 
appropriate regulation of these mechanisms depends on the host’s ability to cope with 
the altered physiological conditions imposed by the toxin (Fulda et al., 2010). The 
observation that Candidalysin induces epithelial lesions strongly suggests that it may 
also induce multiple stresses in epithelial cells which may result in cell death. Hence, in 
this study we set out to investigate the role of Candidalysin peptides (Ece1-III62-93KR and 
Candidalysin (Ece1-III62-92K)) in inducing cell stress and cell death processes in TR146 oral 
epithelial cells. 
Membrane permeability is widely considered to be a robust marker of cellular stress and 
cell death. The permeability of epithelial plasma membranes was first assessed by 
investigating LDH release. While TR146 oral epithelial cells infected with fungus induced 
significant release of LDH, cells infected with C. albicans ECE1 mutants that are unable 
to synthesise and secrete Candidalysin were incapable of causing epithelial damage 
((Moyes et al., 2016) and this study), confirming Candidalysin as a driver of epithelial 
membrane perturbation. Furthermore, epithelial cells exposed to Candidalysin peptides 
responded by releasing LDH in a dose-dependent manner. These observations are in 
agreement with studies that have demonstrated release of LDH from epithelial cells in 
response to other microbial toxins, such as Streptococcus pneumoniae pneumolysin 
(Hirst et al., 2002), Clostridium difficile Toxin B (Chumbler et al., 2012) and 
Staphylococcus aureus α-toxin (Gonzalez-Juarbe et al., 2017). 
Membrane permeability was additionally observed by fluorescent microscopy, 
employing Eth Homo III as a marker for necrosis and Annexin V as an indicator of 
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apoptosis. Necrosis is a form of cell death resulting from drastic membrane rupture, 
facilitating access of Eth Homo III to the nucleus. Apoptosis, in contrast, is a carefully 
regulated process where the stoichiometry of the plasma membrane changes, allowing 
Annexin V to bind to phosphatidylserine residues that become exposed on the outer 
leaflet of the plasma membrane (Thompson, 1995). Previous studies have shown that 
epithelial cells respond to the presence of C. albicans by inducing apoptosis and necrosis 
(Villar et al., 2012; Villar and Zhao, 2010; Wagener et al., 2012). Treatment of oral 
epithelial cells with 30 and 70 µM of Candidalysin peptides induced visual phenotypes 
consistent with both apoptosis (Annexin V-positive staining) and necrosis (Eth Homo III-
positive staining), suggesting a potential role for Candidalysin in driving these cell death 
mechanisms. However, the recruitment of Annexins to the site of damage caused by 
toxins is also closely associated with membrane repair (Romero et al., 2017). Thus, given 
that Annexin V-positive staining was weaker than Eth Homo III staining, it is more likely 
that Candidalysin-induced cell death is due to necrotic rather than apoptotic 
mechanisms (see Chapters 4 and 5). 
In addition to membrane destabilisation, microbial toxins can also compromise the 
function of host cell organelles. Mitochondria are a major source of ROS and ATP, the 
modulation of which are important during cellular stress and the induction of cellular 
death (Jiang et al., 2012). The accumulation of intracellular ROS within a cell can result 
in damage to biological macromolecules and, if sustained, may result in cell death by 
apoptosis or necrosis (Trachootham et al., 2008). Dysfunction of epithelial mitochondria 
(as measured by MTT assay) was observed in a dose- and time-dependent manner in 
response to Candidalysin peptides, concomitant with the generation of intracellular ROS 
and depletion of intracellular ATP.  
Both ROS generation and depletion of intracellular ATP levels can determine cell fate 
and modulate the activation of cell death pathways (Eguchi et al., 1997). The generation 
of ROS following severe insult contributes to the release of cytochrome c through 
oxidation of the mitochondrial membrane (Orrenius et al., 2007). Cytochrome c released 
from the mitochondria into the cytosol activates caspases to induce apoptosis (Arnoult 
et al., 2009). However, in addition to causing apoptosis, ROS can also circumvent the 
apoptotic pathway to induce death by necrosis (Samali et al., 1999). The switch from 
apoptosis to necrosis can also occur following the oxidation of the caspase active site by 
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ROS (Samali et al., 1999). All caspases contain an active site cysteine nucleophile, which 
is prone to oxidation through the modulation of the redox status of the cell and the 
oxidation of the cysteine residues in caspases (Hampton and Orrenius, 1997). The shift 
from apoptosis to necrosis can also occur following severe depletion of intracellular ATP 
caused by the failure of mitochondrial energy production by oxidants (Samali et al., 
1999). Candidalysin peptides were observed to deplete intracellular ATP levels in a dose- 
and time-dependent manner. Given that apoptosis is an energy-dependent mechanism 
with ATP as key factor for the formation of the apoptosome (Apaf-1-cytochrome c 
complex, which cleaves and activates caspase-9 during the intrinsic apoptosis process 
(Jiang and Wang, 2000)), critically low levels of intracellular ATP prevent apoptosome 
formation, resulting in cell death via necrosis (Eguchi et al., 1997). 
In addition to the observed loss of mitochondrial fitness, reduction in ATP and elevation 
of intracellular ROS, Candidalysin peptides were also observed to cause calcium influx. 
Influx of calcium ions from the extracellular environment is consistent with peptide-
induced membrane permeabilisation and LDH release. Calcium signaling plays an 
important role in the initiation and effectuation of both apoptotic and necrotic 
pathways. Necrosis and apoptosis are both associated with a perturbation of 
intracellular calcium homeostasis (Orrenius et al., 2003).  
Cytoplasmic calcium overload can lead to abnormal mitochondrial calcium uptake. Such 
an abnormal uptake of calcium into the mitochondria can trigger the mitohondrial 
permeability transition (MPT) and swelling of the organelle with release of 
mitochondrial proteins into the cytosol. One of these proteins is cytochrome c that, 
together with Apaf-1 and ATP, form the apoptosome complex which leads to apoptosis. 
Thus, successful activation of the apoptosome is in part dependent on the available pool 
of intracellular ATP; ATP is required for apoptosome activation and induction of 
apoptosis, whereas cells that contain insufficient levels of ATP fail to activate the 
apoptosome and instead undergo necrosis (Kim et al., 2003).  
While Ece1-III62-93KR and Candidalysin appear to function through the induction of similar 
epithelial cell stresses, some notable differences were observed between peptide 
treatments. Compared with Ece1-III62-93KR, Candidalysin was observed to be more potent 
in reducing mitochondrial fitness and increasing levels of intracellular ROS, whereas it 
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was less effective in promoting membrane permeability, increases in intracellular 
calcium and depletion of intracellular ATP. 
Both peptides are predicted to adopt an α-helical conformation in solution as revealed 
by circular dichroism spectroscopy (Moyes et al., 2016). However, compared with Ece1-
III62-93KR, Candidalysin lacks a positively charged arginine (R) at its C-terminus (Moyes et 
al., 2016). The absence of this C-terminal arginine residue could conceivably alter the 
net charge of the toxin, which may result in altered interactions with components of the 
epithelial plasma membrane, accounting for the differeces in epithelial responses 
observed. 
While both peptides were capable of causing epithelial damage, Ece1-III62-93KR was more 
damaging than Candidalysin, causing more efficient membrane permeabilisation 
concomitant with rapid calcium influx. In addition to damage, Candidalysin induced 
more potent intracellular toxicity compared with Ece1-III62-93KR, by causing greater 
oxidative stress and affecting mitochondrial fitness. 
Mitochondria are a major source of ATP (Jiang et al., 2012), however, the observed loss 
of mitochondrial fitness induced by peptide exposure did not correlate precisely with 
the observed levels of intracellular ATP depletion. Specifically, while the epithelial 
response to Ece1-III62-93KR resulted in a modest reduction in mitochondrial fitness and a 
significant depletion of intracellular ATP, the opposite response, comprised of a 
significant reduction in mitochoindrial fitness and a modest reduction in intracellular 
ATP was observed in response to Candidalysin.  
One possibility that may explain these observations relates to the damage capacity of 
Ece1-III62-93KR when compared with Candidalysin. Ece1-III62-93KR is more damaging to 
epithelial cells when compared with Candidalysin (Moyes et al., 2016). Thus, an inverse 
relationship may exist between damage and the capacity to induce effective intracellular 
signalling; the more damaging the peptide (Ece1-III62-93KR compared with Candidlaysin), 
the less likely that effective intracellular signalling may be sustained to induce 
appropriate stress responses. In contrast, a peptide that has a reduced capacity to cause 
damage (Candidalysin compared with Ece1-III62-93KR) may allow epithelial activation to 
occur sufficiently for intracellular stress responses to be induced. 
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Nevertheless, despite the difference in responses observed following treatment of 
epithelial cells with Ece1-III62-93KR or Candidalysin, it is Candidalysin (and not Ece1-III62-
93KR) that is detectable in the extracellular environment following infection of epithelial 
cells with C. albicans (Moyes et al., 2016). Given this observation, it is the epithelial 
phenotypes observed in response to Candidalysin (and not Ece1-III62-93KR) that can be 
considered to be physiologically relevant in the context of fungal infection at the 
mucosal surface.  
The data presented here demonstrate that Candidalysin triggers a variety of epithelial 
stress responses that are strongly associated with the common readouts and 
characteristics of cellular death. These characteristics include plasma membrane 
permeabilisation, mitochondrial dysfunction, generation of ROS, ATP depletion and 
calcium influx. Given the multiple and detrimental effects of these cellular stresses and 
their impact on the induction of cell death pathways, it is unclear which specific 
pathways of cell death are activated by Candidalysin. The study of these cell death 




Chapter 4: Role of Candidalysin in driving apoptotic death in 
human oral epithelial cells 
 
4.1 Introduction 
The interaction between C. albicans and oral mucosal tissues during oropharyngeal 
candidiasis results in epithelial cell damage and cell death. This process results in tissue 
dysfunction and occurs during intracellular fungal invasion when Candidalysin, a 
cytolytic peptide toxin of C. albicans, is secreted from the fungus (Moyes et al., 2016).  
Apoptosis is a biological process that describes a specific, tightly-regulated form of 
cellular death. It is an integral component of initial tissue development and homeostasis, 
but also occurs in response to stress conditions such as infections (Hotchkiss et al., 
2009).  Apoptosis can be initiated through extrinsic and intrinsic pathways (Chapter 1, 
Figure 1-9).  
The extrinsic pathway is activated by ligands that bind to death receptors expressed on 
the surface of various cells types. Upon ligand binding, several proteins are recruited to 
the death receptor to form Complex 1 (Chapter 1, Figure 1-7). Among these proteins, 
the cellular inhibitor of apoptosis proteins (cIAPs) play a critical role in the initiation of 
the extrinsic apoptotic pathway through negative regulation of ripoptosome formation 
(a protein complex that forms in the cytosol in the absence of cIAPs; Chapter 1, Figure 
1-7). The ripoptosome is the death platform that permits activation of caspase-8 and 
propagation of the apoptotic process. The intrinsic apoptosis pathway is activated 
through signals that promote disruption of mitochondrial integrity. Dysfunctional 
mitochondria release proteins including cytochrome c that amplify an intracellular 
caspase cascade.  
Both extrinsic and intrinsic apoptosis pathways feed into the apoptotic execution 
pathway, characterised by activation of caspase-3. Activated caspase-3 proteolytically 
degrades the cytoskeleton of the host cell and inactivates substrates essential for cell 
repair such as PARP. Finally, intrinsic and extrinsic apoptotic signalling culminates in cell 
shrinkage, DNA fragmentation, externalisation of phosphatidylserine and induction of 
membrane “blebbing”, which is followed by the release of apoptotic bodies into the 
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extracellular environment that are subsequently phagocytosed by macrophages (Taylor 
et al., 2008).  
Previous studies have demonstrated that C. albicans stimulates apoptosis in oral 
epithelial cells (Villar and Zhao, 2010; Wagener et al., 2012). Furthermore, in Chapter 3 
I showed that treatment of epithelial cells with Candidalysin resulted in cells that were 
weakly positive for Annexin V (binds externalised phosphatidylserine; a cellular 
phenotype that closely resembles apoptosis). Therefore, in this chapter I sought to 
determine whether Candidalysin can drive apoptotic cell death in epithelial cells.  
 
4.2 Methods 
4.2.1 Western blot 
TR146 monolayers were treated with C. albicans strains (Table 4.1) at an MOI of 0.01 
and with Ece1-III62-92K (Candidalysin) at 70, 30, 15, 3 µM for 24 h. Proteins were 
extracted, quantified and separated by size using electrophoresis. Separated proteins 
were transferred to a nitrocellulose membrane which was probed with anti-caspase-8, 
anti-caspase-3, anti-cIAP2 or anti-PARP primary antibody and detected with a HRP-
conjugated secondary antibody (see Section 2.5). 
4.2.2 Quantification of Caspase activity 
TR146 oral epithelial cells were infected with C. albicans strains at a MOI of 0.01 and 
Ece1-III62-92K (Candidalysin) at 70, 30, 15 and 3  μM for 24 h. Caspase activity was 
assessed by adding a substrate solution and measuring luminescence after incubation 
for 30 min (Caspase-3) or 1 h (Caspase-8) (see section 2.4.7). 
4.2.3 Quantification of cytochrome c 
TR146 oral epithelial cells were infected with C. albicans strains at a MOI of 0.01 and 
Ece1-III62-92K (Candidalysin) at 70, 30, 15 and 3  μM for 24 h. Exhausted culture medium 
and epithelial cell lysate was collected and cytochrome c quantified by ELISA (Invitrogen) 





4.2.1 Ripoptosome assembly is Candidalysin-independent  
The cellular inhibitor of apoptosis protein (cIAP) plays important roles in the modulation 
of inflammation and apoptosis (Silke and Meier, 2013).  The presence of cIAP1 and cIAP2 
in particular, can repress apoptotic cell death by inhibiting the formation of the 
ripoptosome (Chapter 1, Figure 1-7) (Tenev et al., 2011).  
Data presented here demonstrates that Candidalysin induces Annexin V positive cells (a 
characteristic associated with apoptotic death; Chapter 3) at 3 h, 6 h and 24 h. In 
addition, gene expression profiling of OKF6/TERT2 oral epithelial cells infected with         
C. albicans showed upregulation of the gene encoding cIAP2 at 8 h post-infection (Villar 
et al., 2012), suggesting that the ripoptosome was not formed at 8 h. I therefore 
investigated ripoptosome assembly at later time points (24 h) by assessing epithelial 
expression of cIAP2 in Candidalysin and C. albicans treated cells. 
TR146 monolayers were incubated with Candidalysin at 70, 30, 15, 3 µM and with              
C. albicans ECE1 mutant strains at a MOI of 0.01 for 24 h. Total protein was isolated and 
analysed by SDS-PAGE and western blotting for the presence of cIAP2 (see sections 
2.5.1-2.5.4). As a positive control, 0.1 µM staurosporine was used to induce apoptosis 
(Nakamura-Lopez et al., 2009). 
Treatment of epithelial cells with 30, 15 and 3 μM (but not 70 μM) Candidalysin 
appeared to result in a modest increase in cIAP2 expression when compared with the 
vehicle control (Figure 4-1). In contrast, staurosporine treatment (an apoptosis inducer) 
strongly decreased cIAP2 expression. Notably, infection of epithelial cells with the            
C. albicans ECE1 mutant strains also decreased cIAP2 expression, irrespective of their 
ability to produce Candidalysin. 
This data suggests that Candidalysin does not promote ripoptosome assembly in 
epithelial cells. In contrast however, challenge of epithelial cells with fungus may 





Figure 4-1. Expression of cIAP2 in oral epithelial cells in response to Candidalysin and Candida 
ECE1 mutant strains. TR146 oral epithelial cells were incubated with Candidalysin (70, 30, 15 
and 3 μM) and Candida ECE1 mutant strains (MOI of 0.01) for 24 h and cell lysate assayed for 
cIAP2 expression by western blot. Data are representative of three biological replicates. 
 
4.2.2 Caspase-8 activity is not induced by Candidalysin 
Having observed that C. albicans may promote ripoptosome assembly in a Candidalysin-
independent manner, I investigated activation of pro-caspase-8 (hallmark of extrinsic 
apoptosis) in C. albicans treated cells. Caspase-8 activation by Candidalysin was also 
investigated to confirm the non-involvement of Candidalysin in inducing extrinsic 
apoptosis in oral epithelial cells.  
TR146 monolayers were incubated with Candidalysin at 70, 30, 15, 3 µM and with              
C. albicans ECE1 mutants at a MOI of 0.01 for 24 h. Total protein was isolated and 
analysed by SDS-PAGE and western blotting for the presence of caspase-8 (see sections 
2.5.1-2.5.4). As a positive control, 0.1 µM staurosporine was used to induce apoptosis 
(Nakamura-Lopez et al., 2009). 
Pro-caspase-8 was observed to be expressed in vehicle treated cells, and no further 
increase in pro-caspase-8 expression was observed following treatment with 
Candidalysin or C. albicans ECE1 mutant strains (Figure 4-2). Only TR146 epithelial cells 
treated with staurosporine exhibited a very modest cleavage of immature caspase-8 (57 
kDa) to produce a product consistent with the molecular weight of active caspase-8 (17 





Figure 4-2. Expression of caspase-8 in oral epithelial cells in response to Candidalysin. TR146 
oral epithelial cells were incubated with Candidalysin (70, 30, 15 and 3 μM) and C. albicans ECE1 
mutant strains (MOI of 0.01) for 24 h and cell lysate assayed for caspase-8 expression by western 
blot. Data are representative of three biological replicates. 
 
Having detected strong expression of pro-caspase-8 in epithelial cells but only a modest 
activation of caspase-8 following staurosporine treatment, I decided to utilise a more 
sensitive luminescence-based assay to detect the generation of active caspase-8 by 
Candidalysin (Figure 4-3).  
As with the western blot data, there was no apparent change in caspase-8 activity in 
epithelial cells treated with Candidalysin when compared with the vehicle control 
(Figure 4-3). In contrast, epithelial cells treated with staurosporine showed significant 
caspase-8 activity. Collectively, these data demonstrate that while TR146 oral epithelial 
cells express a high baseline level of pro-caspase-8, Candidalysin activity does not induce 
the generation of active caspase-8 from pro-caspase-8. Interestingly, however, while not 
significant, there was a decrease in caspase-8 activity in epithelial cells treated with the 






Figure 4-3. Caspase-8 activity in oral epithelial cells infected with Candidalysin and C. albicans 
ECE1 mutants. TR146 oral epithelial cells were incubated with Candidalysin (70, 30, 15 and 3 
μM) and C. albicans ECE1 mutant strains (MOI of 0.01) for 24 h and cells assayed for caspase-8 
activity by luminescence assay. Bars indicate caspase-8 activity relative to the vehicle control 
(fold change). Data are the mean of three biological replicates (+SEM). Statistical significance 
was calculated by one way ANOVA test, *** P<0.001. 
 
4.2.3 Candidalysin contributes to Cytochrome c release only in the context of a fungal 
infection  
Having discounted a role for Candidalysin in activating the extrinsic apoptotic pathway 
in epithelial cells, activation of the intrinsic apoptosis pathway was investigated. 
Activation of the intrinsic apoptotic pathway results in release of cytochrome c from 
mitochondria into the cytosol and/or extracellular environment, promoting the 
assembly of the apoptosome and propagating the apoptotic response (Arnoult et al., 
2009; Renz et al., 2001) (Chapter 1, Figure 1-8).  
Accordingly, TR146 oral epithelial cells were treated with Candidalysin at 70, 30, 15 and 
3 μM, C. albicans ECE1 strains at a MOI of 0.01 and staurosporine at 0.1 µM for 24 h. 
Epithelial cell lysates and exhausted culture medium were collected and cytochrome c 
was quantified by ELISA. 
Treatment of epithelial cells with Candidalysin, C. albicans ECE1 mutant strains or 
staurosporine did not result in a detectable increase in cytochrome c present in cell 
lysates when compared with the vehicle control (Figure 4-3). In contrast, Candidalysin 
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treatment reduced cytochrome c levels in epithelial cell lysates in a dose dependent 
manner, with the highest concentration of Candidalysin (70 μM) and 0.1 μM 
staurosporine treatment inducing similar (non-significant) reductions. Notably, 
significant reductions in cytochrome c levels were observed in epithelial cell lysates after 
treatment with all C. albicans strains, particularly with strains that were able to produce 
Candidalysin (BWP17 and ece1Δ/Δ+ECE1). 
In contrast to epithelial cell lysates, significant levels of cytochrome c were detected in 
the exhausted culture medium of epithelial cells treated with staurosporine and with    
C. albicans strains able to produce Candidalysin (BWP17 and ece1Δ/Δ+ECE1). However, 
C. albicans strains unable to produce Candidalysin (ece1Δ/Δ and ece1Δ/Δ+ECE1Δ184-279) 
did not induce cytochrome c release (Figure 4-4). Interestingly, Candidalysin treatment 
alone also did not induce release of cytochrome c into the medium. 
These data suggest that Candidalysin is able to drive cytochrome c release from 





Figure 4-4. Quantification of cytochrome c release from oral epithelial cells in response to 
Candidalysin and C. albicans ECE1 mutant strains. TR146 oral epithelial cells were incubated 
with Candidalysin (70, 30, 15 and 3 μM) and C. albicans ECE1 mutant strains (MOI of 0.01) for 
24 h. Cytochrome c was quantified in cell lysate and exhausted culture medium by ELISA. Bars 
represent amount of cytochrome c relative to the vehicle control (fold change). Data are the 
mean of three biological replicates (+SEM). Statistical significance was calculated by one way 
ANOVA test, * P<0.05, ** P<0.01 *** P<0.001. 
 
 
4.2.5 Caspase-3 activity is not induced by Candidalysin 
Both extrinsic and intrinsic apoptotic pathways lead to the apoptotic execution phase 
which is induced following activation of caspase-3 (Elmore, 2007). Having investigated 
activation of apoptosis through the extrinsic pathway (via cIAP2 and caspase-8) and 
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through the intrinsic pathway (via cytochrome c release), activation of the pro-apoptotic 
effector protein caspase-3 was determined.  
Accordingly, TR146 monolayers were incubated with Candidalysin at 70, 30, 15, 3 µM 
and with C. albicans ECE1 mutants at a MOI of 0.01 for 24 h. Total protein was isolated 
and analysed by SDS-PAGE and western blotting for the presence of caspase-3 (see 
sections 2.5.1-2.5.4). As a positive control, 0.1 µM staurosporine was used to induce 
apoptosis (Nakamura-Lopez et al., 2009). 
Similar to pro-caspase-8 (Figure 4-2), pro-caspase-3 (31 kDa) was observed to be highly 
expressed in resting (vehicle control) cells. Neither an increase in pro-caspase-3 
expression or cleavage of pro-caspase-3 to generate active caspase-3 (19/17 kDa – white 
arrows) was observed following treatment with Candidalysin or C. albicans ECE1 mutant 
strains (Figure 4-5). Only staurosporine-treated epithelial cells showed a modest 
cleavage of pro-caspase-3 to active caspase-3. 
 
 
Figure 4-5. Expression of caspase-3 in oral epithelial cells in response to Candidalysin and           
C. albicans ECE1 mutant strains. TR146 oral epithelial cells were incubated with Candidalysin 
(70, 30, 15 and 3 μM) and C. albicans ECE1 mutant strains (MOI of 0.01) for 24 h and cell lysate 
assayed for caspase-3 expression by western blot. Data are representative of three biological 
replicates. 
 
Having detected strong expression of pro-caspase-3 in epithelial cells and only a modest 
activation of caspase-3 following staurosporine treatment, we decided to utilise a more 
sensitive luminescence-based assay to detect the generation of active caspase-3 by 
Candidalysin. In agreement with the western blot analysis (Figure 4-5) incubation of 
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epithelial cells with Candidalysin or C. albicans ECE1 mutants did not result in an increase 
in detectable caspase-3 activity when compared with the vehicle control (Figure 4-6). In 
contrast, treatment with staurosporine resulted in significant caspase-3 activity. It 
should be noted that, while not significant, as with the caspase-3 data (Figure 4-2), there 
was a decrease in caspase-8 activity in epithelial cells treated with the C. albicans strains, 
especially those that were able to produce Candidalysin (BWP17 and ece1∆/∆+ECE1). 
 
 
Figure 4-6. Caspase-3 activity in oral epithelial cells treated with Candidalysin and C. albicans 
ECE1 mutant strains. TR146 oral epithelial cells were incubated with Candidalysin (70, 30, 15 
and 3 μM) and C. albicans ECE1 mutant strains (MOI of 0.01) for 24 h and cells assayed for 
caspase-3 activity by luminescence assay. Bars represent caspase-3 activity relative to vehicle 
control (fold change). Data are the mean of three biological replicates (+SEM). Statistical 
significance was calculated by one way ANOVA test, *** p<0.001. 
 
4.2.6 PARP is not cleaved by Candidalysin 
In addition to caspase activation and cytochrome c release, apoptosis is also 
characterised by cleavage of Poly-(ADP-Ribose) Polymerase (PARP) (Kaufmann et al., 
1993).  During apoptosis, PARP is inactivated by caspase-3-mediated cleavage, which 
prevents DNA repair within the cell (Kaufmann et al., 1993).  PARP cleavage is thus a 
convenient readout of caspase-3 activity. Inactivation of PARP may also occur to prevent 




To investigate caspase-3 activity and address the possibility that caspase-independent 
cell death may be occurring in epithelial cells in response to Candidalysin and C. albicans 
ECE1 mutant strains, cleavage of the surrogate marker PARP was assessed by western 
blot analysis. 
TR146 monolayers were incubated with Candidalysin at 70, 30, 15, 3 µM and with              
C. albicans ECE1 mutants at MOI of 0.01 for 24 h. Total protein was isolated and analysed 
by SDS-PAGE and western blotting for the presence of PARP (see sections 2.5.1-2.5.4). 
As a positive control, 0.1 µM staurosporine was used to induce PARP cleavage (Thuret 
et al., 2003). 
Treatment of epithelial cells with Candidalysin or C. albicans ECE1 mutant strains was 
not observed to induce PARP cleavage (Figure 4-7). However, treatment of epithelial 
cells with staurosporine resulted in PARP cleavage (89 kDa). Taken together, these data 
confirm that caspase-3 activity is not a feature of the epithelial response to Candidalysin 
or C. albicans infection in vitro. 
 
 
Figure 4-7. Expression of PARP in oral epithelial cells treated with Candidalysin and C. albicans 
ECE1 mutant strains. TR146 oral epithelial cells were incubated with Candidalysin (70, 30, 15 
and 3 μM) and C. albicans ECE1 mutant strains (MOI of 0.01) for 24 h and cell lysate assayed for 





Candidalysin is an important driver of numerous cellular stresses in oral epithelial cells, 
many of which are strongly associated with characteristics of cellular death (Chapter 3). 
Previous in vitro studies have shown that C. albicans induces phenotypes in oral 
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epithelial cells that are consistent with apoptosis (Villar et al., 2012; Villar and Zhao, 
2010; Wagener et al., 2012). However, it is presently unknown if apoptotic signalling 
occurs in epithelial cells in response to Candidalysin. Therefore, this chapter investigated 
the activation of apoptotic mechanisms in oral epithelial cells following treatment with 
Candidalysin or C. albicans ECE1 mutant strains unable to express and secrete the toxin.  
Apoptosis can be activated by extrinsic and intrinsic signals (Chapter 1, Figure 1-9). The 
extrinsic apoptosis pathway plays a critical role in the transmission of death-inducing 
signals from the extracellular environment via cell surface death receptors, ripoptosome 
formation, caspase-8 and caspase-3.  
The extrinsic pathway is best described by the interaction between TNF-α/TNFR1 ligand-
receptor pairing. Following TNF-α-TNFR1 interaction, TRADD, RIPK1, TRAF2, cIAPs and 
LIUBAC associate with the receptor to form Complex 1 (Chapter 1, Figure 1-7), which is  
essential for the activation of NF-κB signalling. In the absence of cIAP1 and cIAP2, RIPK1 
dissociates from Complex 1 and recruitis FADD and pro-caspase-8 forming a 
ripoptosome complex in the cytosol (Figure 1-7) resulting in the autocatalytic activation 
of pro-caspase-8 (Kischkel et al., 1995). Once caspase-8 is activated, the execution phase 
of apoptosis is triggered.  
Epithelial cells treated with 70 µM Candidalysin induced no change in cIAP2 expression, 
however a small increase in cIAP2 was observed with 30, 15 and 3 μM toxin suggesting 
that Candidalysin may inhibit ripoptosome formation and extrinsic apoptosis by 
maintaning Complex 1 integrity and promoting NF-κB signalling. High concentrations of 
Candidalysin (70 µM) destabilises the epithelial plasma membrane and may therefore 
hamper expression and recruitment of cIAP2 to the membrane receptor TFNR1. 
cIAP2-mediated inhibition of apoptotic signalling has also been observed to occur in 
intestinal epithelial cells in response to the enterotoxin of Bacteroides fragilis (Kim et 
al., 2008). In contrast to treatment with Candidalysin, epithelial cells infected with the 
C. albicans strains showed a decrease in cIAP2 expression. While such a decrease could 
conceivably be associated with ripoptosome formation and apoptosis, activation of 
caspase-8 was not observed in epithelial cells exposed to any of the C. albicans strains 
24 h post-infection, suggesting that even in the absence of cIAP2, extrinsic apoptosis 
was not activated in epithelial cells by C. albicans. This finding is in agreement with 
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previous studies that demonstrated an inability of C. albicans to activate caspase-8 in 
oral epithelial cells (Villar et al., 2012).  
The intrinsic apoptotic signaling pathway can be initiated by numerous non-receptor-
mediated stimuli which act directly on intracellular targets, particularly mitochondria. 
All of these stimuli cause changes in the permeability of the mitochondrial membrane, 
which triggers the release of pro-apoptotic proteins including cytochrome c (Saelens et 
al., 2004). In agreement with Villar et al., C. albicans was observed to cause significant 
release of cytochrome c from oral epithelial cells. Interestingly, C. albicans mutants that 
were unable to express and secrete Candidalysin were unable to induce the release of 
cytochrome c from epithelial cells. Likewise, treatment of epithelial cells with 
Candidalysin alone did not result in cytochrome c release. These data suggest that the 
intrinsic apoptosis pathway is initiated in epithelial cells in response to fungal infection 
but that Candidalysin plays no role in this process.  
Thus, Candidalysin appears unable to drive the initiation of the intrinsic epithelial 
apoptosis pathway. These results also suggest that there are fungal factors besides 
Candidalysin that contribute to cytochrome c secretion. Indeed, it has been reported 
that fungal cell wall N-linked glycans (Wagener et al., 2012), proteases Sap 4-6 (Wu et 
al., 2013) and the the quorum sensing molecule farnesol (Scheper et al., 2008) have a 
role in activating apoptosis in oral epithelial cells. It is therefore conceiveable that 
components of the fungal cell wall and secreted factors distinct from Candidalysin affect 
ripoptosome formation since cIAP2 expression was reduced in response to C. albicans 
in a Candidalysin-independent manner. 
Cytochrome c released from mitochondria into the cytosol binds to Apaf-1 and pro-
caspase-9 in the presence of ATP to form a complex called the apoptosome (Chinnaiyan, 
1999). Apoptosome formation leads to the activation of the intrinsic pathway initiator 
caspase-9 and subsequent activation of the executioner caspase-3 (Chinnaiyan, 1999; 
Hill et al., 2004). No increase in caspase-3 activity was observed in oral epithelial cells 
treated with Candidalysin or C. albicans strains after 24 h. This observation is in 
accordance with studies that showed no caspase-3 activity after 16 h of C. albicans 
infection (Villar et al., 2012).  
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Caspase-3 is a protease that cleaves multiple downstream targets essential for apoptotic 
progression (Janicke et al., 1998). Among these targets, cleavage of PARP is a robust 
indicator of caspase-3 activity within the cell and execution of apoptosis. Epithelial PARP 
was not cleaved following treatment with Candidalysin or infection with the C. albicans 
strains after 24 h, confirming that caspase-3 was not active within the epithelial cells. In 
contrast to these observations, Villar et al., reported a modest cleavage of epithelial 
PARP after 8 h of C. albicans infection, concomitant with transient activation of caspase-
3 (Villar et al., 2012). The difference between the epithelial responses observed here 
and those reported by Villar et al. may be attributable to differences in epithelial cell 
lines (TR146 vs OKF6/TERT2) and the time point chosen for analysis (8 h vs 24 h). 
Neverthless, Villar et al. concluded that the transient activation of caspase-3 was most 
likely insufficient to trigger PARP cleavage observed at 8 h of C. albicans infection. They 
speculated that PARP degradation could be caused partially or entirely by lysosomal 
proteases (Gobeil et al., 2001). Indeed, the (early) activation of apoptosis observed at 8 
h by Villar at al. failed to progress and was not detected at later time points in epithelial 
cells infected with C. albicans. It is therefore possible that apoptotic signalling may be 
initiated in response to C. albicans at earlier time points. However, data presented here 
demonstrate that, if activated, the apoptotic response is insufficient to drive the major 
death response since caspase-3 and PARP activation was not observed. 
Extensive damage occurs to oral epithelial cells during the late phases of C. albicans 
infection (Chiang et al., 2007; Park et al., 2005; Villar et al., 2004).  Thus, it is possible 
that epithelial apoptotic pathways are inhibited during the late stages of infection as a 
result of overwhelming microbial insult, which may promote cellular necrosis. One 
explanation for these observations is that apoptosis may be detrimental to the survival 
of C. albicans during infection. Cells undergoing apoptosis are known to release 
apoptotic bodies that stimulate recruitment of macrophages to the site of production 
(Taylor et al., 2008). Accordingly, it is possible that macrophage recruitment may also 
lead to phagocytosis of the infecting fungus and hence fungal clearance. 
An interesting observation is that when compared with vehicle-treated cells, C. albicans 
mutants able to express and secrete Candidalysin caused a significant reduction in the 
level of intracellular cytochrome c and a non-significant decrese in caspase-8 and -3 
114 
 
activity. These observations suggest that Candidalysin may hamper the expression of 
apoptotic proteins and may instead promote necrosis (Chapter 1, Table 2).  
It should also be noted that C. albicans and Candidalysin activate members of the NF-kB 
family in oral epithelial cells (Moyes et al., 2010; Moyes et al., 2016). Activation of the 
NF-kB signalling pathway leads to the expression of multiple genes including host cell 
anti-apoptotic factors, such as cIAP that block apoptotic cell death and promote necrotic 
cell death (Gyrd-Hansen and Meier, 2010). cIAPs play an important role in the 
modulation of NF-kB signalling and the caspase-independent cell death pathway 
necroptosis (Gyrd-Hansen and Meier, 2010). cIAP2 has been demonstrated to modulate 
apoptotic and necrotic cell death by promoting the assembly of an upstream cell death-
inducing platform called the ripoptosome (Geserick et al., 2009). Formation of the 
ripoptosome, whose core components are comprised of RIPK1, FADD and pro-caspase-
8, can result in the activation of pro-caspase-8 and caspase-dependent cell death. 
However, under circumstances where caspases are not active, the absence of cIAP2 can 
stimulate assembly of the necroptosome to promote necroptotic cell death (Tenev et 
al., 2011). Epithelial cells treated with Candidalysin were observed to express cIAP2, 
which can inhibit apoptosis through NF-kB signalling and the induction of anti-apoptotic 
factors (Silke and Meier, 2013). However, epithelial cells challenged with fungus showed 
reduced cIAP2 expression and no caspase-3/8 activity. This could lead to the formation 
of the necroptosome complex involved in necrosis (Chapter 1, Figure 1-10). Thus,  the 
results of this work demonstrate that neither Candidalysin or C. albicans induced 
apoptosis in oral epithelial cells. Therefore, activation of regulated necrotic pathways by 





Chapter 5: Role of Candidalysin in driving regulated necrotic cell 
death in human oral epithelial cells 
 
5.1 Introduction 
Programmed cell death plays an important role during host-pathogen interactions. It 
regulates tissue development, immune homeostasis and host defence against microbes. 
For a long time, apoptosis was used as a synonym for programmed cell death, whereas 
necrosis was considered to occur inadvertently following physiochemical insult. This 
viewpoint has since changed following recent discoveries that demonstrated the 
existence of different pathways of regulated necrosis such as necroptosis and pyroptosis 
(Vanden Berghe et al., 2014).  
Necroptotic cell death is triggered following activation of cell death receptors, such as 
tumour necrosis factor receptor (TNFR) by extrinsic stimuli (Chan et al., 2003). Activation 
of a cell death receptor induces the recruitment of RIPK1 and several other proteins to 
form complex 1 (Chapter 1, Figure 1-10). Complex 1 then dissociates and RIPK1 forms a 
second complex in the cytosol, known as a ripoptosome, which contains RIPK1, caspase-
8 and FADD (Imre et al., 2011) (Chapter 1, Figure 1-10). Activated caspase-8 cleaves and 
inactivates RIPK1 and RIPK3 (Lin et al., 1999) triggering the pro-apoptotic cascade. Thus, 
caspase-8 activity acts as a negative regulator of the necroptotic pathway. In the 
absence of active caspase-8, RIPK1 and RIPK3 assemble to form a necroptosome 
complex (Wang et al., 2008), which in turn leads to the induction of necroptosis. RIPK3 
phosphorylates MLKL which translocates from the cytosol to the plasma membrane 
causing calcium influx and membrane lysis (Cai et al., 2014). 
Pyroptosis is another form of regulated necrosis and is mechanistically distinct from 
apoptosis as cells undergo lysis rather than membrane blebbing and the process is pro-
inflammatory. Importantly, pyroptosis differs from unregulated necrosis and 
necroptosis as it is mediated by inflammatory caspases such as caspase-1, -4, -5 and -
11; and involves inflammasome activation (Bergsbaken et al., 2009). The canonical 
inflammasome is a complex of proteins formed from a NOD-like receptor (NLR), the 
adaptor protein ASC (apoptosis-associated speck-like protein containing a C-terminal 
caspase-recruitment domain (CARD)) and caspase-1. Caspase-1 processes the cytokines 
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pro-IL-1β and pro-IL-18 from their immature, biologically inactive form into biologically 
functional IL-1β and IL-18 (Fantuzzi and Dinarello, 1999) (Chapter 1, Figure 1-13). During 
pyroptosis, caspase-1 also cleaves gasdermin D resulting in release of the gasdermin D 
N-terminus which acts on plasma membranes causing pores with rapid progression of 
cell swelling and lytic cell death (Kayagaki et al., 2015; Shi et al., 2015). 
The secreted toxins of Bacillus anthracis (Fink et al., 2008), Staphylococcus aureus (Kitur 
et al., 2015) and Streptococcus pneumoniae (Gonzalez-Juarbe et al., 2017) activate 
necroptosis or pyroptosis in macrophages and epithelial cells. In addition, pyroptosis 
and inflammasome activation is triggered in macrophages following C. albicans infection 
(Wellington et al., 2014); and there is evidence of inflammasome activation in the oral 
mucosa (Tomalka et al., 2011). However, the C. albicans factor(s) that activate 
pyroptosis and/or inflammasome activation in epithelial cells have not been identified. 
Thus, the aim of this chapter was to determine the role of Candidalysin in driving 
necroptosis and pyroptosis in oral epithelial cells. 
 
5.2 Methods 
5.2.1 Western blot analysis 
TR146 monolayers were treated with C. albicans strains (Table 5.1) at a MOI of 5 and 
0.01 and with 70, 30, 15 and 3 µM Candidalysin for 6 h and 24 h. Proteins were extracted, 
quantified and separated by size with gel electrophoresis. Separated proteins were 
transferred to a nitrocellulose membrane, which was probed with anti-RIPK1, anti-p-
RIPK1, anti-RIPK3, anti-p-RIPK3, anti-MLKL, anti-p-MLKL, anti-NLRP3, anti-ASC, anti-
caspase-1, anti-IL-1β, anti-IL-18 or anti-gasdermin D primary antibody and then with a 
HRP-conjugated secondary antibody (see Section 2.5). 
5.2.2 Quantification of Caspase activity 
TR146 oral epithelial cells were treated with C. albicans strains at a MOI of 5 and 0.01 
and with 70, 30, 15 and 3 μM Candidalysin for 6 h and 24 h. Caspase activity was assessed 
by adding a substrate solution and measuring luminescence after incubating infected 
cells for 1 h (see section 2.4.7). 
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5.2.3 Quantification of IL-1β and IL-18 
TR146 oral epithelial cells were treated with C. albicans strains at a MOI of 5 and 0.01 
and with 70, 30, 15 and 3  μM Candidalysin for 6 h and 24 h. Exhausted culture medium 
was collected and cytokine levels were quantified using ELISA kits (Invitrogen and MLB) 
(see Section 2.4.8).  
 
5.3 Results 
5.3.1 Expression and phosphorylation of RIPK1 in epithelial cells treated with 
Candidalysin and C. albicans ECE1 mutants  
Necroptosis is a caspase-independent form of cell death and is often characterised by 
phosphorylation of RIPK1, RIPK3 and MLKL that propagate the signal that drives 
necroptotic cell death. Since treatment of epithelial cells with Candidalysin or C. albicans 
was observed to induce necrotic rather than apoptotic cell death (Chapter 4), 
necroptosis was first investigated by assessment of RIPK1 phosphorylation.  
TR146 monolayers were incubated with 70, 30, 15 and 3 µM Candidalysin and with             
C. albicans ECE1 mutants at a MOI of 5 and 0.01 for 6 h and 24 h. Total protein was 
isolated and analysed by SDS-PAGE and western blotting for the expression and 
phosphorylation of RIPK1 (see sections 2.5.1-2.5.4). No positive control for the specific 
induction of necroptosis in TR146 oral epithelial cells has been reported in the literature. 
Therefore, based on observations of necroptosis induction in HT-29 human colorectal 
epithelial cells and U937 human macrophages by TNF, staurosporine and ZVAD  (Cai et 
al., 2014; Dunai et al., 2012; Su et al., 2016), 20 µg/mL TNF, 0.1 µM staurosporine and 
100 µM ZVAD (T/S/Z) were used to induce necroptosis in the TR146 epithelial cell line. 
RIPK1 was expressed in resting (vehicle) treated cells, and no further increase in RIPK1 
expression was observed following treatment with Candidalysin or C. albicans ECE1 
mutant strains (Figure 5-1). However, a slight decrease in RIPK1 expression was 
observed in epithelial cells treated for 24 h with C. albicans strains able to express and 
secrete Candidalysin (BWP17 and ECE1 reintegrant; ece1Δ/Δ+ECE1).  
TR146 epithelial cells treated with T/S/Z exhibited phosphorylation of RIPK1 at 6 h (78-
82 kDa) which was reduced at 24 h. Compared to the vehicle control, no increase in 
RIPK1 phosphorylation was observed following treatment with Candidalysin or                     
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C. albicans ECE1 mutant strains at 6 h and 24 h, except for a slight increase in 
phosphorylation of RIPK1 in response to 15 µM Candidalysin at 24 h. 
These data suggest that at the MOIs and time points tested, C. albicans ECE1 mutants 
do not induce phosphorylation of RIPK1 in TR146 epithelial cells. However, a weak 




Figure 5-1. Expression and phosphorylation of RIPK1 in oral epithelial cells in response to 
Candidalysin and C. albicans ECE1 mutant strains. TR146 oral epithelial cells were incubated 
with 70, 30, 15 and 3 μM Candidalysin or with C. albicans ECE1 mutant strains for 6 h (MOI of 5) 
and 24 h (MOI of 0.01) and cell lysate assayed for p-RIPK1 and RIPK1 expression by western blot. 
T/S/Z was used as positive control for necroptosis. Data are representative of three biological 
replicates. 
 
5.3.2 Expression and phosphorylation of RIPK3 in TR146 epithelial cells treated with 
Candidalysin and C. albicans ECE1 mutants 
Previous studies have shown that necroptosis can be induced independently of RIPK1 
phosphorylation (Kaiser et al., 2013; Tamura et al., 2011). Necroptosis is defined as a 
RIPK3-dependent molecular cascade that promotes regulated necrosis (Moriwaki and 
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Chan, 2013). Thus, phosphorylation of RIPK3 was assessed in epithelial cells treated with 
Candidalysin and C. albicans ECE1 mutants. 
TR146 monolayers were incubated with 70, 30, 15 and 3 µM Candidalysin and with            
C. albicans ECE1 mutants at a MOI of 5 and 0.01 for 6 h and 24 h. Total protein was 
isolated and analysed by SDS-PAGE and western blotting for the expression and 
phosphorylation of RIPK3 (see sections 2.5.1-2.5.4). T/S/Z was used as a positive control 
for necroptosis. 
Epithelial cells exposed to the vehicle control expressed baseline levels of RIPK3, and no 
further increase in RIPK3 expression was observed following treatment with 
Candidalysin or Candida mutant strains (Figure 5-2). Similar to RIPK1, a decrease in RIPK3 
expression was observed in epithelial cells treated for 24 h with Candida strains able to 
express and secrete Candidalysin (BWP17 and ECE1 reintegrant; ece1Δ/Δ+ECE1). 
Epithelial cells treated with Candidalysin and C. albicans ECE1 mutants for 6 h exhibited 
variation in the degree of RIPK3 phosphorylation observed between biological 
replicates. However, a weak but reproducible phosphorylation of RIPK3 at 6 h was 
observed in T/S/Z treated cells (Figure 5-2). No phosphorylation of RIPK3 was detected 







Figure 5-2. Expression and phosphorylation of RIPK3 in oral epithelial cells in response to 
Candidalysin and C. albicans ECE1 mutant strains. TR146 oral epithelial cells were incubated 
with 70, 30, 15 and 3 μM Candidalysin or with C. albicans ECE1 mutant strains for 6 h (MOI of 5) 
and 24 h (MOI of 0.01) and cell lysate assayed for p-RIPK3 and RIPK3 expression by western blot. 
T/S/Z was used as positive control for necroptosis. A single experiment is presented from a total 
of three biological replicates performed.  
 
5.3.3 Expression and phosphorylation of MLKL in TR146 epithelial cells treated with 
Candidalysin and C. albicans ECE1 mutants 
During necroptosis, phosphorylation of RIPK3 causes the recruitment and 
phosphorylation of the necroptotic effector MLKL which translocates to the plasma 
membrane of the cell resulting in pore formation and cell lysis (Chapter 1, Figure 1-10). 
Thus, to investigate if epithelial cell death in response to Candidalysin and C. albicans 
ECE1 mutants occurs by necroptosis, I also investigated phosphorylation of MLKL. 
Accordingly, TR146 monolayers were incubated with 70, 30, 15 or 3 µM Candidalysin 
and with Candida mutants at a MOI of 5 and 0.01 for 6 h and 24 h. Total protein was 
isolated and analysed by SDS-PAGE and western blotting for the expression and 




T/S/Z treated cells showed MLKL expression at 6 h, which was observed to be reduced 
at 24 h post treatment. MLKL expression was observed in vehicle treated cells at 6 h and 
24 h. Addition of low and intermediate concentrations of Candidalysin (3-30 μM) for 6 h 
and 24 h induced negligible MLKL expression while 70 μM Candidalysin induced a 
reduction in MLKL expression when compared with vehicle-treated cells (Fig 5-3). 
Infection of epithelial cells for 6 h with C. albicans ECE1 mutants again induced modest 
levels of MLKL expression which was not maintained at 24 h.   
Treatment of  epithelial cells with T/S/Z for 24 h resulted in weak, but nevertheless 
reproducible phosphorylation of MLKL (54 kDa), whereas treatment with Candidalysin 
or C. albicans ECE1 mutant strains was not observed to stimulate MLKL phosphorylation 
at any time point tested. 
In summary, Candidalysin and C. albicans ECE1 mutants failed to induce MLKL 
phosphorylation in epithelial cells, indicating that necroptotic cell death was not 
induced, and suggesting that epithelial cell death in response to Candidalysin and               







Figure 5-3. Expression and phosphorylation of MLKL in oral epithelial cells treated with 
Candidalysin and C. albicans ECE1 mutants. TR146 oral epithelial cells were incubated with 70, 
30, 15 and 3 μM Candidalysin or with C. albicans ECE1 mutant strains for 6 h (MOI of 5) and 24 
h (MOI of 0.01) and cell lysate assayed for expression and phosphorylation of MLKL by western 




5.3.4 Secretion of IL-1β and IL-18 from TR146 oral epithelial cells in response to 
Candidalysin and C. albicans ECE1 mutant strains 
Having discounted the necroptotic pathway in epithelial responses to Candidalysin and 
C. albicans infection, activation of the pyroptotic cell death pathway (Chapter 1, Figure 
1-13) was investigated. Pyroptosis is a cell death pathway that involves inflammasome 
activation and release of the cytokines IL-1β and IL-18 to activate pro-inflammatory 
responses. To investigate the induction of pyroptosis by Candidalysin and C. albicans 
mutant strains, IL-1β and IL-18 secretion was quantified from epithelial cells. 
TR146 oral epithelial cells were treated with 70, 30, 15 and 3 μM Candidalysin or                  
C. albicans ECE1 mutant strains at a MOI of 5 and 0.01 for 6 h and 24 h. Exhausted culture 
medium was collected and IL-1β and IL-18 were quantified by ELISA. 
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Treatment of epithelial cells with 70 μM Candidalysin for 6 h resulted in a robust and 
significant increase in IL-1β secretion when compared with the vehicle control (Figure 5-
4). No increase in IL-1β secretion was observed with the lower concentrations of 
Candidalysin (3 – 30 µM) at 6 h. Interestingly, an intermediate concentration of 
Candidalysin (15 μM) was observed to induce the greatest level of IL-1β secretion from 
epithelial cells after 24 h. However, while statistically significant, the overall level of IL-
1β secretion observed at 24 h was low (0 - 18 pg/mL) when compared to secretion at 6 
h (~320 pg/mL). 
Epithelial cells infected with C. albicans ECE1 mutant strains for 6 h did not secrete 
appreciable amounts of IL-1β when compared with the vehicle control. However, 
infection of epithelial cells with BWP17 or ECE1 reintegrant (ece1Δ/Δ+ECE1) strains for 
24 h caused significant secretion of IL-1β when compared with the vehicle control. In 
contrast, C. albicans mutant strains that were unable to express and secrete 
Candidalysin (ece1Δ/Δ and ece1Δ/Δ+ECE1Δ184-279) were incapable of inducing significant 
levels of IL-1β secretion from epithelial cells. However, while statistically significant, the 
overall level of IL-1β secretion observed at 24 h was still low (<25 pg/mL) when 





Figure 5-4. Secretion of IL-1β from TR146 oral epithelial cells treated with Candidalysin and     
C. albicans ECE1 mutant strains. TR146 oral epithelial cells were incubated with 70, 30, 15 and 
3 μM Candidalysin or with C. albicans ECE1 mutant strains for 6 h (MOI of 5) and for 24 h (MOI 
of 0.01). IL-1β was quantified in exhausted culture medium by ELISA. Data are the mean of three 
biological replicates (+SEM). Statistical significance was calculated by one way ANOVA, * p<0.05, 
** p<0.01 *** p<0.001. 
 
During pyroptosis (and similar to IL-1β), IL-18 is also synthesised as an inactive precursor 
that is proteolytically processed by inflammatory caspases (a component of the 
inflammasome; Chapter 1, Figure 1-13) into its mature, biologically active form which is 
then secreted from the cell. To further investigate activation of the pyroptotic pathway, 
I quantified secretion of IL-18 from epithelial cells in response to Candidalysin and C. 
albicans ECE1 mutant strains. 
Epithelial cells were observed to secrete IL-18 in a dose-dependent manner in response 
to Candidalysin (Figure 5-5), with a concentration of 70 μM causing significant IL-18 
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secretion after 6 h. Notably, as with IL-1β, treatment of epithelial cells with Candidalysin 
for 24 h induced maximum IL-18 secretion when intermediate concentrations of toxin 
(30 μM and 15 μM) were administered.  
Infection of epithelial cells with BWP17 or ECE1 reintegrant strain (ece1Δ/Δ+ECE1) for 6 
h resulted in an increase in IL-18 secretion from epithelial cells when compared with the 
vehicle control. The observed increase in secretion was maintained and became 
statistically significant at 24 h post-infection. In contrast, C. albicans mutant strains 
unable to express and secrete Candidalysin (ece1Δ/Δ and ece1Δ/Δ+ECE1Δ184-279) were 
incapable of inducing significant IL-18 secretion from oral epithelial cells when 
compared with the vehicle control (Figure 5-5). Importantly, and unlike IL-1β, the levels 
of IL-18 secretion was similar in epithelial cells treated with Candidalysin and C. albicans 
strains (~60 - 150 pg/mL). 
These data demonstrate that Candidalysin induces secretion of IL-18 from oral epithelial 




Figure 5-5. Secretion of IL-18 from oral epithelial cells treated with Candidalysin and                      
C. albicans ECE1 mutants. TR146 oral epithelial cells were incubated with 70, 30, 15 and 3 μM 
Candidalysin, or with C. albicans ECE1 mutant strains for 6 h (MOI of 5) and for 24 h (MOI of 
0.01). IL-18 was quantified in exhausted culture medium by ELISA. Data are the mean of three 
biological replicates (+SEM). Statistical significance was calculated by one way ANOVA, ** p<0.01 
***, p<0.001. 
 
5.3.5 Expression of intracellular IL-1β and IL-18 in oral epithelial cells in response to 
Candidalysin and C. albicans ECE1 mutant strains 
While the general trend of IL-1β and IL-18 secretion from epithelial cells 24 h post 
infection appeared comparable, the pattern of IL-1β and IL-18 secretion observed at 6 h 
post infection varied between cytokines (Figures 5-4 and 5-5). In particular, C. albicans 
strains induced substantial IL-18 secretion compared to IL-1β at 6 h infection, while both 
cytokines were released in significant amounts at 24 h in an ECE1- and Candidalysin-
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dependent manner, potentially suggesting that IL-18, but not IL-1β, was constitutively 
present within the cell ready to be secreted at 6 h infection. Thus, to understand how 
Candidalysin and C. albicans ECE1 mutant strain treatment impacts on the accumulation 
of IL-1β and IL-18, the expression of intracellular IL-1β and IL-18 were investigated. 
TR146 monolayers were incubated with 70, 30, 15 and 3 µM Candidalysin and with 
Candida mutants at a MOI of 5 and 0.01 for 6 h and 24 h respectively. Total protein was 
isolated and analysed by SDS-PAGE and western blotting for the presence of IL-1β and 
IL-18 (see sections 2.5.1-2.5.4). 
Treatment of epithelial cells with Candidalysin for 6 h or 24 h resulted in an increase in 
pro-IL-1β expression when compared with the vehicle control (Figure 5-6).  
Infection of epithelial cells with BWP17 or ECE1 reintegrant (ece1Δ/Δ+ECE1) strain for 6 
h resulted in an increase in pro-IL-1β expression when compared with the vehicle 
control. A slight increase in pro-IL-1β expression was also observed following treatment 
with C. albicans mutant strains unable to express and secrete Candidalysin (ece1Δ/Δ and 
ece1Δ/Δ+ECE1Δ184-279) but only at 6 h. The increase in epithelial pro-IL-1β expression 








Figure 5-6. Epithelial expression of intracellular pro-IL-1β in response to Candidalysin and           
C. albicans ECE1 mutant strains. TR146 oral epithelial cells were incubated with 70, 30, 15 and 
3 μM Candidalysin or with C. albicans ECE1 mutant strains for 6 h (MOI of 5) and for 24 h (MOI 
of 0.01) and cell lysate assayed for pro-IL-1β expression by western blot. Data are representative 
of three biological replicates. 
 
Having observed an increase in the expression of intracellular pro-IL-1β in response to 
Candidalysin and C. albicans strains able to express and secrete Candidalysin, I next 
investigated expression of intracellular pro-IL-18.  
Pro-IL-18 was observed to be expressed in vehicle treated cells, and no further increase 
in pro-IL-18 expression was observed following treatment with Candidalysin or                    
C. albicans ECE1 mutants at 6 h or 24 h (Figure 5-7) suggesting that immature IL-18 is 





Figure 5-7. Epithelial expression of intracellular pro-IL-18 in response to Candidalysin and          
C. albicans ECE1 mutants. TR146 oral epithelial cells were incubated with 70, 30, 15 and 3 μM 
Candidalysin  or with C. albicans ECE1 mutants for 6 h (MOI of 5) and for 24 h (MOI of 0.01) and 
cell lysate assayed for pro-IL-18 expression by western blot. Data are representative of three 
biological replicates. 
 
5.3.6 Expression of NLRP3 in oral epithelial cells in response to Candidalysin and             
C. albicans ECE1 mutants 
Secretion of IL-1β and IL-18 requires the activation of the inflammasome complex which 
includes a NOD-like receptor, ASC adaptor protein, and caspase-1 (Martinon et al., 
2002). Since IL-1β and IL-18 were secreted from epithelial cells in response to 
Candidalysin and C. albicans ECE1 mutants, I investigated activation of the NLRP3 
inflammasome by assessing NLRP3 expression. 
TR146 monolayers were incubated with 70, 30, 15 and 3 µM Candidalysin and with            
C. albicans ECE1 mutants at a MOI of 5 and 0.01 for 6 h and 24 h. Total protein was 
isolated and analysed by SDS-PAGE and western blotting for the presence of NLRP3 (see 
sections 2.5.1-2.5.4). 
Treatment of epithelial cells with intermediate concentrations (30 μM and 15 μM) of 
Candidalysin for 6 h resulted in an increase in NLRP3 expression when compared with 
the vehicle control (Figure 5-8). However, treatment of cells with higher (70 μM) or 
lower (3 μM) concentrations of Candidalysin induced only modest NLRP3 expression. In 
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contrast to 6 h, treatment of epithelial cells with Candidalysin for 24 h resulted in robust, 
dose-dependent NLRP3 expression. 
Expression of NLRP3 in response to C. albicans was observed to occur in an ECE1- and 
Candidalysin-dependent manner at 6 h when compared to vehicle-treated cells. In 
contrast to the 6 h NLRP3 expression profile, infection of epithelial cells for 24 h was not 
observed to induce NLRP3 expression. 
These data suggest that Candidalysin induces NLRP3 expression in oral epithelial cells 
and that the region of ECE1 that encodes Candidalysin is important for the expression 
of epithelial NLRP3 at 6 h post infection. 
 
Figure 5-8. Expression of NLRP3 in epithelial cells treated with Candidalysin and C. albicans 
ECE1 mutants. TR146 oral epithelial cells were incubated with 70, 30, 15 and 3 μM Candidalysin 
or with C. albicans ECE1  mutants for 6 h (MOI of 5) and for 24 h (MOI of 0.01) and cell lysate 
assayed for NLRP3 expression by western blot. Data are representative of three biological 
replicates. 
 
5.3.7 Expression of ASC in oral epithelial cells in response to Candidalysin and                    
C. albicans ECE1 mutants 
Having observed expression of NLRP3 in epithelial cells in response to Candidalysin at 
both 6 h and 24 h and C. albicans ECE1 mutants at 6 h post-treatment, expression of the 
adaptor protein ASC (a component of the NLRP3 inflammasome) was investigated. 
TR146 monolayers were incubated with 70, 30, 15 and 3 µM Candidalysin and with           
C. albicans ECE1 mutant strains at a MOI of 5 and 0.01 for 6 h and 24 h, respectively. 
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Total protein was isolated and analysed by SDS-PAGE and western blotting for the 
presence of ASC (see sections 2.5.1-2.5.4). 
ASC was observed to be expressed in vehicle treated cells, and no further increase in 
ASC expression was observed following treatment with Candidalysin or C. albicans ECE1 
mutant strains at 6 h or 24 h (Figure 5-9). These data suggest that the adaptor protein 
ASC is constitutively expressed in the TR146 epithelial cell line. 
 
 
Figure 5-9. Expression of ASC in epithelial cells treated with Candidalysin and C. albicans ECE1 
mutants. TR146 oral epithelial cells were incubated with 70, 30, 15 and 3 μM  Candidalysin  or 
with C. albicans ECE1 mutant strains for 6 h (MOI of 5) and for 24 h (MOI of 0.01) and cell lysate 
assayed for ASC expression by western blot. Data are representative of three biological 
replicates. 
 
5.3.8 Expression and activity of caspase-1 in TR146 epithelial cells treated with 
Candidalysin and C. albicans ECE1 mutants 
Caspase-1 is a cysteine protease that cleaves inflammatory cytokines such as pro-IL-1β 
and pro-IL-18 into their mature, biologically active forms (Thornberry et al., 1992). 
Activation of caspase-1 occurs through a molecular platform termed the inflammasome 
that includes caspase-1, ASC, and NLRP3 (Martinon et al., 2002). When the 
inflammasome is assembled, caspase-1 undergoes autocatalytic activation, generating 
products between 30-48 kDa, and two active subunits of 20 kDa and 10 kDa, respectively 
(Alnemri et al., 1995). Having observed epithelial secretion of IL-1β, IL-18 and expression 
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of NLRP3 in response to Candidalysin and C. albicans ECE1 mutant strains, expression of 
caspase-1 was assessed by western blot. 
TR146 monolayers were incubated with 70, 30, 15 and 3 µM Candidalysin and with           
C. albicans ECE1 mutants at a MOI of 5 and 0.01 for 6 h and 24 h, respectively. Total 
protein was isolated and analysed by SDS-PAGE and western blotting for the presence 
of caspase-1 (see sections 2.5.1-2.5.4). 
Caspase-1 isoforms (ranging in molecular weight between 30-45 kDa) were observed to 
be expressed in vehicle treated epithelial cells (Figure 5-10). Treatment of epithelial cells 
with Candidalysin induced a dose-dependent decrease in the expression of the 30 kDa 
caspase-1 isoform at 6 h, which was more pronounced at 24 h post treatment. No 
difference in caspase-1 expression was observed in response to C. albicans ECE1 
mutants at 6 h post infection when compared to the vehicle control. In contrast, 
infection with C. albicans ECE1 mutants for 24 h prevented caspase-1 (30-45 kDa) 
expression in epithelial cells, most notably with C. albicans strains able to express and 
secrete Candidalysin (BWP17 and ECE1 reintegrant; ece1Δ/Δ+ECE1). Treatment of 
epithelial cells with Candidalysin or C. albicans ECE1 mutants was not observed to induce 







Figure 5-10. Expression of Caspase-1 in epithelial cells treated with Candidalysin and                     
C. albicans ECE1 mutants. TR146 oral epithelial cells were incubated with 70, 30, 15 and 3 μM 
Candidalysin or with C. albicans ECE1 mutants for 6 h (MOI of 5) and for 24 h (MOI of 0.01) and 
cell lysate assayed for caspase-1 expression by western blot. Data are representative of three 
biological replicates. 
 
Having detected strong expression of pro-caspase-1 but no expression of the active 
isoforms of caspase-1, I decided to utilise a more sensitive luminescence-based assay to 
detect the generation of active caspase-1 by Candidalysin or Candida ECE1 mutants. In 
agreement with the western blot analysis, which showed no expression of active 
caspase-1 isoforms (10-20 kDa) (Figure 5-10), incubation of epithelial cells with 
Candidalysin or Candida ECE1 mutants did not result in an increase in caspase-1 activity 
when compared with the vehicle control at 6 or 24 h (Figure 5-11). However, there did 
appear to be a (non-significant) reduction in caspase-1 activity with C. albicans strains 
able to express and secrete Candidalysin (BWP17 and ECE1 reintegrant; ece1Δ/Δ+ECE1) 
at 6 h and more specifically at 24 h. 
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Figure 5-11. Caspase-1 activity in oral epithelial cells treated with Candidalysin and C. albicans 
ECE1 mutants. TR146 oral epithelial cells were incubated with 70, 30, 15 and 3 μM Candidalysin 
or with C. albicans ECE1 mutants for 6 h (MOI of 5) and for 24 h (MOI of 0.01) and cells assayed 
for caspase-1 activity by luminescence assay. Bars represent caspase-1 activity relative to vehicle 
control (fold change). Data are the mean of three biological replicates (+SEM). No statistical 
differences were found using one-way ANOVA. 
 
5.3.9 Detection of IL-1β and IL-18 secreted from TR146 epithelial cells in response to 
Candidalysin and C. albicans ECE1 mutants 
The secretion of active IL-1β and IL-18 from cells first requires that their inactive 
isoforms (pro-IL-1β and pro-IL-18) are processed by proteases such as caspase-1 
(inflammasome component) (Martinon et al., 2002). However, data from this study 
indicates that epithelial cells secrete IL-1β and IL-18 in response to Candidalysin in a 
caspase-1 independent manner (Figure 5-4,  5-5 and 5-11). Given the established role of 
caspase-1 in IL-1β and IL-18 maturation, I investigated whether the IL-1β and IL-18 
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secreted from epithelial cells in response to Candidalysin and C. albicans ECE1 mutants 
were secreted as mature (active) or immature (inactive) isoforms.    
TR146 oral epithelial cells were treated with 70, 30, 15 and 3 μM Candidalysin or                  
C. albicans ECE1 mutants at a MOI of 5 and 0.01 for 6 h and 24 h respectively. Exhausted 
culture medium was collected and secretion of IL-1β and IL-18 was determined by 
western blot. As a positive control for processed IL-1β and IL-18, 2.5 ng of recombinant 
human IL-1β and 0.2 pg of recombinant human IL-18 were included in the analysis.  
Treatment of epithelial cells with Candidalysin and C. albicans ECE1 mutants for 6 h and 
24 h did not result in detectable levels of pro-IL-1β or mature IL-1β in the exhausted 
culture medium (Figure 5-12). Only recombinant human IL-1β (positive control) was 
detected at 17 kDa.  
 
 
Figure 5-12. Secretion of IL-1β from epithelial cells in response to Candidalysin and C. albicans 
ECE1 mutant strains. TR146 oral epithelial cells were incubated with 70, 30, 15 and 3 μM 
Candidalysin or with C. albicans ECE1 mutants for 6 h (MOI of 5) and for 24 h (MOI of 0.01) and 
exhausted culture medium was quantified for IL-1β by western blot. Recombinant human IL-1β 
was used as a positive control for processed, biologically active cytokine. Data are representative 




Like pro-IL-1β, pro-IL-18 must also be processed by the inflammasome in order to 
generate an active cytokine (Fantuzzi and Dinarello, 1999). Exhausted culture medium 
from epithelial cells treated with Candidalysin and C. albicans ECE1 mutants able to 
secrete Candidalysin contained pro-IL-18 (24 kDa) but not mature IL-18 (17 kDa) (Figure 
5-13). The human recombinant IL-18 positive control produced a band at 17 kDa (mature 
IL-18), suggesting that the IL-18 secreted from epithelial cells in response to Candidalysin 
and C. albicans ECE1 mutants was unprocessed and therefore inactive. 
 
 
Figure 5-13. Secretion of IL-18 from epithelial cells in response to Candidalysin and C. albicans 
ECE1 mutants. TR146 oral epithelial cells were incubated with 70, 30, 15 and 3 μM Candidalysin 
or with C. albicans ECE1 mutants for 6 h (MOI of 5) and for 24 h (MOI of 0.01) and exhausted 
culture medium was quantified for IL-18 by western blot. Recombinant human IL-18 was used 
as a positive control for processed, biologically active cytokine. Data are representative of three 
biological replicates. 
 
5.3.10 Expression of gasdermin D in epithelial cells in response to Candidalysin and       
C. albicans ECE1 mutants 
It was recently shown that in addition to inflammasome activation, gasdermin D  is a key 
protein that can trigger pyroptotic cell death (Shi et al., 2015). When cleaved, gasdermin 
D translocates to the plasma and organelle membranes of affected cells, causing pore 
formation (Liu et al., 2016). Gasdermin D is cleaved by pro-inflammatory caspase-1, -4, 
-5 and -11 to generate N- and C- terminal products (of molecular weight 31 kDa and 22 
kDa respectively), that trigger pyroptotic death and release of inflammatory cytokines 
such as IL-1β and IL-18 (Shi et al., 2015). Given that no appreciable caspase-1 activity 
was detected in epithelial cells in response to Candidalysin and C. albicans ECE1 mutants 
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(Figure 5-10), I examined gasdermin D expression to determine if caspase-4, -5 and -11 
were potentially activated under identical treatment conditions. 
Accordingly, TR146 monolayers were incubated with 70, 30, 15, 3 µM Candidalysin and 
with C. albicans ECE1 mutants at a MOI of 5 and 0.01 for 6 h and 24 h respectively. Total 
protein was isolated and analysed by SDS-PAGE and western blotting for the presence 
of gasdermin D (see sections 2.5.1-2.5.4). 
Intact gasdermin D (53 kDa) was observed to be expressed in vehicle treated cells, and 
no further increase in gasdermin D expression was observed following treatment with 
Candidalysin or C. albicans ECE1 mutant strains after 6 h (Figure 5-14). Intriguingly 
however, a decrease in gasdermin D expression was observed in epithelial cells treated 
for 24 h with Candida strains able to express and secrete Candidalysin (BWP17 and ECE1 
reintegrant; ece1Δ/Δ+ECE1). 
These data suggest that at 6 h, epithelial cells do not respond to Candidalysin or                   
C. albicans ECE1 mutants by cleaving gasdermin D. While the observed lack of gasdermin 
D cleavage in response to Candidalysin was maintained at 24 h, expression (but not 
cleavage) of gasdermin D did appear to be partially influenced by the ability of                      





Figure 5-14. Epithelial expression of gasdermin D in response to Candidalysin and C. albicans 
ECE1 mutants. TR146 oral epithelial cells were incubated with 70, 30, 15 and 3 μM Candidalysin 
or with C. albicans ECE1 mutants for 6 h (MOI of 5) and for 24 h (MOI of 0.01) and cell lysate 





5.4.1 The epithelial necroptotic response to Candidalysin 
In the past, while the traditional view of necrosis was that of a dysregulated, 
uncontrolled form of cell death, recent studies have now demonstrated that necrotic 
cell death can be a regulated event that contributes to tissue development and 
biological homeostasis. Among programmed cell death pathways, necroptosis (Degterev 
et al., 2005) and pyroptosis (Cookson and Brennan, 2001) have been used to describe 
models of non-apoptotic cell death that display aspects of programmed necrosis. 
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Necroptosis is a pro-inflammatory, caspase-independent form of cell death that is 
triggered following the activation of a cell death receptor by TNF family members, FAS 
ligand, LPS, genotoxic stress and physiochemical perturbations (Chan et al., 2003). The 
interaction between TNF and TNFR1 is a well-characterised activator of necroptosis that 
results in the recruitment of TRADD and RIPK1 to the cytoplasmic domain of the 
activated receptor to form complex 1 (Chapter 1, Figure 1-10). Complex 1 then 
dissociates, releasing RIPK1 which participates in ripoptosome formation with caspase-
8 and FADD (Chapter 1, Figure 1-10) (Imre et al., 2011). Importantly however, in the 
absence of active caspase-8, ripoptosome assembly evolves, resulting in the formation 
of a necroptosome complex that drives necroptotic rather than apoptotic death (Wang 
et al., 2008). The necroptosome complex assembles through a series of RIPK1- and 
RIPK3-mediated auto- and trans-phosphorylation events that in turn lead to the 
induction of necroptosis (Cho et al., 2009 148).  
Candidalysin and C. albicans ECE1 mutants did not induce caspase-8 activity in epithelial 
cells (Chapter 4), suggesting that the toxin or fungus may induce necroptosome 
assembly, thereby propagating necroptotic signalling.  However, RIPK1 was not 
phosphorylated in response to C. albicans ECE1 mutants, and only a weak 
phosphorylation of RIPK1 was observed in response to 15 µM Candidalysin at 24 h. 
These observations suggest that the necroptotic process was not initiated by C. albicans 
despite the lack of caspase-8 activity, although it may have been transiently initiated in 
response to an intermediate concentration of Candidalysin. 
Nevertheless, different signalling pathways are capable of inducing RIPK3 activation, and 
necroptotic death is known to occur independently of RIPK1 in some instances. For 
example, fibroblast TLR3/TLR4 can phosphorylate RIPK3 through a RIP kinase homotypic 
interaction motif-dependent association with TRIF (Kaiser et al., 2013). Therefore, 
necroptosis is defined as a RIPK3-dependent molecular cascade promoting programmed 
cell necrosis. Phosphorylation of RIPK3 stimulates the recruitment of MLKL, which is 
subsequently phosphorylated (Sun et al., 2012). Phosphorylated MLKL is the effector of 
necroptosis that translocates to and associates with the plasma membrane, inducing 
rupture, and the release of intracellular contents (Cai et al., 2014; Wang et al., 2014).  
Epithelial cells treated with Candidalysin and C. albicans ECE1 mutants for 6 h exhibited 
variable levels of RIPK3 phosphorylation between experiments, and phosphorylation of 
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RIPK3 at 24 h was not observed. Likewise, phosphorylation of MLKL was not observed in 
response to Candidalysin or C. albicans ECE1 mutants at 6 h and 24 h, suggesting that 
transient and/or variable RIPK3 phosphorylation was insufficient to drive MLKL 
activation at the time points tested. Furthermore, these data demonstrate that LDH 
release and calcium influx caused by Candidalysin and C. albicans ECE1 mutant strains 
(Chapter 3) was not induced through the formation of p-MLKL pores. 
Collectively, these observations suggest that Candidaysin and C. albicans ECE1 mutant 
strains do not induce necroptotic cell death in oral epithelial cells. 
5.4.2 The epithelial pyroptotic response to Candidalysin 
To further investigate the potential role of Candidalysin as a driver of regulated necrosis, 
the activation of pyroptosis was investigated. Pyroptosis is known to be induced in 
macrophages that phagocytose C. albicans yeast cells (Wellington et al., 2014). 
Following internalisation, the acidic environment of the phagolysosome stimulates the 
yeast cell to undergo morphological switching, resulting in the production of hyphal 
filaments that physically rupture the phagolysosome membrane and the plasma 
membrane of the macrophage, facilitating fungal escape (Jimenez-Lopez and Lorenz, 
2013). Interestingly, the induction of pyroptosis is known to precede hyphal escape from 
macrophages (Uwamahoro et al., 2014). The ECE1 gene of C. albicans is highly expressed 
during hyphal growth (Birse et al., 1993) and results in the production of Candidalysin, 
which is secreted from the hyphal form of the fungus (Moyes et al., 2016). Since 
Candidalysin is critical for the success of C. albicans mucosal infection in vivo, (Moyes et 
al., 2016), I hypothesised that Candidalysin may be required to activate pyroptotic 
responses in epithelial cells. 
Induction of pyroptosis is dependent upon the activation of the inflammasome. The 
inflammasome has been reported to play an essential role in defences against                      
C. albicans infection (Hise et al., 2009; Tomalka et al., 2011; van de Veerdonk et al., 
2011). Activation of the inflammasome leads to cleavage of inactive pro-IL-1β and pro-
IL-18 to produce mature, biologically active cytokines that trigger pro-inflammatory 
responses (Fantuzzi and Dinarello, 1999). Therefore, to determine whether 
inflammasome activation and pyroptosis was induced by Candidalysin and C. albicans 
ECE1 mutant strains, secretion of IL-1β and IL-18 from oral epithelial cells was quantified.  
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Secretion of IL-1β and IL-18 was significantly increased when epithelial cells were 
exposed to 70 µM Candidalysin for 6 h. Interestingly, secretion of IL-1β and IL-18 at 24 
h was observed to be greatest in response to 15 µM but not 70 µM Candidalysin, when 
compared to the vehicle control. It is possible that high concentrations of toxin may 
overwhelm the epithelial cell, affecting cytokine expression, and preventing assembly 
and activation of the inflammasome and hence secretion of mature IL-1β and IL-18. 
Indeed, high concentration of toxin (70 µM) induced extensive cell stress including 
plasma membrane permeabilisation, mitochondrial dysfunction, generation of ROS, ATP 
depletion and calcium influx (Chapter 3). Notably, C. albicans mutant strains unable to 
express and secrete Candidalysin (ece1Δ/Δ and ece1Δ/Δ+ECE1Δ184-279) were unable to 
stimulate IL-1β and IL-18 secretion from epithelial cells. These observations 
demonstrate that Candidalysin is required to stimulate secretion of IL-1β and IL-18 from 
epithelial cells, and further confirm the role of Candidalysin as a critical inducer of pro-
inflammatory epithelial responses (Moyes et al., 2016).  
Robust secretion of IL-1β from epithelial cells was observed at 6 h, but an equivalent 
level of secretion was not maintained at 24 h, highlighting temporal differences in IL-1β 
secretion from epithelial cells in response to Candidalysin. Conversely, infection of 
epithelial cells with C. albicans ECE1 mutant strains required more time to induce 
significant levels of IL-1β secretion when compared with Candidalysin alone, an 
observation that is most likely consistent with the lag-phase that precedes the induction 
of hyphal growth and the time taken to accumulate damage-inducing concentrations of 
Candidalysin from C. albicans hyphae in vitro. 
In contrast to the observations of others that showed substantial secretion of IL-1β from 
macrophages at 24 h (9000 pg/mL) (Uwamahoro et al., 2014), secretion of IL-1β from 
epithelial cells in response to Candidalysin and C. albicans ECE1 mutant strains was 
observed to be low (15 pg/mL and 24 pg/mL). The low levels of IL-1β secretion observed 
at 24 h could be attributed either to the fact that epithelial cells do not produce 
significant levels of IL-1β themselves (Bui et al., 2016; Thinwa et al., 2014), or because 
IL-1β can be damaging to the cell. Paradoxically, while IL-1β is essential for resistance to 
infections, it can nevertheless cause tissue damage (Dinarello, 2010). In view of these 
findings, it is plausible that the secretion of IL-1β from epithelial cells is tightly regulated 
in order to prevent damage to surrounding cells and tissues. Minimal IL-1β secretion 
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from epithelial cells in response to C. albicans at 24 h has been observed elsewhere 
(Schaller et al., 2004). Importantly, Schaller et al. showed that low IL-1β levels secreted 
(25 pg/mL) from epithelial cells combined with other cytokines (Interferon gamma, 
TNFα, IL-10, IL-6 and IL-8) were sufficient for neutrophil recruitment to the epithelium 
and for fungal clearance (Schaller et al., 2004). Like IL-1β, IL-6 is involved in the 
recruitment of neutrophils (Naglik et al., 2011) and has been shown to be secreted from 
TR146 oral epithelial cells in response to C. albicans and Candidalysin (Moyes et al., 
2010; Moyes et al., 2016). It is, therefore, conceivable that the low levels of IL-1β 
secretion observed in response to Candidalysin and C. albicans may be sufficient to 
trigger neutrophil recruitment.   
IL-18, like IL-1β, is a pro-inflammatory cytokine released during pyroptosis. Data 
obtained in this study demonstrates that oral epithelial cells respond to Candidalysin 
and C. albicans ECE1 mutant strains by secreting substantial amounts of IL-18. While 
these observations corroborate previous studies that demonstrated secretion of IL-18 
from oral epithelial cells infected with C. albicans (Rouabhia et al., 2002; Tardif et al., 
2004a), the work presented here identifies Candidalysin as the fungal moiety that drives 
IL-18 secretion.  
While the pattern of IL-1β and IL-18 secretion from epithelial cells was observed to be 
similar at 24 h, the pattern of IL-1β and IL-18 secretion observed at 6 h was clearly 
different (Figures 5-3 and 5-4). Expression of pro-IL-1β increased in response to 
Candidalysin and C. albicans strains able to express and release the toxin, whereas no 
increase in pro-IL-1β expression was observed following infection with C. albicans 
mutant strains unable to express and secrete Candidalysin. Expression of pro-IL-18 did 
not vary between untreated and treated oral epithelial cells. One possible explanation 
for this observation is that unlike pro-IL-1β, pro-IL-18 is constitutively present in oral 
epithelial cells ((Sugawara et al., 2001) and Fig 5-7) and in this regard, pro-IL-18 is similar 
to IL-1α and IL-33 (Moussion et al., 2008). However, like pro-IL-1β, pro-IL-18 is 
synthesised as an inactive precursor requiring processing by the inflammasome into a 
biologically active cytokine. Collectively, these observations suggest that the 
inflammasome might be activated in oral epithelial cells and mediates the release of 
pro-IL-1β and pro-IL-18 in response to Candidalysin treatment and C. albicans infection.  
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Data obtained in this study shows that TR146 oral epithelial cells respond to 
Candidalysin and C. albicans by expressing the NOD-like receptor NLRP3. These 
observations correlate with in vivo studies by others that demonstrated the importance 
of the NLRP3 receptor in mucosal and systemic infections caused by C. albicans (Hise et 
al., 2009; Joly et al., 2009; Tomalka et al., 2011). Importantly, the data presented here 
extend the findings of Hise, Joly and Tomalka by identifying a Candidalysin-dependent 
mechanism of NLRP3 expression. Expression of NLRP3 at 6 h was observed to increase 
in response to C. albicans strains able to express and secrete Candidalysin, whereas no 
increase in NLRP3 expression was observed in response to strains compromised for toxin 
production.  
Interestingly, no expression of NLRP3 was observed in epithelial cells infected with           
C. albicans ECE1 mutant strains at 24 h suggesting that NLRP3 may be degraded by other 
proteins late during the infection. Indeed, it has been reported that chronic TLR 
stimulation (12-24 h) by LPS dampens NLRP3 expression through IL-10 autocrine NLRP3 
regulation in macrophages (Gurung et al., 2015). Another study showed that TLR2/TLR4 
engagement resulted in upregulation of plasminogen activator inhibitor type 2 (PAI-2), 
which promoted autophagy and a subsequent reduction in NLRP3 expression (Chuang 
et al., 2013). Fungal cell wall components are known to interact with host TLRs, in 
particular TLR2 and TLR4 (Gow et al., 2011). Given that Candidalysin alone induced 
NLRP3 expression very clearly at 24 h, it is conceivable that longer term infections with 
C. albicans induces the activation of NLRP3 degradation mechanisms via fungal cell wall-
host PRR interaction. Thus, the finding that NLRP3 expression is Candidalysin-dependent 
during early stages of infection (Figure 5-8) suggests that the NLRP3 inflammasome is 
first activated by the toxin, but then later other fungal-mediated mechanisms might 
promote NLRP3 degradation. 
The adaptor protein ASC plays a central role in NLRP3 inflammasome assembly. The 
NLRP3 receptor does not contain a CARD domain, and so cannot directly interact with 
caspase-1. However, the pyrin domain of NLRP3 is capable of binding to the ASC adaptor 
protein, forming a heterodimeric complex, which in turn interacts directly with caspase-
1 to form the NLRP3 inflammasome (Martinon et al., 2002). Expression of ASC was 
observed in vehicle, Candidalysin and C. albicans ECE1 mutant-treated cells and no 
alteration in ASC expression was observed between treatment groups, suggesting that 
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ASC is constitutively expressed in TR146 oral epithelial cells to enable inflammasome 
assembly without the need for upregulation. Given this observation, ASC is presumed to 
be available to participate in inflammasome formation at 6 h and 24 h post-treatment 
with Candidalysin and C. albicans ECE1 mutants.  
The interaction of NLRP3 with ASC creates a protein complex into which caspase-1 is 
first recruited, and then subsequently activated through an autocatalytic mechanism 
(Martinon et al., 2002). Epithelial cells exposed to Candidalysin or C. albicans ECE1 
mutants exhibited baseline expression of pro-caspase-1, and only treatment with a high 
concentration of toxin (70 μM), or infection with C. albicans strains for 24 h prevented 
pro-caspase-1 expression in epithelial cells. A decrease in epithelial pro-caspase-1 
expression in response to C. albicans 24 h infection has been observed elsewhere 
(Rouabhia et al., 2002). It is possible that during the course of a C. albicans infection 
where ECE1 expression is robustly induced and maintained, Candidalysin reaches 
concentrations capable of causing significant cell stress (Chapter 3) which may 
subsequently activate mechanisms that degrade caspase-1. Nevertheless, neither 
Candidalysin nor C. albicans strains induced caspase-1 activity.  
A previous study demonstrated that expression and secretion of IL-1β in response to      
C. albicans is dependent on the NLRP3 inflammasome (Hise et al., 2009). However, the 
essential role of the NLRP3 inflammasome and caspase-1 in particular against C. albicans 
infection is controversial. Indeed, another group reported that caspase-1 is not 
indispensable for the release of mature IL-1β in a systemic murine model of candidiasis 
(Mencacci et al., 2000), suggesting that release of active IL-1β during C. albicans 
infection can proceed through different mechanisms. 
Data from this study collectively suggest that release of IL-1β and IL-18 from TR146 oral 
epithelial cells occurred through a caspase-1-independent mechanism. It is therefore 
conceivable that a non-canonical inflammasome (Kayagaki et al., 2011) might be 
activated in oral epithelial cells in response to Candidalysin and C. albicans ECE1 
mutants.  
Activation of the canonical NLRP3 inflammasome leads to pro-IL-1β and pro-IL-18 
processing and release of mature cytokines. In contrast, the non-canonical NLRP3 
inflammasome is unable to cleave pro-IL-1β and pro-IL-18 (Kayagaki et al., 2011). Data 
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from this study show that IL-18 secreted from epithelial cells challenged with 
Candidalysin and C. albicans ECE1 mutants was not proteolytically cleaved or activated. 
Only inactive IL-18 (24 kDa) was detected in the exhausted culture medium of treated 
cells. Although inactive, release of immature cytokines following cell death may not be 
biologically irrelevant. Indeed, several studies have demonstrated that inactive IL-1β 
and IL-18 can be processed by extracellular proteases produced from other cells in vivo 
(Beausejour et al., 1998; Joosten et al., 2009). For instance, proteinase 3 derived from 
infiltrating neutrophils drives the extracellular processing of IL-18 secreted from oral 
epithelial cells (Sugawara et al., 2001). 
Previous work has shown that C. albicans strains able to secrete Candidalysin (BWP17 
and ECE1 reintegrant) caused neutrophil infiltration into infected tongue tissues. 
Contrarily, tongue tissue infected with C. albicans strains unable to secrete Candidalysin 
showed no inflammatory infiltrates (Moyes et al., 2016). It is thus conceivable that a 
non-canonical inflammasome is activated in epithelial cells in response to Candidalysin 
and C. albicans strains that stimulates secretion of pro-IL-1β and pro-IL-18, which are 
then subjected to extracellular processing by proteinase 3, neutrophil elastase and 
cathepsin G secreted from neutrophils recruited to the site of fungal infection (Afonina 
et al., 2015; Joosten et al., 2009).  
In addition to inflammasome activation, cleavage of gasdermin D is required to trigger 
pyroptosis (Kayagaki et al., 2015; Shi et al., 2015). Cleavage of gasdermin D can be 
initiated by canonical and non-canonical inflammasomes, which release the gasdermin 
D N-terminal domain that associates and damages the host cell plasma membrane by 
forming pores (Liu et al., 2016). If affected cells are unable to repair the damage inflicted 
by pore formation, pyroptotic death is initiated as a means to control damage that could 
potentially induce long term deleterious consequences to cells and tissues if permitted 
to continue unchecked (Jorgensen et al., 2017).  
Gasdermin D cleavage was not observed in epithelial cells exposed to Candidalysin or    
C. albicans ECE1 mutant strains. Full-length (unprocessed) gasdermin D was expressed 
in vehicle-treated cells with no further change in expression following exposure to 
Candidalysin. However, epithelial cells infected for 24 h with C. albicans ECE1 mutant 
strains able to secrete Candidalysin exhibited a decrease in the expression of full-length 
gasdermin D. It is therefore conceivable that infection of epithelial cells with C. albicans 
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induces the degradation of gasdermin D 24 h post-infection, although the mechanism 
underpinning this observation is currently unknown. 
Interestingly, Candidalysin produced in the context of a fungal infection prevented 
expression of most proteins involved in necroptosis and pyroptosis pathways at 24 h. 
The expression and activation of proteins involved in regulated necrosis pathways may 
be detrimental to the fungus because they trigger pro-inflammatory responses 
facilitating fungal clearance. To avoid this, it is possible that long term C. albicans 
infections may prevent the activation of regulated necrosis pathways by inducing 
degradation mechanisms that have yet to be identified.   
In summary, the work in this chapter suggests that Candidalysin does not induce classical 
necroptotic or pyroptotic cell death pathways in oral epithelial cells. However, 
Candidalysin appears to play an essential role in inducing the expression of NLRP3, IL-1β 
and IL-18, and the subsequent secretion of pro-IL-1β and pro-IL-18 from the epithelial 
cell, which may then be processed into their active forms by other host enzymes. Indeed, 
Candidalysin plays an essential role in neutrophil recruitment to the site of infection 
(Moyes et al., 2016). Thus, the Candidalysin-dependent release of immature cytokines 
from epithelial cells may occur in order to prevent overreaction of the immune response 




Chapter 6: General discussion  
Candidiasis is the most prevalent fungal infection of humans, and is a frequent cause of 
morbidity in healthy individuals and mortality in patients with a wide spectrum of 
immune deficiencies (Fidel, 2006; Hasan et al., 2009). C. albicans has an asymptomatic 
carriage rate of approximately 60% in the human population and is the most pathogenic 
Candida species. The morphological plasticity of C. albicans is a major virulence trait, 
enabling the fungus to invade mucosal surfaces causing infection.  
A key virulence factor of C. albicans hyphae is Candidalysin, a cytolytic peptide toxin 
derived from the hypha-associated gene ECE1 (Moyes et al., 2016). Candidalysin causes 
epithelial damage and activates epithelial immunity, resulting in the production of 
immune modulators that recruit immune cells to the site of infection, which facilitate 
fungal clearance (Verma et al., 2017). Given this striking effect on epithelial cells, it is 
likely that detection of Candidalysin activity is the trigger for the host to determine when 
this normally commensal fungus has turned into a potentially dangerous pathogen. 
This thesis investigated the hypothesis that Candidalysin triggers specific cellular 
responses that promote the death of oral epithelial cells. To characterise these events, 
the activation of epithelial cell stress and death pathways in response to Candidalysin 
was investigated. 
 
6.1 Epithelial cell death responses to Candidalysin  
Cell death can occur following periods of cell stress, injury and/or infection, and is linked 
to tissue damage and progression of disease. During oropharyngeal candidiasis, fungal 
invasion through the mucosal barrier and into underlying tissues is accompanied by 
damage and destruction of oral epithelial cells, which present as erosions and 
ulcerations of the buccal mucosa. Hypha-induced tissue damage causes localised 
discomfort, altered taste sensation, dysphagia and may also contribute to malnutrition, 
further impacting quality of life.  
Microbial infection places cells under considerable stress and can induce signalling 
cascades that trigger apoptosis and necrosis. Sources of stress and stress signals, can be 
derived from the extracellular environment (damage, PAMPs and/or DAMPs), and from 
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intracellular sources (mitochondrial damage, oxidative stress and ATP/calcium 
fluctuations) (Fulda et al., 2010).    
Since Candidalysin is a virulence factor that is essential for epithelial damage during 
mucosal infection by C. albicans, we hypothesised that Candidalysin may induce cell 
stress and cell death responses when applied to oral epithelial cells. Accordingly, the 
activation of Candidalysin peptide-dependent stress responses associated with cell 
death was investigated in TR146 oral epithelial cells. 
Several oral epithelial cell lines have been used in the study of C. albicans infection and 
C. albicans-induced cell death, including FaDu pharyngeal cells (Park et al., 2005), 
OKF6/TERT-2 oral epithelial cells (Villar et al., 2012; Zhu et al., 2012) and SCC15 tongue 
cells (Villar and Zhao, 2010). The data presented in this study were derived from the 
TR146 oral epithelial cell line which can form stratified layers, thereby mimicking the 
human buccal mucosa (Rupniak et al., 1985).  The TR146 cell line was used previously to 
characterise epithelial responses to Candidalysin (Moyes et al., 2016) and is 
representative of cells that are typically infected by C. albicans during oropharyngeal 
candidiasis. 
During the course of characterising Candidalysin (Moyes et al., 2016), computational 
analysis of C. albicans Ece1p predicted that Kex2p-mediated proteolysis would result in 
the production of several peptide fragments, each terminating with a C-terminal lysine-
arginine (KR) motif. Therefore, to characterise cell death responses to Candidalysin, 
epithelial cells were initially treated with a peptide composed of the following amino 
acid sequence; SIIGIIMGILGNIPQVIQIIMSIVKAFKGNKR (Ece1-III62-93KR). However, 
subsequent mass spectroscopy analysis of Candidalysin secreted from the hyphae of       
C. albicans revealed that the toxin was in fact comprised of the following sequence; 
SIIGIIMGILGNIPQVIQIIMSIVKAFKGNK (Ece1-III62-92K) (Moyes et al., 2016). Accordingly, 
work continued using this toxin sequence exclusively.  
The present study demonstrates that oral epithelial cells respond to Candidalysin 
peptides by eliciting a range of cellular stress responses that are strongly associated with 
cell death. Cellular stress responses included membrane permeability, loss of 
mitochondrial fitness, generation of intracellular ROS, loss of intracellular ATP and 
calcium influx (Chapter 3). 
149 
 
Interestingly, differences were observed in some of the epithelial responses to Ece1-III62-
93KR and Candidalysin sequences. While Ece1-III62-93KR was observed to be more damaging 
to epithelial cells, Candidalysin induced stronger intracellular toxicity. However, despite 
these intriguing observations, Candidalysin (Ece1-III62-92K) but not Ece1-III62-93KR is 
secreted from the hyphae of infecting C. albicans, and is therefore the most 
physiologically relevant molecule in the context of fungal infection (Moyes et al., 2016).  
An interesting question that arises from these observations is "why does C. albicans 
secrete a virulence factor that induces less cellular damage but more intracellular 
toxicity?" One possible explanation for these observations may lie in the general 
mechanism of mucosal infection caused by the fungus. Following adhesion of C. albicans 
yeast to the epithelial surface, the transcriptional machinery induces numerous genes 
required for the yeast-to-hypha morphological transition, and for expression of adhesins 
and secreted virulence factors, including Candidalysin. Once the morphological 
transition is activated, germ tubes are typically produced within 90 min, and continue to 
develop into hyphae, resulting in enhanced adhesion of the fungus to the mucosal 
surface. During these early stages of infection, it may not be advantageous to secrete a 
virulence factor that induces potent inflammatory and immune-stimulatory responses, 
as this may lead to a heightened host response to the infiltrating fungus, resulting in 
rapid clearance from the body.  
Indeed, oral epithelial cells have evolved an exquisitely sensitive mechanism of 
morphological discrimination (Chapter 1, Figure 1-4), which is dependent upon hyphal 
burden/Candidalysin secretion. Accordingly, a toxin that elicits a less robust response 
may facilitate persistence during the early stages of infection, allowing the fungus to 
establish a niche from which a more severe infection can be initiated. 
Epithelial cells respond to Candidalysin with potent intracellular alarm signals, which 
activate host defences against the infecting fungus. These responses are most likely a 
product of host pathogen co-evolution, and are thus likely to influence fungal 
pathogenicity and host defence strategies simultaneously.  
This study has identified numerous Candidalysin-induced epithelial cell stress responses 
that contribute to cell death. Although this work was conducted entirely in vitro with an 
oral epithelial cell line, it nevertheless provides a robust and reproducible model for the 
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study of oral epithelial cell responses to Candidalysin. However, additional research 
should also be conducted using primary cells and organotypic models (and eventually 
animal models) to further confirm the importance of these experimental observations. 
 
6.2 Epithelial apoptotic responses to Candidalysin 
Given the multiple and detrimental effects of epithelial cellular stresses in response to 
Candidalysin and their impact on the induction of cell death pathways, I first investigated 
epithelial apoptotic responses to Candidalysin. Apoptosis contributes to several 
biological processes including maintenance of cellular homeostasis and morphogenesis, 
but can also occur in response to stress conditions such as damage or intracellular stress. 
The data presented in this study (Chapter 4) clearly demonstrate that oral epithelial cells 
do not undergo apoptosis in response to Candidalysin and C. albicans.  
It is possible that epithelial cells may have evolved to induce particular forms of cell 
death other than apoptosis to promote specific biological outcomes in response to 
microbial insult. Apoptosis does not elicit pro-inflammatory responses, and thus the 
value of apoptotic death in response to microbial infection may be limited. Thus 
necrosis, which induces a robust pro-inflammatory response, may be a preferred form 
of cell death, as the pro-inflammatory molecules that are released from the infected cell 
will persist in the extracellular environment and continue to recruit immune cells to the 
site of infection following death of the infected cell. 
 
6.3 Epithelial necrotic responses to Candidalysin 
Given the essential role of Candidalysin in driving epithelial cell damage and stress 
responses, and having observed that epithelial cells treated with Candidalysin do not 
undergo apoptosis, I investigated the induction of regulated necrotic processes in 
response to Candidalysin. Necroptosis and pyroptosis are well-characterised forms of 
regulated necrosis and both are activated by microbes and pore-forming toxins to 
induce cell death (Fink et al., 2008; Gonzalez-Juarbe et al., 2017; Kitur et al., 2015), and 
reviewed in (Ashida et al., 2011). Thus, I investigated the activation of necroptotic and 
pyroptotic events in epithelial cells in response to Candidalysin. 
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6.3.1 Epithelial necroptotic responses to Candidalysin 
Historically, cellular necrosis was considered to occur as a consequence of inflammation. 
More recently, however, the concept that cell death may precede or augment 
inflammatory responses has gained increasing attention. In this regard, necroptosis has 
been proposed to occur as a means of positively reinforcing the inflammatory response 
through the release of DAMPs from damaged or stressed cells (Kaczmarek et al., 2013). 
However, necroptosis may also influence inflammation through a number of alternative 
mechanisms including the disruption of epithelial plasma membranes and weakening of 
mucosal barrier function, which may trigger microbe-induced immune responses. The 
release of DAMPs has been suggested to enhance non-resolving inflammatory 
conditions and contribute to the pathogenesis of inflammatory conditions including 
Crohn’s disease, ulcerative colitis and allergic colitis (Pierdomenico et al., 2014). 
Necroptotic responses to C. albicans infection have yet to be characterised. However, 
previous studies have demonstrated the release of epithelial DAMPs (including IL-1α, 
S100A8 and S100A9) in response to C. albicans and Candidalysin (Moyes et al., 2010; 
Moyes et al., 2014; Moyes et al., 2016). Accordingly, I investigated Candidalysin-induced 
epithelial signalling events that are associated with the necroptotic pathway. 
The data presented in this study demonstrates that epithelial cells do not respond to     
C. albicans or Candidalysin by activating the necroptosis pathway (Chapter 5), suggesting 
that the DAMPs that were observed to be released following C. albicans and 
Candidalysin treatment were released through an alternative necrotic pathway. Given 
these observations, I next investigated pyroptosis, an additional regulated necrotic cell 
death pathway that culminates in cell lysis and the release of immune modulators, 
including DAMPs. 
6.3.2 Epithelial pyroptotic responses to Candidalysin 
Similar to necroptosis, pyroptosis is also a pro-inflammatory regulated form of cell 
death. However, unlike necroptosis, pyroptosis is characterised by inflammasome 
activation. C. albicans activates the NLRP3 inflammasome, the non-canonical 
inflammasome and pyroptosis in macrophages. Importantly, the pyroptotic machinery 
is also expressed in epithelial cells (Liu and Lieberman, 2017; Nadatani et al., 2016), 
suggesting that pyroptotic responses may also occur at mucosal surfaces.  
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Inflammasome activation has been studied extensively in immune cells. Typically, 
activation of the inflammasome requires two signals that can be provided 
simultaneously (Juliana et al., 2012). The first of these activator signals is a priming 
event, in which stimuli-mediated receptor signalling and/or stimuli-mediated cellular 
stress drive the activation of the transcription factor NF-κB. The activation of NF-κB is 
critical for the transcription of both pro-IL-1β and NLRP3, as pro-IL-1β is not 
constitutively expressed and basal levels of NLRP3 are not sufficient for inflammasome 
formation (Bauernfeind et al., 2009). In contrast, transcriptional induction of ASC, pro-
caspase-1 or pro-IL-18 is not required, as these factors are present in sufficient 
quantities for inflammasome assembly in steady-state cells (Bauernfeind et al., 2009).  
The second activator signal is provided by agonists including exogenous ATP and pore-
forming toxins, that trigger NLRP3 activation, assembly of the inflammasome complex, 
and activation of pro-caspase-1 (Nomura et al., 2015; Zha et al., 2016). Inflammasome 
activation results in IL-1β and IL-18 secretion, which trigger pro-inflammatory responses, 
and processing of gasdermin D, which causes plasma membrane damage and pyroptotic 
cell death (Liu et al., 2016).  
Given that Candidalysin induces epithelial stress responses and damages epithelial 
plasma membranes (Chapter 3), I investigated whether Candidalysin was capable of 
simultaneously providing both of the activator signals required for inflammasome 
activation. This study reveals for the first time that Candidalysin is essential for inducing 
the expression of NLRP3 and pro-IL-1β in oral epithelial cells (Chapter 5, Figure 5-6 and 
Figure 5-8). However, notably, Candidalysin does not induce the processing of pro-IL-1β 
and pro-IL-18 into its active forms prior to secretion from the cell. Thus, Candidalysin 
appears to drive the secretion of pro-IL-1β and pro-IL-18 from epithelial cells. 
Importantly, a key consequence of Candidalysin activity is the recruitment of neutrophils 
to the mucosal site of infection (Moyes et al., 2016; Richardson et al., 2017). Neutrophils 
secrete proteinase 3, elastase and cathepsin G, proteinases that can cleave pro-IL-1β 
and pro-IL-18 to produce active IL-1β and IL-18, which in turn trigger innate and adaptive 
Th17 and Th1 responses against C. albicans infection (Afonina et al., 2015; Joosten et al., 
2009; Robertson et al., 2006). Therefore, it is plausible that secretion of Candidalysin 
from C. albicans hyphae induces the release of pro-IL-1β and pro-IL-18 from epithelial 
cells, which are then subsequently activated by secreted proteinases produced by 
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infiltrating neutrophils. This mechanism might be highly advantageous to the host, as 
secretion of inactive inflammatory mediators into the extracellular environment would 
avoid premature and unnecessary localised innate immune responses, which could 
result in destruction of the mucosal barrier and facilitate microbial invasion from the 
resident commensal flora. However, further studies are required to investigate how pro-
IL-1β and pro-IL-18 are activated once secreted from epithelial cells. 
The present study also demonstrates that, despite inducing NLRP3 expression, oral 
epithelial cells do not respond to Candidalysin or C. albicans by activating the 
inflammasome or gasdermin D processing (Chapter 5). These observations suggest that 
oral epithelial cells do not undergo classical pyroptosis in response to fungal challenge. 
Further studies of the epithelial response to Candidalysin should therefore focus on 
alternative pathways of regulated necrosis. 
 
6.4 Conclusions 
Recent research has advanced our understanding of the complex molecular events 
involved in the interaction between C. albicans and the oral mucosa. Epithelial cells are 
typically the first point of contact between host and pathogen, and are actively involved 
in orchestrating mucosal immunity by secreting antimicrobial, pro-inflammatory and 
immune-modulatory molecules that can recruit and activate immune cells. It is 
becoming increasingly clear that in addition to classical immune responses, the process 
of cell death contributes to host defence during infection. The aims of this project were 
to determine the role of Candidalysin in activating oral epithelial cell death responses 
by investigating classical hallmarks of cellular stress; and to investigate oral epithelial 
apoptotic, necrotic, necroptotic and pyroptotic responses to Candidalysin. This study 
demonstrates that oral epithelial cells respond to the secreted fungal toxin Candidalysin 
by inducing cell stress responses, which are intimately linked with cell death. Epithelial 
cells treated with Candidalysin were observed to undergo necrotic, but not apoptotic, 
necroptotic or pyroptotic death, and promoted inflammation through a mechanism 
involving necrosis-dependent pro-IL-1β and pro-IL-18 release. Unravelling the specific 
mechanism of epithelial necrosis in response to Candidalysin may ultimately result in 
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the development of new therapeutics to manipulate host signalling pathways to 
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The experimental research presented in this thesis was acknowledged as an important 
contribution to several conceptual advances in our understanding of Candidalysin 
biology. Specifically, data obtained during the course of my research was published in 
the journal Nature (Figure 2c and 4g of Moyes et al., 2016), a publication in which I was 
listed as a co-author.  
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The ability of mucosal surfaces to discriminate between commensal and 
pathogenic microbes is essential to human health. The fungus Candida 
albicans is normally a benign member of the human microbiota, but is 
also responsible for millions of mucosal infections each year in 
immuno compromised hosts, often with severe morbidity1. A defin-
ing feature of C. albicans pathogenesis is the transition from yeast to 
invasive filamentous hyphae2. Hyphae damage mucosal epithelia and 
induce activation of the activating protein-1 (AP-1) transcription factor, 
c-Fos (via p38-MAPK) and the MAPK phosphatase MKP1 
(via ERK1/2-MAPK), which trigger pro-inflammatory cytokine 
responses3–7. These signalling events constitute a ‘danger response’ 
against invasive hyphae, thus serving as a sensor of pathogenic C. albicans 
invasion8–14. However, it is unclear how C. albicans hyphae induce 
epithelial inflammatory responses and cell damage during mucosal 
infections. Here we identify and characterize Candidalysin, the first, 
to our knowledge, cytolytic peptide toxin isolated from any human 
fungal pathogen, as the hyphal factor critical for epithelial immune 
activation and C. albicans mucosal infection.
Ece1p is vital for epithelial activation and damage
Despite the well-known association between filamentation and viru-
lence, the molecular mechanism underlying hypha-driven epithelial 
activation and mucosal damage has remained obscure. To elucidate this 
mechanism, we screened a panel of C. albicans gene deletion mutants 
that targeted key processes, pathways and proteins known or predicted 
to be associated with the yeast–hyphal transition and pathogenicity (62 
strains). Only hypha-producing strains induced MKP1 phosphorylation 
(p-MKP1), c-Fos, cytokines (IL-1α, IL-6, G-CSF) and damage in oral 
epithelial cells (Extended Data Table 1). However, one C. albicans  
mutant (ece1∆/∆)15 formed normal hyphae but was incapable of 
inducing these epithelial danger responses. The C. albicans extent of 
cell elongation 1 gene (ECE1) is highly expressed by hyphae during epi-
thelial infection (Extended Data Fig. 1a, b), and is predicted to encode 
a secreted protein16. To probe its function, we generated a panel of 
C. albicans ECE1 mutants (Extended Data Table 2). The ece1∆/∆ strain 
formed normal hyphae on (Extended Data Fig. 1c), and adhered to 
and invaded human epithelial cells similarly to wild-type C. albicans 
(Extended Data Fig. 1d, e). The strain ece1∆/∆ was capable of exten-
sive epithelial invasion, penetrating through multiple epithelial cells 
(Extended Data Fig. 1f). Despite this, invasive ece1∆/∆ hyphae did not 
damage epithelia or induce p-MKP1/c-Fos-mediated danger responses 
or cytokine secretion (Fig. 1a–d). Thus, Ece1p is critical for epithelial 
damage and innate recognition of C. albicans hyphae in vitro.
Ece1p is critical for mucosal pathogenesis
We next assessed the role of ECE1 in two in vivo models of C. albicans 
mucosal infection. In murine oropharyngeal candidiasis (OPC)17, 
mice infected with C. albicans wild-type or ECE1 re-integrant 
(ece1∆/∆ + ECE1) strains exhibited disease symptoms, including 
extensive hyphal invasion of the tongue epithelium, micro-abscesses 
of infiltrating neutrophils and tissue damage (Fig. 1e, f, h, i). In contrast, 
tongue tissue from ece1∆/∆-infected animals (n =  17/20) showed no 
invasive fungi and no inflammatory infiltrates or damage (Fig. 1g). 
We detected very low numbers of ece1∆/∆ cells in only 3/20 mice 
Cytolytic proteins and peptide toxins are classical virulence factors of several bacterial pathogens which disrupt epithelial 
barrier function, damage cells and activate or modulate host immune responses. Such toxins have not been identified 
previously in human pathogenic fungi. Here we identify the first, to our knowledge, fungal cytolytic peptide toxin in the 
opportunistic pathogen Candida albicans. This secreted toxin directly damages epithelial membranes, triggers a danger 
response signalling pathway and activates epithelial immunity. Membrane permeabilization is enhanced by a positive 
charge at the carboxy terminus of the peptide, which triggers an inward current concomitant with calcium influx. 
C. albicans strains lacking this toxin do not activate or damage epithelial cells and are avirulent in animal models of 
mucosal infection. We propose the name ‘Candidalysin’ for this cytolytic peptide toxin; a newly identified, critical 
molecular determinant of epithelial damage and host recognition of the clinically important fungus, C. albicans.
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(Extended Data Fig. 2a), which showed no evidence of local epithelial 
damage (data not shown). Quantification of histology sections indi-
cated that the percentage of epithelial surface infected was significantly 
greater with the wild-type and ECE1 re-integrant strains (Extended 
Data Fig. 2b). In a zebrafish swimbladder model of mucosal infec-
tion18,19, neutrophil recruitment and tissue damage were both sig-
nificantly lower following ece1∆/∆ infection as compared with the 
wild-type strain (Fig. 1j, k and Extended Data Fig. 2c, d). Therefore, 
C. albicans Ece1p is critical for mucosal pathogenesis and is an innate 
immune activator in vivo.
Ece1p encodes a cytolytic peptide toxin
Ece1p is an in vitro substrate for Kex2p, a Golgi-located protease that 
cleaves proteins after lysine–arginine (KR) motifs20. Ece1p contains 
seven KR-processing sites, suggesting it has the potential to produce 
eight secreted peptides from C. albicans20 (Extended Data Fig. 3a, b). 
Liquid chromatography–tandem mass spectrometry (LC-MS/MS) 
analysis confirmed that recombinant Kex2p (rKex2p) processes recom-
binant Ece1p (rEce1p), and that all eight peptides generated terminated 
in KR (and fragments thereof, showing that less efficient processing 
occurs also after a single K or R) (Supplementary Information). The 
importance of Kex2p-mediated Ece1p processing was demonstrated 
using a kex2∆/∆ null strain21, which was unable to damage oral epi-
thelia or induce p-MKP1/c-Fos-mediated danger responses or cytokine 
secretion (Extended Data Table 1). To determine which Ece1p pep-
tide(s) were responsible for epithelial activation and damage, oral epi-
thelial cells were incubated with peptides Ece1-I–VIII (1.5–70 µM). 
Only Ece1-III62–93 induced p-MKP1, c-Fos, cytokines and damage 
(Fig. 2a–c, Extended Data Fig. 3c–e). Notably, low Ece1-III62–93 con-
centrations (1.5–15 µM) were sufficient to induce c-Fos DNA binding 
(Fig. 2d), G-CSF and GM-CSF (Fig. 2c and Extended Data Fig. 3c), 
whereas high Ece1-III62–93 concentrations (70 µM) were required to 
induce damage (Fig. 2e) and the damage-associated cytokines IL-1α 
and IL-6, respectively (Extended Data Fig. 3d, e). Ece1-III62–93 could 
also directly lyse multiple human epithelial cell types and induce 
haemolysis of red blood cells, a classical test for cytotoxin activity (not 
shown). Neither the N-terminal hydrophobic region (Ece1-III62–85) nor 
the C-terminal hydrophilic region (Ece1-III86–93) induced p-MKP1, 
c-Fos, cytokines or damage of epithelial cells, either individually or in 
combination (Extended Data Fig. 3f–h), demonstrating that the peptide 
containing both regions is required for activity. Therefore, Ece1-III62–93 
is the active region of Ece1p, acting as an epithelial immune activator 
and a cytolytic agent.
To confirm that Ece1-III62–93 drives epithelial activation and fun-
gal pathogenicity, we generated a C. albicans strain lacking only the 
Ece1-III62–93 region (ece1∆/∆ + ECE1∆184–279). LC-MS/MS analy-
sis showed that the modified protein in this strain is stable, secreted 
and processed into each of the predicted peptide fragments, with the 
exception of the deleted peptide toxin (Supplementary Information). 
Like ece1∆/∆, ece1∆/∆ + ECE1∆184–279 efficiently formed invasive 
hyphae (not shown). However, ece1∆/∆ + ECE1∆184–279 was unable to 
induce p-MKP1, c-Fos DNA binding, cytokines, or damage epithelia 
(Extended Data Fig. 3i–l). In murine OPC, unlike the ece1∆/∆ + ECE1 
complemented strain, ece1∆/∆ + ECE1∆184–279-infected mice demon-
strated absent (n =  4/10) or low (n =  6/10) fungal burdens, with no 
evidence of inflammatory infiltrates or local epithelial damage 
(Fig. 2f–h and Extended Data Fig. 4a, b). Likewise, ece1∆/∆ + 
ECE1∆184–279 did not induce full damage in the zebrafish swimblad-
der model (Fig. 2i and Extended Data Fig. 4c). In contrast, injection 
of lytic doses of Ece1-III62-93 into the swimbladder induced epithelial 
damage (Fig. 2j, k). Thus, Ece1-III62–93 is both necessary and sufficient 
for epithelial immune activation, damage and mucosal infection in vivo.
The amphipathic properties of Ece1-III62–93 (SIIGIIMGILGNIPQ 
VIQIIMSIVKAFKGNKR) coupled with the α-helical structure of the 
N-terminal hydrophobic region (Extended Data Fig. 5a, b) indicated 
that this fungal peptide may act similarly to cationic antimicrobial 
peptides and peptide toxins such as melittin22 (honey bee), magainin 2 
(ref. 23) (African clawed frog) and alamethicin24 (Trichoderma 
viride). Cytolytic peptide toxins have not previously been found in 
human pathogenic fungi, but bacterial cytolytic toxins are known to 
induce lesions after binding to target cell membranes25,26. To investigate 
the importance of lipid composition for Ece1-III62–93-mediated cytol-
ysis, we used Förster resonance energy transfer (FRET) and electrical 
impedance spectroscopy to analyse the interactions of Ece1-III62–93 
with model membranes comprised of lipid bilayers of dioleoylphos-
phatidylcholine (DOPC) with or without cholesterol. Although Ece1-
III62–93 was able to efficiently intercalate into DOPC membranes 
(Extended Data Fig. 5c), Ece1-III62–93 permeabilization was enhanced 
in the presence of cholesterol (Fig. 3a). Ece1-III62–93-induced lesions 
were heterogeneous and transient (Extended Data Fig. 5d), indicating 
that the peptide may damage target membranes through a ‘carpet-like’ 
mechanism27. Patch-clamp analysis of epithelial cells demonstrated that 
lesion formation by Ece1-III62–93 is rapid and causes an inward current 
(Fig. 3b), associated with calcium influx (Fig. 3c). Similar phenomena 








































































































































































































Figure 1 | ECE1 is required for epithelial activation and C. albicans 
infection. TR146 cells were infected with the indicated C. albicans strains. 
a, LDH release 24 h post-infection (p.i.) (MOI =  0.1). b, Induction of 
p-MKP-1 and c-Fos at 2 h p.i. (MOI =  10). c, c-Fos DNA binding at 3 h 
p.i. (MOI =  10). d, G-CSF production at 24 h p.i. (MOI =  0.01). e–i, PAS-
stained tongues from mice subjected to OPC 2 days p.i. Whole-mount 
(×25) (e, g, h) and high-magnification (f, i) (×200) views of PAS-stained 
tongues of mice infected with C. albicans wild type (e, f), ece1∆/∆ (g) 
and ece1∆/∆ + ECE1 (h, i). Invading hyphae (black arrowhead) and 
inflammatory cells (blue arrowhead) are indicated. j, Quantification of 
neutrophils in zebrafish swimbladder following infection with wild-type  
C. albicans (number of fish (n) =  47), ece1∆/∆ (n =  53) or PBS (n =  40).  
k, Quantification of damaged cells in zebrafish swimbladder after infection 
with C. albicans wild-type (n =  73) or ece1∆/∆ strains (n =  59) or vehicle 
(n =  63). Data are representative (b, e–i) or the mean (a, c, d, j, k) of three 
biological replicates. Error bars ±  s.e.m. Data were analysed by one-way 
ANOVA (a, d), paired t-test (c) or Kruskal–Wallis test (j, k). *P <  0.05, 
**P <  0.01, ***P <  0.001. For gel image, see Supplementary Fig. 1.
© 2016 Macmillan Publishers Limited. All rights reserved









































































































































































































































































Figure 2 | Ece1-III62–93 is the active region of 
Ece1p and is required for TR146 cell activation 
and mucosal C. albicans infection. a, Induction 
of p-MKP-1 and c-Fos 2 h post-stimulation (p.s.) 
with Ece1 peptides at 1.5 µM. b, LDH release 
24 h p.s. with 70 µM Ece1 peptides. c, Induction 
of G-CSF 24 h p.s. with Ece1-III62–93. d, c-Fos 
DNA binding induction 3 h p.s. with sub-lytic 
concentrations of Ece1-III62–93. e, LDH release 24 h 
p.s. with Ece1-III62–93. f–h, PAS-stained tongue 
sections from mice subjected to OPC, 2 days p.i. 
with C. albicans ece1∆/∆ + ECE1 (×25 and ×200) 
(f, g) or ece1∆/∆ + ECE1∆184–279 (h). Invading 
hyphae (black arrowheads) and infiltrating 
inflammatory cells (blue arrowhead) are shown. 
i, Damaged cells in a zebrafish swimbladder 24 h 
p.i. with C. albicans ece1∆/∆ + ECE1 (number of 
fish (n) =  44), ece1∆/∆ + ECE1∆184-279  (n =  58) 
or vehicle (n =  58). j, Damaged cells in zebrafish 
swimbladders after stimulation with 9 ng (n =  51) 
or 1.25 ng (n =  56) Ece1-III62-93, or vehicle (40% 
DMSO, n =  54 and 5% DMSO, n =  55). k, Co-
localization of adherens junctions (α-catenin-
citrine) with Ece1-III62–93-damaged cells (Sytox 
Orange-positive cells) in a zebrafish swimbladder. 
Scale bar, 100 µm. Data are representative (a, f–h, k)  
or mean (b–e, i, j) of three biological replicates 
(a–d) or ten mice or fish (f–h, k). Error bars 
show ±  s.e.m. Data were analysed by one-way 
ANOVA (b, c, e) paired t-test (d) or Kruskal–
Wallis (i, j). *P <  0.05, **P <  0.01, ***P <  0.001 
(compared with vehicle control unless otherwise 
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Figure 3 | Ece1-III62–93 functions as a cytolytic 
peptide toxin. a, Kinetic changes in conductance 
of tethered lipid membranes after exposure  
to different concentrations of Ece1-III62–93.  
b, Evoked inward current at a membrane potential 
of −60 mV in TR146 cells post-addition of Ece1-
III62–93 or ionomycin (positive control); individual  
(representative) and cumulative changes  
(bar chart indicates number of cells analysed  
below each bar) shown. c, Intracellular calcium 
level kinetics in TR146 cells post-stimulation  
(p.s.) with Ece1-III62–93 wild type (Ece1-III62–93KR) 
or Ece1-III62–93 AA C-terminal substitution  
(Ece1-III62–93AA). d, Kinetic changes in 
conductance of tethered DOPC membranes  
after exposure to different concentrations of  
Ece1-III62-93KR and Ece1-III62–93AA. e, f, LDH 
release (e) and secretion of IL-1α (f) from TR146 
cells 24 h p.s. with Ece1-III62–93KR or Ece1-III62–93AA. 
Data shown are representative (a, d) or mean  
(b, c, e, f) of three biological replicates. Error bars 
show ±  s.e.m. Data were analysed by one-way 
ANOVA (c, e and f). **P <  0.01, ***P <  0.001.
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We postulated that the positively-charged C-terminal KR residues of 
Ece1-III62–93 might be critical for interacting with negatively-charged 
components of host membranes to promote lesion formation. 
Substitution of the KR motif to AA (alanine–alanine; Ece1-III62–93AA) 
did not affect membrane intercalation (not shown) but significantly 
reduced the peptide’s ability to permeabilize membranes, damage 
epithelial cells and induce calcium influx (Fig. 3c–e). Thus, the pos-
itive C terminus of Ece1-III62–93 is critical for lesion formation and 
damage induction in epithelial membranes. Notably, Ece1-III62–93AA 
still induced p-MKP1, c-Fos and the non-damage associated cytokine 
G-CSF (Extended Data Fig. 5e, f), but not the damage-associated 
cytokine IL-1α (Fig. 3f), suggesting that Ece1-III62–93AA can be recog-
nized by epithelial immunity without damaging cells. The importance 
of this finding is that it means epithelial cells are not only responding to 
damage, but have evolved to specifically recognize the peptide.
Ece1-III62–92K is a secreted cytolytic peptide toxin
To demonstrate that Ece1-III is generated during epithelial infection, 
we performed LC-MS/MS analysis on the secretome from wild-type 
C. albicans hyphae grown in the presence and absence of epithelial 
cells (Supplementary Information). Notably, Ece1-III was the only 
peptide detected in the presence of epithelial cells, indicating that 
the fungus secretes this toxin during mucosal infection. However, 
the predominant form of secreted Ece1-III terminated in a K residue 
(SIIGIIMGILGNIPQVIQIIMSIVKAFKGNK; Ece1-III62–92K) and not 
KR (SIIGIIMGILGNIPQVIQIIMSIVKAFKGNKR; Ece1-III62–93KR) 
(Extended Data Table 3). In fungi, it is known that following Kex2p 
processing, many proteins are subsequently cleaved by Kex1p29 (also 
in the Golgi), removing the C-terminal R. LC-MS/MS analysis on the 
hyphal secretome of a kex1∆/∆ mutant demonstrated that the pre-
dominant peptide secreted terminates in KR (not K) (Supplementary 
Information). Therefore, Ece1p is also subject to ordered Kex2p/Kex1p 
processing. Accordingly, we confirmed that Ece1-III62–92K functioned 
similarly to Ece1-III62–93KR with respect to epithelial cell activation. 
Specifically, Ece1-III62-92K is also α-helical (not shown) and induces 
c-Fos, p-MKP1, cytokines (IL-1α, G-CSF), damage (LDH), membrane 
intercalation and permeabilization, and calcium influx (Fig. 4a–g). 
Thus, the dominant peptide secreted from C. albicans hyphae during 
mucosal infection is Ece1-III62–92K, which acts as a cytolytic peptide 
toxin that activates epithelial cells.
Based on these data, we propose a model of C. albicans mucosal 
infection whereby invasive hyphae secrete Ece1-III62-92K into a 
membrane-bound ‘invasion pocket’30,31, facilitating peptide accumula-
tion (Extended Data Fig. 6). During early stages of infection, sub-lytic 
concentrations of Ece1-III62–92K induce epithelial immunity by activat-
ing the ‘danger response’ pathway (p-MKP1/c-Fos), alerting the host 
to the transition from colonizing yeast to invasive, toxin-producing 
hyphae. As infection progresses, Ece1-III62–92K levels accumulate 
and elicit direct tissue damage. Mechanistically, we propose that the 
asymmetric distribution of charge along the α-helix of Ece1-III62–92K 
facilitates correct peptide orientation relative to the host membrane, 
enabling intercalation, permeabilization and calcium influx. Our data 
identifies C. albicans Ece1-III62–92K as the first cytolytic peptide toxin 
in a human fungal pathogen and reveals the molecular mechanisms 
of epithelial damage and host recognition of this clinically important 
fungus. We propose the name ‘Candidalysin’ for this newly discovered 
fungal toxin.
Online Content Methods, along with any additional Extended Data display items and 
Source Data, are available in the online version of the paper; references unique to 
these sections appear only in the online paper.
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d, Förster resonance energy transfer (FRET) showing intercalation 
of Ece1-III62–92K (10 µM) into lipid liposomes. e, Average peptide 
concentration-dependent changes in conductance of tethered lipid 
membranes. f, Ece1-III62–92K (4 µM) induced permeabilization of planar 
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METHODS
Data reporting. No statistical methods were used to predetermine sample size. The 
experiments were not randomized. The investigators were not blinded to allocation 
during experiments and outcome assessment.
Cell lines, reagents and Candida strains. Experiments were carried out using 
the TR146 buccal epithelial squamous cell carcinoma line32 obtained from the 
European Collection of Authenticated Cell Cultures (ECACC) and grown in 
Dulbecco’s Modified Eagle’s Medium (DMEM, Sigma-Aldrich) supplemented with 
10% fetal bovine serum (FBS) and 1% penicillin-streptomycin. Cells were routinely 
tested for mycoplasma contamination using mycoplasma-specific primers and 
were found to be negative. Prior to stimulation, confluent TR146 cells were serum-
starved overnight, and all experiments were carried out in serum-free DMEM. 
C. albicans wild-type strains included the autotrophic strain BWP17 + CIp30 
(ref. 33) and the parental strain SC5314 (ref. 34). Other C. albicans strains used 
and their sources are listed in Extended Data Tables 1 and 2. C. albicans cultures 
were grown in YPD medium (1% yeast extract, 2% peptone, 2% dextrose) at 30 °C 
overnight. Cultures were washed in sterile PBS and adjusted to the required 
cell density. Antibodies to phospho-MKP1 and c-Fos were from Cell Signalling 
Technologies (New England Biolabs UK), mouse anti-human α-actin was from 
Millipore (UK), and goat anti-mouse and anti-rabbit horseradish peroxidase 
(HRP)-conjugated antibodies were from Jackson Immunologicals (Stratech 
Scientific, UK). Ece1p peptides were synthesized commercially (Proteogenix 
(France) or Peptide Synthetics (UK).
Generation of C. albicans ECE1 mutant strains. ECE1 deletion was performed 
as previously described35. Deletion cassettes were generated by PCR36. Primers 
ECE1-FG and ECE1-RG were used to amplify pFA-HIS1 and pFA-ARG4 -based 
markers. C. albicans BWP17 (ref. 37), was sequentially transformed38 with the 
ECE1-HIS1 and ECE1-ARG4 deletion cassettes and then transformed with 
CIp10 (ref. 39), yielding the ece1∆/∆ deletion strain. For complementation, the 
ECE1 gene plus upstream and downstream intergenic regions were amplified 
with primers ECE1-RecF3k and ECE1-RecR and cloned into plasmid CIp10 at 
MluI and SalI sites. This plasmid was transformed into the uridine auxotrophic 
ece1∆/∆ strain, yielding the ece1∆/∆ + ECE1 complemented strain. For gener-
ation of the ece1∆/∆ + ECE1∆184–279 strain, the CIp10-ECE1 was amplified with 
primers Pep3-F1 and Pep3-R1, digested with ClaI and re-ligated, yielding the 
CIp10 + ECE1∆184–279 plasmid. This plasmid was transformed into the uridine 
auxotrophic ece1∆/∆ strain, yielding the ece1∆/∆ + ECE1∆184–279 strain. All 
integrations were confirmed by PCR/sequencing and at least two independent 
isogenic transformants were created to confirm results. KEX1 deletion was per-
formed exactly as the ECE1 deletion but using primers KEX1-FG and KEX1-RG 
for creating the deletion cassette. Fluorescent strains of ece1∆/∆ and BWP17 were 
constructed as previously described40. Briefly, the ece1∆/∆ and BWP17 strains 
were transformed with the pENO1-dTom-NATr plasmid. Primers used to clone 
and construct the ECE1 genes and intragenic regions are listed in Extended Data 
Table 4. Strains are listed in Extended Data Table 2.
Construction of C. albicans ECE1 promoter–GFP strain. ECE1 promoter (prim-
ers 5′ECE1prom–NarI / 3′ECE1prom–XhoI) and terminator (5′ECE1term–SacII / 
5′ECE1term–SacI) were amplified and cloned into pADH1-GFP. Resulting pSK-
pECE1-GFP was verified by sequencing. C. albicans SC5314 was transformed with 
the pECE1-GFP transformation cassette38. Resistance to nourseothricin was used 
as selective marker and correct integration of GFP into the ECE1 locus was verified 
by PCR. Primers for cloning and validation are listed in Extended Data Table 4. 
Strains are listed in Extended Data Table 2.
RNA isolation and real-time PCR analysis. C. albicans cells grown on TR146 
epithelial cells were collected into RNA pure (PeqLab), centrifuged and the 
pellet resuspended in 400 µl AE buffer (50 mM Na-acetate pH 5.3, 10 mM 
EDTA, 1% SDS). Samples were vortexed (30 s), and an equal volume of phenol/ 
chloroform/isoamyl alcohol (25:24:1) was added and incubated for 5 min (65 °C) 
before subjected to 2× freeze-thawing. Lysates were clarified by centrifugation 
and the RNA precipitated with isopropyl alcohol/0.3 M sodium acetate by incu-
bating for 1 h at −20 °C. Precipitated pellets were washed (2× 1 ml 70% ice-cold 
ethanol), resuspended in DEPC-treated water and stored at −80 °C. RNA integrity 
and concentration was confirmed using a Bioanalyzer (Agilent). RNA (500 ng) was 
treated with DNase (Epicentre) and cDNA synthesized using Reverse Transcriptase 
Superscript III (Invitrogen). cDNA samples were used for qPCR with EVAgreen 
mix (Bio&Sell). Primers (ACT1-F and ACT1-R for actin, ECE1-F and ECE1-R 
for ECE1 Extended Data Table 4) were used at a final concentration of 500 nM. 
qPCR amplifications were performed using a Biorad CFX96 thermocycler. Data 
was evaluated using Bio-Rad CFX Manager 3.1 (Bio-Rad) with ACT1 as the refer-
ence gene and t0 as the control sample.
Western blotting. TR146 cells were lysed using a modified RIPA lysis buffer 
(50 mM Tris-HCl pH 7.4, 150 mM NaCl, 1 mM EDTA, 1% Triton X-100, 1% 
sodium deoxycholate, 0.1% SDS) containing protease (Sigma-Aldrich) and 
phosphatase (Perbio Science) inhibitors41, left on ice (30 min) and then clarified 
(10 min) in a refrigerated microfuge. Lysate total protein content was determined 
using the BCA protein quantitation kit (Perbio Science). 20 µg of total protein was 
separated on 12% SDS–PAGE gels before transfer to nitrocellulose membranes 
(GE Healthcare). After probing with primary (1:1,000) and secondary (1:10,000) 
antibodies, membranes were developed using Immobilon chemiluminescent sub-
strate (Millipore) and exposed to X-ray film (Fuji film). Human α-actin was used 
as a loading control.
Transcription factor DNA binding assay. DNA binding activity of transcription 
factors was assessed using the TransAM transcription factor ELISA system (Active 
Motif) as previously described41,42. Serum-starved TR146 epithelial cells were 
treated for 3 h before being differentially lysed to recover nuclear proteins using 
a nuclear protein extraction kit (Active Motif) according to the manufacturer’s 
protocol. Protein concentration was determined (BCA protein quantitation kit 
(Perbio Science)) and 5 µg of nuclear extract was assayed in the TransAM system 
according to the manufacturer’s protocol. Data was expressed as fold-change in 
A450 nm relative to resting cells.
Cytokine determination. Cytokine levels in cell culture supernatants were deter-
mined using the Performance magnetic Fluorokine MAP cytokine multiplex kit 
(Bio-techne) and a Bioplex 200 machine. The data were analysed using Bioplex 
Manager 6.1 software to determine analyte concentrations.
Cell damage assay. Following incubation, culture supernatant was collected 
and assayed for lactate dehydrogenase (LDH) activity using the Cytox 96 Non-
Radioactive Cytotoxicity Assay kit (Promega) according to the manufacturer’s 
instructions. Recombinant porcine LDH (Sigma-Aldrich) was used to generate 
a standard curve.
Epithelial adhesion assay. Quantification of C. albicans adherence to TR146 epi-
thelial cells was performed as described previously43. Briefly, TR146 cells were 
grown to confluence on glass coverslips for 48 h in tissue culture plates in DMEM 
medium. C. albicans yeast cells (2 × 105) were added into 1 ml serum-free DMEM, 
incubated for 60 min (37 °C/5% CO2) and non-adherent C. albicans cells removed 
by aspiration. Following washing (3× 1 ml PBS), cells were fixed with 4% para-
formaldehyde (Roth) and adherent C. albicans cells stained with Calcofluor White 
and quantified using fluorescence microscopy. The number of adherent cells was 
determined by counting 100 high-magnification fields of 200 µm × 200 µm size. 
Exact total cell numbers were calculated based on the quantified areas and the 
total size of the cover slip.
Epithelial invasion assay. C. albicans invasion of epithelial cells was determined as 
described previously43. Briefly, TR146 epithelial cells were grown to confluence on 
glass coverslips for 48 h and then infected with C. albicans yeast cells (1 × 105), for 
3 h in a humidified incubator (37 °C/5% CO2). Following washing (3× PBS), the 
cells were fixed with 4% paraformaldehyde. All surface adherent fungal cells were 
stained for 1 h with a rabbit anti-Candida antibody and subsequently with a goat 
anti-rabbit-Alexa Fluor 488 antibody. After rinsing with PBS, epithelial cells were 
permeabilized (0.1% Triton X-100 in PBS for 15 min) and fungal cells (invading 
and non-invading) were stained with Calcofluor White. Following rinsing with 
water, coverslips were visualized using fluorescence microscopy. The percentage 
of invading C. albicans cells was determined by dividing the number of (partially) 
internalized cells by the total number of adherent cells. At least 100 fungal cells 
were counted on each coverslip.
Imaging of C. albicans growth and invasion of epithelial cells. TR146 cells 
(105 per ml) seeded on glass coverslips in DMEM/10% FBS were infected with 
C. albicans (2.5 × 104 cfu per ml) in DMEM and incubated for 6 h (37 °C/5% CO2). 
Cells were washed with PBS, fixed overnight (4 °C in 4% paraformaldehyde) and 
stained with Concanavalin A-Alexa Fluor 647 in PBS (10 µg ml−1) for 45 min at 
room temperature in the dark with gentle shaking (70 r.p.m.) to stain the fungal 
cell wall. Epithelial cells were permeabilized with 0.1% Triton X-100 for 15 min 
at 37 °C in the dark, then washed and stained with 10 µg ml−1 Calcofluor White 
(0.1 M Tris-HCl pH 9.5) for 20 min at room temperature in the dark with gentle 
shaking. Cells were rinsed in water and mounted on slides with 6 µl of ProLong 
Gold anti-fade reagent, before air drying for 2 h in the dark. Fluorescence micros-
copy was performed on a Zeiss Axio Observer Z1 microscope, and 5 phase images 
were taken per picture.
Scanning electron microscopy. For scanning electron microscopy (SEM) analysis, 
TR146 cells were grown to confluence on Transwell inserts (Greiner) and serum 
starved overnight in serum-free DMEM. After 5 h of C. albicans incubation on 
epithelial cells at an MOI of 0.01, cell media was removed and samples were fixed 
overnight at 4 °C with 2.5% (v/v) glutaraldehyde in 0.05 M HEPES buffer (pH 7.2) 
and post-fixed in 1% (w/v) osmium tetroxide for 1 h at room temperature. After 
washing, samples were dehydrated through a graded ethanol series before being 
critical point dried (Polaron E3000, Quorum Technologies). Dried samples were 
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mounted using carbon double side sticky discs (TAAB) on aluminium pins (TAAB) 
and gold coated in an Emitech K550X sputter coater (Quorum Technologies Ltd). 
Samples were examined and images recorded using a FEI Quanta 200 field emis-
sion scanning electron microscope operated at 3.5 kV in high vacuum mode.
Zebrafish swimbladder mucosal infection model. Zebrafish infections were per-
formed in accordance with NIH guidelines under Institutional Animal Care and 
Use Committee (IACUC) protocol A2009-11-01 at the University of Maine. To 
determine sample size, a power calculation was done for all experiments based on 
two-tailed t-tests in order to detect a minimum effect size of 0.8, with an alpha error 
probability of 0.05 and a power (1 – beta error probability) of 0.95. This gave a min-
imum number of 42 fish for each group. The fish selected for the experiments were 
randomly assigned to the different groups by picking them from a pool without bias 
and the groups were injected in different orders. No blinding was used to read the 
results. Ten to twenty zebrafish per group per experiment were maintained at 33 °C 
in E3 + PTU and used as previously described40. Briefly, 4 days post-fertilization 
(dpf) larvae were treated with 20 µg ml−1 dexamethasone dissolved in 0.1% DMSO 
1 h before infection and thereafter. For tissue damage and neutrophil recruitment, 
individual AB or mpo:GFP fish (respectively) were injected into the swimbladder 
with 4 nl of PBS with or without 25–40 C. albicans yeast cells of ece1∆/∆-dTomato, 
ece1∆/∆ + ECE1 + dTomato, ece1∆/∆ + ECE1∆184–279 + dTomato or BWP17-
dTomato. For tissue damage, 1 nl of Sytox green (0.05 mM in 1% DMSO) was 
injected at 20 h post-infection into the swimbladder and fish were imaged by confo-
cal microscopy at 24 h post-infection. For neutrophil recruitment, fish were imaged 
at 24 h post-injection. For synthetic peptide damage, AB or α-catenin:citrine44 fish 
were injected with 2 nl of peptide (9 ng or 1.25 ng per fish) or vehicle (40% DMSO 
or 5% DMSO) + SytoxGreen (0.05 mM in 1% DMSO) or SytoxOrange (0.5 mM 
in 10% DMSO) and the fish imaged by confocal microscopy 4 h later. Numbers of 
neutrophils and damaged cells observed were counted and tabulated for each fish.
Zebrafish swimbladder fluorescence microscopy. Live zebrafish imaging was car-
ried out as previously described40. Briefly, fish were anaesthetized in Tris-buffered 
Tricaine (200 µg ml−1, Western Chemicals) and further immobilized in a solution 
of 0.4% low-melting-point agarose (LMA, Lonza) in E3 + Tricaine in a 96-well 
plate glass-bottom imaging dish (Greiner Bio-On). Confocal imaging was carried 
out using an Olympus IX-81 inverted microscope with an FV-1000 laser scanning 
confocal system (Olympus). Images were collected and processed using Fluoview 
(Olympus) and Photoshop (Adobe Systems). Panels are either a single slice for the 
differential interference contrast channel (DIC) with maximum projection over-
lays of fluorescence image channels (red-green), or maximum projection overlays 
of fluorescence channels. The number of slices for each maximum projection is 
specified in the legend of individual figures.
Murine oropharyngeal candidiasis model. Murine infections were performed 
under UK Home Office Project Licence PPL 70/7598 in dedicated animal facilities 
at King’s College London. No statistical method was used to pre-determine sample 
size. No method of randomization was used to allocate animals to experimental 
groups. Mice in the same cage were part of the same treatment. The investigators 
were not blinded during outcome assessment. A previously described murine 
model of oropharyngeal candidiasis using female BALB/c mice45 was modified to 
use for investigating early infection events. Briefly, mice were treated subcutane-
ously with 3 mg per mouse (in 200 µl PBS with 0.5% Tween 80) of cortisone acetate 
on days −1 and +1 post-infection. On day 0, mice were sedated for ∼ 75 min with 
an intra-peritoneal injection of 110 mg per kg ketamine and 8 mg per kg xylazine, 
and a swab soaked in a 107 cfu per ml of C. albicans yeast culture in sterile saline 
was placed sublingually for 75 min. After 2 days, mice were euthanized, the tongue 
excised and divided longitudinally in half. One half was weighed, homogenized 
and cultured to derive quantitative Candida counts. The other half was processed 
for histopathology and immunohistochemistry.
Immunohistochemistry of murine tissue. C. albicans-infected murine tongues 
were fixed in 10% (v/v) formal-saline before being embedded and processed in 
paraffin wax using standard protocols. For each tongue, 5-µm sections were pre-
pared using a Leica RM2055 microtome and silane coated slides. Sections were 
dewaxed using xylene, before C. albicans and infiltrating inflammatory cells were 
visualized by staining using Periodic Acid-Schiff (PAS) stain and counterstaining 
with haematoxylin. Sections were then examined by light microscopy. Histological 
quantification of infection was undertaken by measuring the area of infected epi-
thelium and expressed as a percentage relative to the entire epithelial area.
Whole cell patch clamp. TR146 epithelial cells were grown in 35-mm Petri dishes 
(Nunc) for 48 h before recordings at low cell density (10–30% confluence). Cells 
were superfused with a modified Krebs solution (120 mM NaCl, 3 mM KCl, 2.5 mM 
CaCl2, 1.2 mM MgCl2, 22.6 mM NaHCO2, 11.1 mM glucose, 5 mM HEPES pH 7.4). 
Isolated cells were recorded at room temperature (21–23 °C) in whole cell mode 
using microelectrodes (5–7 MΩ) containing 90 mM potassium acetate, 20 mM 
KCl, 40 mM HEPES, 3 mM EGTA, 3 mM MgCl2, 1 mM CaCl2 (free Ca2+ 40 nM), 
pH 7.4. Cells were voltage clamped at −60 mV using an Axopatch 200A amplifier 
(Axon Instruments) and current/voltage curves were generated by 1 s steps 
between −100 to +50 mV. Treatments were applied to the superfusate to produce 
the final required concentration, with vehicle controls similarly applied. Data was 
recorded using Clampex software (PClamp 6, Axon Instrument) and analysed with 
Clampfit 10.
Calcium flux. TR146 cells were grown in a 96-well plate overnight until conflu-
ent. The medium was removed and 50 µl of a Fura-2 solution (5 µl Fura-2 (Life 
Technologies) (2.5 mM in 50% Pluronic F-127 (Life Technologies):50% DMSO), 
5 µl probenecid (Sigma) in 5 ml saline solution (NaCl (140 mM), KCl (5 mM), 
MgCl2 (1 mM), CaCl2 (2 mM), glucose (10 mM) and HEPES (10 mM), adjusted 
to pH 7.4)) was added and the plate incubated for 1 h at 37 °C/5% CO2. The Fura-2 
solution was replaced with 50 µl saline solution and baseline fluorescence read-
ings (excitation 340 nm/emission 520 nm) taken for 10 min using a FlexStation 3 
(Molecular Devices). Ece1 peptides were added at different concentrations and 
readings immediately taken for up to 3 h. The data was analysed using Softmax 
Pro software to determine calcium present in the cell cytosol and expressed as the 
ratio between excitation and emission spectra.
Impedance spectroscopy of tethered bilayer lipid membranes (tBLMs). tBLMs 
with 10% tethering lipids and 90% spacer lipids (T10 slides) were formed using the 
solvent exchange technique46,47 according to the manufacturer’s instructions (SDx 
Tethered Membranes Pty Ltd, Sydney, Australia). Briefly, 8 µl of 3 mM lipid solu-
tions in ethanol were added, incubated for 2 min and then 93.4 µl buffer (100 mM 
KCl, 5 mM HEPES, pH 7.0) was added. After rinsing 3× with 100 µl buffer the 
conductance and capacitance of the membranes were measured for 20 min before 
injection of Ece1 peptides at different concentrations. All experiments were per-
formed at room temperature. Signals were measured using the tethaPod (SDx 
Tethered Membranes Pty, Sydney, Australia).
FRET intercalation experiments. Intercalation of Ece1 peptides into phospho-
lipid liposomes was determined by FRET spectroscopy applied as a probe-dilution 
assay48. Phospholipids mixed with each 1% (mol/mol) of the donor dye NBD-
phosphatidylethanolamine (NBD-PE) and of the acceptor dye rhodamine-PE, 
were dissolved in chloroform, dried, solubilized in 1 ml buffer (100 mM KCl, 5 mM 
HEPES, pH 7.0) by vortexing, sonicated with a titan tip (30 W, Branson sonifier, cell 
disruptor B15), and subjected to three cycles of heating to 60 °C and cooling down 
to 4 °C, each for 30 min. Lipid samples were stored at 4 °C for at least 12 h before 
use. Ece1 peptide was added to liposomes and intercalation was monitored as the 
increase of the quotient between the donor fluorescence intensity ID at 531 nm and 
the acceptor intensity IA at 593 nm (FRET signal) independent of time.
Circular Dichroism spectroscopy. CD measurements were performed using a 
Jasco J-720 spectropolarimeter (Japan Spectroscopic Co., Japan), calibrated as 
described previously49. CD spectra represent the average of four scans obtained 
by collecting data at 1 nm intervals with a bandwidth of 2 nm. The measurements 
were performed in 100 mM KCl, 5 mM HEPES, pH 7.0 at 25 °C and 40 °C in a 
1.0 mm quartz cuvette. The Ece1-III concentration was 15 µM.
Planar lipid bilayers. Planar lipid bilayers were prepared using the Montal-Mueller 
technique50 as described previously51. All measurements were performed in 5 mM 
HEPES, 100 mM KCl, pH 7.0 (specific electrical conductivity 17.2 mS per cm) at 
37 °C.
Hyphal secretome preparation for LC-MS/MS analysis. Candida strains were 
cultured for 18 h in hyphae inducing conditions (YNB medium containing 2% 
sucrose, 75 mM MOPSO buffer pH 7.2, 5 mM N-acetyl-d-glucosamine, 37 °C). 
Hyphal supernatants were collected by filtering through a 0.2 µm PES filter, and 
peptides were enriched by solid phase extraction (SPE) using first C4 and subse-
quently C18 columns on the C4 flowthrough. After drying in a vacuum centrifuge, 
samples were resolubilized in loading solution (0.2% formic acid in 71:27:2 ACN/
H2O/DMSO (v/v/v)) and filtered through a 10 kDa MWCO filter. The filtrate was 
transferred into HPLC vials and injected into the LC-MS/MS system. LC-MS/
MS analysis was carried out on an Ultimate 3000 nano RSLC system coupled to a 
QExactive Plus mass spectrometer (ThermoFisher Scientific). Peptide separation 
was performed based on a direct injection setup without peptide trapping using 
an Accucore C4 column as stationary phase and a column oven temperature of 
50 °C. The binary mobile phase consisting of A) 0.2% (v/v) formic acid in 95:5 
H2O/DMSO (v/v) and B) 0.2% (v/v) formic acid in 85:10:5 ACN/H2O/DMSO 
(v/v/v) was applied for a 60 min gradient elution: 0–1.5 min at 60% B, 35–45 min 
at 96% B, 45.1–60 min at 60% B. The Nanospray Flex Ion Source (ThermoFisher 
Scientific) provided with a stainless steel emitter was used to generate positively 
charged ions at 2.2 kV spray voltage. Precursor ions were measured in full scan 
mode within a mass range of m/z 300–1600 at a resolution of 70k FWHM using 
a maximum injection time of 120 ms and an automatic gain control target of 1e6. 
For data-dependent acquisition, up to 10 most abundant precursor ions per scan 
cycle with an assigned charge state of z =  2–6 were selected in the quadrupole for 
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further fragmentation using an isolation width of m/z 2.0. Fragment ions were 
generated in the HCD cell at a normalized collision energy of 30 V using nitro-
gen gas. Dynamic exclusion of precursor ions was set to 20 s. Fragment ions were 
monitored at a resolution of 17.5k (FWHM) using a maximum injection time of 
120 ms and an AGC target of 2e5.
Protein database search. Thermo raw files were processed by the Proteome 
Discoverer (PD) software v1.4.0.288 (Thermo). Tandem mass spectra were 
searched against the Candida Genome Database (http://www.candidagenome.
org/download/sequence/C_albicans_SC5314/Assembly22/current/C_albicans_
SC5314_A22_current_orf_trans_all.fasta.gz; status: 2015/05/03) using the Sequest 
HT search algorithm. Mass spectra were searched for both unspecific cleavages 
(no enzyme) and tryptic peptides with up to 4 missed cleavages. The precursor 
mass tolerance was set to 10 p.p.m. and the fragment mass tolerance to 0.02 Da. 
Target Decoy PSM Validator node and a reverse decoy database was used for 
(q value) validation of the peptide spectral matches (PSMs) using a strict target 
false discovery (FDR) rate of < 1%. Furthermore, we used the score versus charge 
state function of the Sequest engine to filter out insignificant peptide hits (xcorr 
of 2.0 for z =  2, 2.25 for z =  3, 2.5 for z =  4, 2.75 for z =  5, 3.0 for z =  6). At least two 
unique peptides per protein were required for positive protein hits.
Statistics. TransAM and patch clamp data were analysed using a paired t-test while 
cytokines, LDH and calcium influx data were analysed using one-way ANOVA 
with all compared groups passing an equal variance test. Murine in vivo data was 
analysed using the Mann–Whitney test. Zebrafish data was analysed using the 
Kruskal–Wallis test with Dunn’s multiple comparison correction. In all cases, 
P <  0.05 was taken to be significant.
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Extended Data Figure 1 | C. albicans ECE1 expression and phenotypic 
effects of ECE1 gene deletion. a, Relative expression (vs t =  0) of ECE1 
in C. albicans wild type over time after addition of yeast cells to TR146 
epithelial cells as measured by RT-qPCR. b, Imaging confirmation of 
ECE1 expression over time within C. albicans wild-type strain. C. albicans 
cells expressing GFP under the control of the ECE1 5′ intragenic region, 
containing the ECE1 promoter, were grown on TR146 epithelial cells and 
stained with calcofluor white (CFW, post-permeabilization) to show cell 
wall chitin and Alexa-Fluor-647-labelled concanavalin A (ConA, pre-
permeabilization) to show carbohydrates. A composite image showing 
CFW, ConA, GFP and the brightfield (BF) image is shown. c, Scanning 
electron micrographs (top panels, 5 h) and light microscopy (bottom 
panels, 24 h) showing no gross abnormalities in hypha formation between 
C. albicans wild-type (BWP17 + CIp30), ECE1-deletion (ece1∆/∆) and 
ECE1 re-integrant (ece1∆/∆ + ECE1) strains after infection of TR146 
epithelial cells. d, No difference in adhesion of C. albicans wild-type, 
ece1∆/∆ and ece1∆/∆ + ECE1 strains to TR146 epithelial cells after 
60 min. e, No difference in invasion of C. albicans wild-type, ece1∆/∆  
and ece1∆/∆ + ECE1 strains into TR146 epithelial cells after 3 h.  
f, Fluorescence staining of C. albicans wild-type and ece1∆/∆ hyphae 
invading through TR146 epithelial cells. Fungal cells are stained with 
calcofluor white (CFW, post-permeabilization) and Alexa-Fluor-647-
labelled concanavalin A (ConA, pre-permeabilization) to show cell 
wall chitin and carbohydrates, respectively, and to distinguish between 
invading hyphae (only stained after permeabilization) and non-invading 
hyphae (stained both pre- and post-permeabilization). Levels of chitin and 
β-glucan are comparable in both strains. White arrows indicate invasion 
into epithelial cells. Data shown are representative (b, c, f) or the mean  
(a, d, e) of three biological replicates. Error bars show ±  s.e.m.
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Extended Data Figure 2 | See next page for caption.
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Extended Data Figure 2 | C. albicans Ece1p is critical for mucosal 
virulence in vivo. a, Fungal burdens recovered from the tongues of 
mice infected with C. albicans wild-type (BWP17 + CIp30) (number 
of mice(n) =  13), ECE1-deletion (ece1∆/∆) (n =  20) and ECE1 re-
integrant (ece1∆/∆ + ECE1) (n =  24) strains after a 2-day oropharyngeal 
infection. b, Average percentage of the entire tongue epithelium area 
infected in different groups of mice infected with the different C. albicans 
strains. c, Confocal imaging of 4-day post-fertilization (dpf) mpo-gfp 
transgenic zebrafish swimbladders infected with C. albicans wild-type 
(BWP17 + CIp30 + dTomato), ECE1-deletion (ece1∆/∆ + dTomato)  
and ECE1 re-integrant (ece1∆/∆ + ECE1 + dTomato) strains for 24 h.  
C. albicans cells appear red while neutrophils appear green. Red dots outline 
the swimbladder. Images are composites of maximum projections in the 
red and green channels (25 slices each, approximately 100 µm depth) with 
(left) or without (right) a single slice in the DIC channel overlay. Scale bars 
represent 100 µm. d, Confocal imaging of 4 dpf zebrafish swimbladders 
infected with C. albicans wild-type (BWP17 + CIp30 + dTomato), 
ECE1-deletion (ece1∆/∆ + dTomato) and ECE1 re-integrant 
(ece1∆/∆ + ECE1 + dTomato) strains for 24 h stained with the fluorescent 
exclusion dye Sytox Green. C. albicans cells appear red and damaged 
epithelial cells appear green. White dots outline the pronephros and 
red dots outline the swimbladder. Images are composites of maximum 
projections in the red and green channels (25 slices each, approximately 
100 µm depth) with (left) or without (right) a single slice in the DIC 
channel overlay. High magnification images of the white boxes are shown. 
Scale bars (bottom right) represent 100 µm (low magnification) and 30 µm 
(high magnification). Data shown are the mean (a, b) or representative  
(c, d) of at least three biological replicates. Error bars show ±  s.e.m. Data 
were analysed by Mann–Whitney U-test. ***P <  0.001.
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Extended Data Figure 3 | See next page for caption.
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Extended Data Figure 3 | Ece1-III62–93 is the active region of Ece1p.  
a, Amino acid sequence of Ece1p and a schematic of the protein, indicating 
the signal peptide (SP), lysine-arginine motifs (KR) at the C terminus 
of each peptide, and the processed peptides (Ece1-I–VIII) produced 
by Kex2p cleavage. b, Amino acid sequences of the processed peptides 
(Ece1-I–VIII) produced by Kex2p cleavage. c–e, Induction of GM-CSF (c), 
IL-1α (d) and IL-6 (e) secreted after stimulation of TR146 epithelial  
cells for 24 h with varying concentrations of Ece1-III62–93 (1.5–70 µM).  
f, Phosphorylation of MKP-1 and c-Fos production after 2 h treatment of 
TR146 epithelial cells with 15 µM of Ece1-III62–85 (hydrophobic region), 
Ece1-III86–93 (hydrophillic region), Ece1-III62–85 and Ece1-III86–93 together, 
or Ece1-III62–93 alone. g, Induction of G-CSF secretion after 24 h treatment 
of TR146 epithelial cells with 15 µM of Ece1-III62–85, Ece1-III86–93,  
Ece1-III62–85 and Ece1-III86–93 together, or Ece1-III62–93 alone. h, Fold 
change induction of LDH release after 24 h treatment of TR146 epithelial 
cells with 70 µM of Ece1-III62-85, Ece1-III86-93, Ece1-III62–85 and Ece1-
III86–93 together, or Ece1-III62–93 alone. i, Induction of p-MKP-1 and c-Fos 
2 h post-infection (p.i.) with the indicated C. albicans strains (MOI =  10).  
j, c-Fos DNA binding induction 3 h p.i. with indicated C. albicans strains 
(MOI =  10). k, G-CSF secretion and l, LDH release 24 h p.i. with indicated 
C. albicans strains (MOI =  0.01). Data shown are representative (f, i) or the 
mean (c–e, g, h, j–l) of three biological replicates. Error bars show ±  s.e.m. 
Data were analysed by one-way ANOVA (c–e, g, h, k–l) or t-test (j). 
*P <  0.05, **P<  0.01, ***P <  0.001 (compared with vehicle control). For 
gel image, see Supplementary Fig. 1.
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Extended Data Figure 4 | Ece1-III62–93 is required for C. albicans 
mucosal infection. a, Fungal burdens recovered from the tongues of  
mice infected with C. albicans wild-type (BWP17 + CIp30) (number of 
mice (n) =  13), ECE1-deletion (ece1∆/∆) (n =  20), ECE1 re-integrant  
(ece1∆/∆ + ECE1) (n =  24) and Ece1-III62–93 deletion (ece1∆/∆ + 
ECE1∆184–279) (n =  10) strains after 2-day oropharyngeal infection.  
b, Average percentage of the entire tongue epithelium area infected in 
different groups of mice infected with the different C. albicans strains.  
c, Confocal imaging of 4 dpf zebrafish swimbladders infected with  
C. albicans Ece1-III62–93 deletion (ece1∆/∆ + ECE1∆184–279 + dTomato) 
and ECE1 re-integrant (ece1∆/∆ + ECE1 + dTomato) strains for 24 h 
stained with the fluorescent exclusion dye Sytox Green. C. albicans cells 
appear red and damaged cells appear green. White dots outline the 
pronephros and red dots outline the swimbladder. Images are composites 
of maximum projections in the red and green channels (25 slices each, 
approximately 100 µm depth) with (left) or without (right) a single slice in 
the DIC channel overlay. Scale bars (bottom right) represent 100 µm. Data 
shown are the mean (a, b) or representative (c), of at least three biological 
replicates. Error bars show ±  s.e.m. Data were analysed by Mann–Whitney 
U-test. **P <  0.01, ***P <  0.001.
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Extended Data Figure 5 | See next page for caption.
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Extended Data Figure 5 | Ece1-III62–93 is a cytolytic α-helical peptide. 
a, Circular dichroism spectra showing the α-helical conformation of 
Ece1-III62–93 in buffer (100 mM KCl, 5 mM HEPES, pH 7). Increasing the 
temperature from 25 °C to 40 °C did not affect the stability of the α-helical 
structure. b, Diagram to illustrate the amphipathic nature of Ece1-III62–93 
(residues 62–78, left panel; residues 79–93, right panel). Residues with 
hydrophobic or polar/charged side chains are displayed with a blue and 
white background, respectively. Modified from output generated in 
PEPWHEEL (http://emboss.bioinformatics.nl/cgi-bin/emboss/pepwheel). 
c, Förster resonance energy transfer (FRET) experiments show the 
intercalation of Ece1-III62–93 into lipid liposomes (10 µM) composed 
of DOPC in the absence or presence of cholesterol. Peptide titration of 
Ece1-III62–93 to liposomes showed slightly enhanced intercalation for 
pure DOPC. d, Ece1-III62–93 induced the permeabilization of planar lipid 
membranes composed of DOPC. The graph shows heterogeneous and 
transient lesions leading finally to a rupture of the membrane. Ece1-III62–93 
concentration was 0.125 µM. e, Induction of p-MKP-1 and c-Fos 2 h in 
TR146 cells post stimulation (p.s.) with Ece1-III62–93KR or Ece1-III62–93AA. 
f, Secretion of G-CSF from TR146 cells 24 h p.s. with Ece1-III62–93KR or 
Ece1-III62–93AA. Data shown are representative (a–e) or mean (f) of at least 
three biological replicates. Error bars show ±  s.e.m. Data were analysed by 
one-way ANOVA (f). *P <  0.05, **P <  0.01, ***P <  0.001 (compared with 
vehicle control). For gel images, see Supplementary Fig. 1.
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Extended Data Figure 6 | Schematic of the role of Ece1-III in  
C. albicans infection of epithelial cells. a–h, During early stage infection 
of the mucosal surface by C. albicans, Ece1-III (red α-helix) is secreted 
into the invasion pocket created by the invading hypha (a), Sub-lytic 
concentrations of Ece1-III trigger epithelial signal transduction through 
MAPK, p38/MKP-1 and c-Fos (b), resulting in the production of immune 
regulatory cytokines (c), As the severity of the infection increases, Ece1-III 
accumulates (d), and once lytic concentrations are reached, causes 
membrane damage and the release of lactate dehydrogenase from the 
host epithelium (e), concomitant with calcium influx (f). Epithelial signal 
transduction is maintained (g), and additionally induces the release of 
damage associated cytokines, such as IL-1α (h). Ece1-III may also have 
activity on the epithelial surface outside of the invasion pocket and on 
neighbouring cells not in contact with hyphae if Ece1-III is produced in 
sufficient concentrations.
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Extended Data Table 1 | C. albicans strains used in this study
References 52–108 are cited in this table.
*Morphology recorded 2 h post-infection on TR146 buccal cell monolayers; hyphae includes pseudohyphae.
†Data based on western blotting.
‡Cytokines include IL-1α, IL-6 and G-CSF.
§Damage measured by LDH assay.
|| New ece1∆/∆ also created in this study (see Extended Data Table 2). Original mutant (in red) produced by ref. 27 using the URA-blaster protocol3. A set of ece1 mutants, including partial deletion of 
ECE1 and a revertant, was produced in this study in the same genetic background using strain BWP17 to avoid a URA3 effect based on genomic location109,110.
¶Partial activation is due to lack of adhesion.
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Extended Data Table 2 | C. albicans mutant strains constructed and used in this study
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Extended Data Table 3 | LC-MS/MS analysis of C. albicans Ece1-III
*The number of peptide spectrum matches. Data for ece1∆/∆ and ece1∆/∆ + ECE1∆184–279 are not included as no Ece1-III peptides were detected in either strain, as expected.
†Percentage of SIIGIIMGILGNIPQVIQIIMSIVKAFKGNK or SIIGIIMGILGNIPQVIQIIMSIVKAFKGNKR detected amongst all Ece1-III peptides found by LC-MS/MS.
‡Percentage of SIIGIIMGILGNIPQVIQIIMSIVKAFKGNK or SIIGIIMGILGNIPQVIQIIMSIVKAFKGNKR detected amongst all Ece1p peptides found by LC-MS/MS.
§n/d; not detected.
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Extended Data Table 4 | Oligonucleotide primers used in this study
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